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Kurzfassung 
Carolina Martínez Lamenca 
„Synthese von neuen dioxatricyclische Oxetanen and Aza-Analoga von dem marinen 
Naturstoff Dictyoxetan“ 
Das dioxatricyclische Grundgerüst des Dictyoxetans und verwandte Strukturen besitzen ein 
hohes pharmakologisches Potential. In der vorliegenden Arbeit wurden dioxatricyclische 
Oxetane und Aza-Analoga der Dictyoxetan synthetisiert. 
Oxygenierte 2,7-Dioxatricyclo[4.2.1.03,8]nonane wurden ausgehend von 8-
Oxabicyclo[3.2.1]oct-6-en-3-on mit verschiedenen Estergruppen am C3-Kohlenstoffatom 
dargestellt. Das Pivaloat erwies sich als die beste Schutzgruppe. Die Verwendung eines 
deoxygenierten Dioxatricyclus führte zu Oxetan und tricyclischen Fünfring-Ethern. 
Die Verkürzung der Synthese von Dioxatricyclen wurde mittels einer Lewissäure-induzierten 
Tandem Entschützungs-Cyclisierungs-Reaktion versucht, was zum Oxetan (4-exo-tet) und zu 
tricyclischen Ethern (5-exo-tet) führte. Im Gegensatz dazu ermöglichte die Umsetzung mit 
BCl3 die Synthese von 2,6-Dioxatricyclo[3.3.1.03,7]nonanen mit dem Grundgerüst der TXA2-
Analoga. 
Die Einführung eines Bromoisoxazolins am C3-Kohlenstoffatom wurde mittels einer 1,3-
dipolaren Cycloaddition vor dem Ringschluss zum Oxetan versucht. Die Addition von 
Nitriloxid mit oxabicyclischen Dialkenen lief chemoselektiv an der endocyclischen 
Doppelbindung ab, während die Epoxidierung ein Gemisch von Epoxid und Bisepoxid ergab. 
Durch quantitative PCC Oxidation von tricyclischen Epoxyalkoholen und einer Grignard-
Reagenz-induzierten Tandem-Additions-Cyclisierungs-Reaktion wurden C2-alkylierte 
tricyclische Oxetane generiert. 
Nach einer sechs-stufigen Synthese wurden Aza-Analoga von Dictyoxetan ausgehend von 
funktionalisierten 8-Oxabicyclo[3.2.1]oct-6-en-3-on dargestellt. Die Sequenz aus reduktive 
Aminierung mit nachfolgender Cyclisierung ergab ausgehen von den Epoxyketonen 
tricyclischen Azetidine, die Vorläufer von Aminoglykoside sind. 
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Abstract 
Carolina Martínez Lamenca 
“Synthesis of New Dioxatricyclic Oxetanes and Aza-analogues of the Marine Natural Product 
Dictyoxetane” 
The dioxatricyclic core of dictyoxetane and structurally related segments are potential 
pharmacologically active compounds. In this PhD thesis, highly functionalized dioxatricyclic 
oxetanes and aza-analogues of dictyoxetane were synthesized. 
New oxygenated 2,7-dioxatricyclo[4.2.1.03,8]nonanes were prepared starting from 8-
oxabicyclo[3.2.1]oct-6-en-3-one. After some tuning of the oxygen protecting group at carbon 
C3, pivaloyl protection proved to be more advantageous in terms of yield and stability. 
Synthesis of deoxygenated dioxatricycle led to oxetane and more stable bistetrahydrofuran. 
Shortening of the synthetic route towards dioxatricyclic compounds by tandem Lewis acid-
catalyzed debenzylation-cyclization reaction afforded oxetanes (4-exo-tet) and tricyclic ethers 
(5-exo-tet). In contrast, the tandem strategy using BCl3 provided 2,6-
dioxatricyclo[3.3.1.03,7]nonanes as TXA2-analogues. 
The introduction of a highly versatile isoxazoline ring at carbon C3 was attempted by 1,3-
dipolar cycloaddition before the oxetane ring closure. Addition of bromonitrile oxide to 
oxabicyclic dialkenes occurred selectively on the endocyclic double bond while epoxidation 
proceeded non-selectively on both double bonds. 
After quantitative PCC oxidation of tricyclic epoxy alcohols and tandem Grignard reagent-
mediated addition-cyclization reaction, C2-arylated and alkylated oxatricyclic oxetanes were 
synthesized. 
Aza-analogues of dictyoxetane were prepared following a short and efficient route starting 
from functionalized 8-oxabicyclo[3.2.1]oct-6-en-3-ones. Tandem reductive amination-
cyclization reaction of epoxy ketones afforded highly functionalized tricyclic azetidines 
which are potential bioactive compounds and precursors of a wide variety of derivatives 
including azaglycosides. 
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Preliminary Remarks 
The stereochemical notation in the present work follows the convention proposed by H. 
Maehr.1 Bold and hashed wedges indicate absolute configuration. Bold and hashed lines 
represent relative configuration of racemic compounds. 
O
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HO
OMe
(+)-113
O
O
HO
OMe
rac-58
 
Oxabicycles, dioxatricycles and oxaazatricycles are named according to the IUPAC rules.2  
The numeration of oxabicycles follow the IUPAC regulations. For the sake of clarity the 
oxabicyclic atom numbering is maintained in dioxatricycles and oxaazatricycles. 
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Background and Overview 
1. Introduction 
Plant-based medicines have been used since prehistoric times and are still being used by a 
large part of the world population either in traditional (e.g. Chinese) or alternative medicine 
(in developed countries). Natural products have also been the basis for many pharmaceutical 
drugs in the past and their future importance is out of question, being one of the reasons why 
biological diversity has attracted such international attention in the last few decades. Even 
though Brazil and India are usually quoted as being hotspots of biodiversity,3 the oceans could 
easily rival them in terms of both biological and chemical diversity. Marine animals, algae, 
fungi and bacteria exhibit not only unusual and beautiful chemical structures, but these often 
show exceptional levels of biological activity combined with unique modes of action. 
Obviously, marine natural products have a great potential of yielding lead compounds for the 
development of new generation pharmaceuticals whose novel activity could lessen such 
problems as the antibiotic resistance in bacteria and fungi or the multi-drug resistance (MDR) 
in cancer chemotherapy. 
In order to fully develop the potential of a natural product, enough quantities of the compound 
must be available for the initial evaluation. This is where total synthesis offers two major 
advantages: produces useful quantities of the target compound and allows synthetic analogues 
that might be even more interesting than the natural product itself. 
1.1 Naturally Occurring Oxetanes 
Several important naturally occurring compounds enclose the oxetane ring, which is difficult 
to build by standard chemical reactions. Examples include taxol® (a potent anti-cancer drug), 
oxetanocin (anti- AIDS activity) and thromboxane A (the counterpart of the prostaglandins) 
(see Scheme 1). 
                                                 
3
 “Biodiversity.” Wikipedia. 2004. 17 June 2004 <http://en.wikipedia.org/wiki/Biodiversity>. 
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The marine natural product dictyoxetane 1 has been isolated from the brown algae Dictyota 
dichotoma and is structurally related to the class of diterpenoid dolabellanes,4 which show a 
wide spectrum of biological activities. The compact molecule of dictyoxetane 1 encloses a 
small ring ether (n=4), three normal ring ethers (n=5-7) and even a medium ring diether 
(n=8), a 1,4-dioxacyclooctane. Such an intricate dioxatricyclic framework has not been 
encountered in any other natural product. A biogenetic pathway has been suggested for 
dictyoxetane 1 from a known dolabellane metabolite supported by the experimental 
introduction of the oxetane moiety in vitro.2 
A potent anti-cancer drug and naturally occurring oxetane is paclitaxel (taxol)5 3, a tricyclic 
diterpene (C20) isolated from the bark of the western yew (Taxus brevifolia),6 a slow-growing 
tree found in the Pacific Northwest forests. Paclitaxel 3, considered a prototype for new 
chemotherapeutic agents,7 shows high activity against different tumor types like mama or 
ovarian cancer. In contrast to other microtubule antagonists, paclitaxel promotes microtubule 
assembly, rather than disassembly. The increase of tubulin’s polymerization and the 
consequent stabilization of microtubules cause disruption of mitosis. The oxetane ring seems 
to be essential for its biological activity.8 One of the major problems with the development of 
paclitaxel 3 as a chemotherapeutic agent has been the supply. It is only isolated from the 
Pacific yew tree, despite its low content (100 mg/kg of dry bark). Therefore, other sources has 
been investigated, like for instance, the synthesis from natural precursor. An example is 
baccatin III, whose precursor can be isolated from the needles of several types of yews, 
including some ornamental yews. 
The counter part of the prostaglandins, thromboxane A2 (TXA2) 3, has a bicyclic oxane-
oxetane structure. It is synthesized predominantly by platelets to promote vasoconstriction 
and platelet aggregation. With a half-life of thirty seconds, TXA2 is an unstable intermediate 
between prostaglandin endoperoxides and inactive thromboxane B2 (TXB2).9 
                                                 
4
 a) Pullaiah, K. C.; Suprapaneni, R. K.; Rao, C. B.; Albizati, K. F.; Faulkner, D. J.; Cunheng, H.; Clardy, J. J. Org. Chem. 1985, 50, 3666; b) 
Pullaiah, K. C.; Suprapaneni, R. K.; Rao, C. B.; Albizati, K. F.; Faulkner, D. J.; Cunheng, H.; Clardy, J. J. Org. Chem. 1986, 51, 2736. 
5
 Paclitaxel is the generic name for Taxol®, which is now a registered trademark. 
6
 Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. J. Am. Chem. Soc. 1971, 93, 2325. 
7
 a) Taxol Science and Applications; Suffnes, M., Ed.; CRC Press: Boca Raton, 1995; b) The Chemistry and Pharmacology of Taxol and Its 
Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995; c) Paclitaxel in Cancer Treatment; McGuire, W. P., Rowinski, E. K., Eds.; Marcel 
Dekker: New York, 1995. 
8
 Wang, M.; Cornett, B.; Nettles, J.; Liotta, D. C.; Snyder J. P. J. Org. Chem. 2000, 65, 1059. 
9
 a) New Synthetic Routes of Prostaglandins and Thromboxane; Roberts, S. M., Scheimann, F., Eds.; Academic Press: London, 1982; b) 
Hamman, P. R.; Still, W. C. J. Am. Chem. Soc. 1985, 107, 6372; c) Corey, E. J. Angew. Chem. Int. Ed. Eng. 1991, 30, 455. 
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Another example of natural product containing an oxetane ring is pennigritem 4, a toxin 
isolated from Penicillium nigricans and related to the family of penitrems. The penitrems 
belong to the tremorgenic mycotoxins and have been isolated from the ergot fungus 
Penicillium crustosum. Penitrems intercede in amino-acid neurotransmitter-release 
mechanisms. These toxins induce an excessive release of neurotransmitters into the synaptic 
cleft and over stimulate the receptors on the postsynaptic membrane. 
OO
OH
1    Dictyoxetane
N
N N
N
O
CH2OH
CH2OH
NH2
5   Oxetanocin A
O
COOH
NH2
6   Oxetin
O
OAcAcO O
O
O
OH
NH
Ph
Bz
HO OAcOBz
H
2    Paclitaxel
OH
O
7  "oxatricyclic norbornane"
O
O
(CH2)3CO2H
C5H11
OH
3   Thromboxane A2 (TXA2)
N
H O
H
OH
H
Cl
O H
OH
O
4   Pennigritem
O
 
Scheme 1: Natural products containing an oxetane ring. 
Oxetanocin A 5 is a potent antiviral antibiotic, formally a nucleoside with an oxetanosyl-N-
glycoside, which has been isolated from a culture filtrate from Bacillus megaterium.10 Natural 
occurring oxetanocin A 5 and its synthetic derivatives are reverse transcriptases of retrovirus 
and therefore potential drugs for the treatment of AIDS,11 cytomegalovirus (CMV),12 hepatitis 
B-virus and herpes simplex-virus (HSV-1 and HSV-2). 
                                                 
10
 Shimada, N.; Hasegawa, S.; Harada, T.; Tomisawa, T.; Fujii, A.; Takita, T. J. Antibiotics 1986, 39, 1623. 
11
 a) Jacobo-Molina, A.; Ding, J.; Nanni, R. G.; Clark, A. D.; Lu, X.; Tantillo, C.; Williams, R. L.; Kamer, G.; Ferris, A. L.; Clark, P.; Hizi, 
A.; Hughes, S. H.; Arnold, E. Proc. Natl. Acad. Sci. 1993, 90, 6320; b) Arnold, E.; Ding, J.; Hughes, S. H.; Hostomsky Z. Curr. Opin. Struct. 
Biol. 1995, 5, 27. 
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Another naturally occurring oxetane is oxetin 6, an amino acid-antimetabolite produced by a 
fermentation broth of a Streptomyces sp. It can inhibit the growth of Bacillus subtilis and 
Piricularia oryzae.13 Oxetin also exhibits herbicidal activity and is a non-competitive 
inhibitor of glutamine synthetase. 
Finally, oxatricyclic “norbornane” 7 is a potent herbicide and plant growth regulator.14 
1.2 Naturally Occurring Azetidines 
The azetidine ring is a rare structure that has been identified in few natural products 
comprising significant biological activity like (S)-azetidine-2-carboxylic acid (proline 
antagonist) or penaresidines (azetidine alkaloids).15 
A first example of naturally occurring azetidine is (S)-azetidine-2-carboxylic acid (AZC) 9 
which found in roots and leaves of some species of the Liliaceae, like lily-of-the-valley 
(Convallaria majalis), and also in seeds of some legumes like Clavaria miyabeana.16 This L-
proline analogue is a competitive inhibitor of the proline transport system. In other words, 
AZC is integrated into proteins competitively with L-proline and induces the synthesis of 
abnormal misfolded proteins, thus inhibiting cell growth in both bacterial and animal cells. 
Azetidine alkaloids are rare substances mostly found in nature as sphingosine-like compounds 
containing an azetidin-3-ol nucleus.17 Penaresidin A 10 and B 11 and penazetidin A 12 are 
original azetidine alkaloids isolated from the marine sponges Penares sp.18 and Penares 
sollasi,19 respectively. Penaresidin A 10 and B 11 have shown potent actomyosin ATPase-
                                                                                                                                                        
12
 a) Nishiyama, Y.; Yamamoto, Y.; Yamada, Y.; Daikoku, T.; Ichikawa, T.; Takahashi, K. J. Antibiotics 1989, 52, 1854; b) Braitman, A.; 
Swerdel, M. R.; Olsen, S. J.; Tuomari, A. V.; Lynch, J. S.; Blue, B.; Michalik, T.; Field, A. K.; Bonner, D. P.; Clark, J. M. Antimicrob. 
Agents Chemother. 1991, 35, 1464. 
13
 a) Omura, S.; Murata, M.; Imamura, N.; Iwai, Y.; Tanaka, H.; Furusaki, A; Matsumoto, T. J. Antibiot. 1984, 37, 1324; b) Kawahata, Y.; 
Takatsuto, S.; Ikekawa, N.; Murata, M.; Omura, S. Chem. Pharm. Bull. 1984, 34, 3102; c) Shimada, N. J. Antibiot. 1988, 41, 1868; d) Greco, 
F. A. J. Nat. Prod. 1991, 54, 207; e) Betina, S. chap. 16, Chem: Express: 1992, 8, 177; f) rac-oxetin: Bach, T.; Schroeder, J. Liebigs 
Ann./Recueil 1997, 11, 2265; g) Bach, T.; Bergmann, H.; Brummerhop, H.; Lewis, W.; Harms, K. Chem. Eur. J. 2001, 7, 4512 and 
references therein; h) Griesbeck, A. G.; Bondock, S.; Gudipati, M. S. Angew. Chem. Int. Ed. Engl. 2001, 40, 4684 and preceding work. 
14
 Soloway, S. B.; Vogel, P.; Le Drian, C. H. A.; Powell, J. E. U.S. Patent 916 334, 1986; Eur. Pat. Appl. 87201907.87201900, 1987. 
15
 de Kimpe, N. Comprehensive Heterocyclic Chemistry; Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Elsevier Science Ltd.: 
Oxford, 1996; p. 507. 
16
 Burkhard Fugmann, B.; Lang-Fugmann, S.; Steglich, W. Römpp-Lexikon Naturstoffe; Georg Thieme Verlag: Stuttgart, 1997. 
17
 Kobayashi, J.; Ishibashi, M.; Walchli, M. R.; Yamamura, S.; Ohizumi, Y. J. Chem. Soc. Heterocycles 1996, 42, 943. 
18
 Kobayashi, J.; Cheng, J.; Ishibashi, M.; Walchli, M. R.; Yamamura, S.; Ohizumi, Y. J. Chem. Soc., Perkin Trans. 1 1991, 1135. 
19
 Alvi, K. A.; Jaspars, M.; Crews, P. Bioorg. Biomed. Chem. Lett. 1994, 4, 2447. 
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activating activity,18 while penazetidin A 12 exhibits protein kinase C inhibitory activity.19 In 
view of their unusual structure and pharmacological properties, several reports on the 
synthesis of these azetidine alkaloids and structural analogues have emerged in the 
literature.20 
An azetidine ring system is also present in polyoxin A 13. It belongs to a class of peptidyl 
nucleoside antibiotics and has been isolated from cultures of Streptomyces cacaoi var. 
asoensis.21 Structurally, polyoxins include two distinct structural components: the right hand 
side is a nucleoside fragment and the left hand side is the peptidyl region. These natural 
products inhibit the synthesis of chitin, an essential component of the cell wall. As a result, 
these antibiotics are active against various fungi like the phytopathogenic fungus Pellicularia 
filamentosa f. sasakii, which causes sheath blight disease of rice plants, or the human 
pathogenic fungus Candida albicans.22 Polyoxins have been widely used as efficient 
agricultural fungicides in Japan since 1966. 
Mugineic acid 14 and nicotinamine (NA) 15 are naturally occurring azetidines ubiquitously 
present in graminaceous plants. Nicotianamine 15, a chelator of various transition metals, is 
the direct precursor of phytosiderophores like mugineic acid 14, an amino acid secreted from 
the roots to solubilize ferric iron from the root environment under conditions of iron 
deficiency. 
An example of azetidine antibiotic is antibiotic FR-29038 16, one of a number of structurally 
similar antibiotics isolated from cultures of Nocardia uniformis subsp. tsuyamanensis. It has 
been found to be effective against Bacillus, Escherichia, Klebsiella, Pseudomonas, 
Salmonella and Shiguella species.23 
                                                 
20
 For reported synthesis of azetidine alkaloids and analogues: a) Hiraki, T.; Yamagiwa, Y.; Kamikawa, T. Tetrahedron Lett. 1995, 36, 4841; 
b) Takikawa, H.; Maeda, T.; Mori, K. Tetrahedron Lett. 1995, 36, 7689; c) Yoda, H.; Oguchi, T.; Takabe, K. Tetrahedron: Asymmetry 1996, 
7, 2113; d) Yashima, A.; Takikawa, H.; Mori, K. Liebigs Ann. 1996, 7, 1083; e) Mori, K. J. Heterocyclic Chem. 1996, 33, 1497; f) Yoda, H.; 
Oguchi, T.; Takabe, K. Tetrahedron Lett. 1997, 38, 3283; g) Knapp, S.; Dong, Y. Tetrahedron Lett. 1997, 38, 3813; h) Takikawa, H.; Maeda, 
T.; Seki, M. J. Chem. Soc., Perkin Trans. 1 1997, 2, 97; i) Lin, G. Q.; Liu, D. G. Heterocycles 1998, 47, 337; j) Lin, G. Q.; Liu, D. G. 
Tetrahedron Lett. 1999, 40, 337; k) Salgado, A.; Boeykens, M.; Gauthier, C.; Declercq, J.; De Kimpe, N. Tetrahedron 2002, 58, 2763; l) 
Yoda, H.; Uemura, T.; Takabe, K. Tetrahedron Lett. 2003, 44, 977; m) Salgado, A.; Boeykens, M.; Gauthier, C.; Dejaegher, Y.; Verniest, G.; 
Lopin, C.; Tehrani, K. A.; De Kimpe, N. Tetrahedron 2003, 59, 2231. 
21
 Suzuki, S.; Isono, K.; Nagatsu, J.; Mizutani, T.; Kawashima, Y.; Mizuno, T. J. Antibiot. 1965, 131. 
22
 For reviews, see: a) Isono, K. J. Antibiot. 1988, 41, 1711; b) Garner, P. Synthetic approaches to complex nucleoside antibiotics. In Studies 
in Natural Products Chemistry. Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1988; Stereoselective synthesis (Part A), Vol. 1, 397; c) Isono, 
K. Pharmacol. Ther. 1991, 52, 269; d) Knapp, S. Chem. Rev. 1995, 95, 1859; e) Zhang, D.; Miller, M. J. Curr. Pharm. Design, 1999, 5, 73. 
23
 Glasby, J. S. Encyclopedia of Antibiotics; Wiley: Chichester, 1979. 
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Scheme 2: Natural products containing an azetidine ring. 
In a greater extent, ß-lactam antibiotics also contain an azetidine ring system.24 Antibiotics are 
specific chemical substances derived from living organisms capable of destroying bacteria 
through the inhibition of the synthesis of the bacterial cell wall. In addition to their 
bactericidal action, many antibiotics are also capable of inhibiting tumor cell growth by DNA 
intercalation. These antibiotics possess very low toxicity and new semisynthetic or total 
synthetic derivatives with an enhanced spectrum of biological activites have been developed 
                                                 
24
 For reviews on ß-lactams, see: a) The Chemistry of ß-Lactams; Page, M. I., Ed.; Blackie Academic & Professional: New York, 1992; b) 
Chemistry and Biology of ß-Lactam Antibiotics; Morin, R. B., Gorman, M., Eds.; Academic: New York, 1982; Vol. 1; c) The Organic 
Chemistry of ß-Lactams; Georg, G. I., Ed.; VCH: New York, 1993; d) Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. 
W., Scriven, E. F. V., Eds.; Pergamon: New York, 1996; Vol. 1B, Chapters 1.18-1.20; e) Synthesis of ß-Lactam Antibiotics; Bruggink, A., 
Ed.; Kluwer: Dordrecht, Netherlands, 2001; f) Ojima, I.; Delaloge, F. Chem. Soc. Rev. 1997, 26, 377; g) Ojima, I. Acc. Chem. Res. 1995, 28, 
383. 
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continuously. Over 3,000 antibiotics have been identified but only a few dozen are used in 
medicine.25 
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Scheme 3: ß-Lactam antibiotics. 
These ß-lactam antibiotics share beta-lactam ring which is essential for the bactericidal 
activity. According to their structure ß-lactam antibiotics can be classified into penicillins 17, 
cephalosporins 18, carbapenems 19, clavams 20 and monolactams – monobactams 21 and 
norcardicines 22 (see Scheme 3).26 
                                                 
25
 Kuhn, D.; Coates, C.; Daniel, K.; Chen, D.; Bhuiyan, M.; Kazi, A.; Turos, E.; Dou, Q. P. Frontiers in Bioscience, 2004, 9, 2605. 
26
 Gunda, T. E. “On the ß-Lactam Antibiotics.” 1 June 2004 <http://www.cic.klte.hu/~gundat/betalaca.htm>. 
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2. Literature Review 
2.1 Dioxatricyclic Subunits of Dictyoxetane 
Research on the total synthesis of dictyoxetane 1 has focused on the synthesis of the 
oxatricyclic substructure 23, the 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonane (see 
Scheme 4). Three strategies have been published for the synthesis of this oxatricyclic skeletal 
structure. In 1995, J. Reinecke and H. M. R. Hoffmann reported the first synthesis of a 2,7-
dioxatricyclo[4.2.1.03,8]nonane27 (see Section 2.1.1). A second strategy appeared one year 
later by Heathcock et al.28 (see Section 2.1.2). In 1998, J. Wittenberg and H. M. R. Hoffmann 
presented an improved de novo synthesis of deoxygenated and oxygenated dioxatricyclic 
segments with cytostatic activity towards tumor cells (see Section 2.1.3).29 Following the 
same strategy, S. Proemmel and H. M. R. Hoffmann published the synthesis of new 
dioxatricyclic compounds in 2002 (see Section 2.1.4).30 Amongst the reported oxetanes, one 
showed cytostatic activity towards tumor cells. More recently, M. Vidal Pascual synthesized a 
series of new ether substituted dioxatricyclononanes (see Section 2.1.5).31 
O
OOO
OH
1     Dictyoxetane
(relative stereochemistry)
23    dioxatricyclic core
[4.2.1.03,8]
O
O
 
Scheme 4: Dioxatricyclic core 23 from of dictyoxetane 1. 
2.1.1 Synthetic Strategy by J. Reinecke 
The first strategy towards the synthesis of the dioxatricyclic framework 23 was designed 
starting from 2,5-dimethyl-8-oxabicyclo[3.2.1]ketone 25, a valuable synthetic building block 
                                                 
27
 a) Reinecke, J. PhD Thesis, Universität Hannover, 1994; b) Reinecke, J.; Hoffmann, H. M. R. Chem. Eur. J. 1995, 1, 3682. 
28
 Marshall, K. A.; Mapp, A. K.; Heathcock, C. H. J. Org. Chem. 1996, 61, 9135. 
29
 a) Wittenberg, J. PhD Thesis, Universität Hannover, 1998; b) Wittenberg, J.; Beil, W.; Hoffmann, H. M. R. Tetrahedron Lett. 1998, 39, 
8259. 
30
 Proemmel, S.; Wartchow, R.; Hoffmann, H. M. R. Tetrahedron 2002, 58, 6199. 
31
 Vidal Pascual, M. PhD Thesis, Universität Hannover, 2003. 
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for the synthesis of several natural products.32 [4+3] Cycloaddition between a furan ring and 
an oxyallyl cation offers rapid access to functionalized seven-membered carbocycles with and 
oxygen bridgehead, which already contain two of the three rings of the skeletal structure 2,7-
dioxatricyclo[4.2.1.03.8]nonane 23.33 
O
Br
Br
Br
Br
O
O
1) 2,5-Dimethylfuran,
B(OEt)3, Zn, THF, rt
2) Zn/CuCl, NH4Cl, 15°C-rt,
MeOH, 59% (over 2 steps)
24 25
 
Scheme 5: Synthesis of 1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one 25 by J. Reinecke. 
1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one 25 was prepared by the ethyl borate method 
introduced by Hoffmann and Iqbal from 2,5-dimethylfuran and 1,1,3,3-tetrabromo-2-
propanone in 59% overall yield (see Scheme 5). Stereoselective reduction of oxabicyclic 
ketone 25 with diisobutylaluminium hydride (DIBAH) afforded the endo-alcohol, which was 
converted into the mesylate and then subjected to a combined hydroboration/oxidation to give 
ketomesylate 26 (see Scheme 6). A base mediated elimination of ketomesylate 26 afforded 
the desired ketoolefin 27 as the major product (27:28 = 8:1). Moreover, the isomers 27 and 28 
were separable by column chromatography. Isolated olefin 27 was then converted into 
precursor 30 over six steps in 63% overall yield. Deprotection and cyclization of tosylate 30 
in a one-pot reaction proceeded well using tetrabutylammonium fluoride (TBAF) in the 
presence of molecular sieves. Dioxatricyclononane 31 was obtained as a volatile liquid in 
39% yield. The low yield may be due to the low boiling point of oxetane 31. 
                                                 
32
 [3.2.1]Oxabicycles as precursors in the synthesis of natural products, see: a) Weiss, J. M.; Hoffmann, H. M. R. Tetrahedron Asymmetry 
1997, 8, 3913; b) Nowakowski, M.; Hoffmann, H. M. R. Tetrahedron Lett. 1997, 38, 1001; c) Beck, H.; Hoffmann, H. M. R. Eur. J. Org. 
Chem. 1999, 2991; d) Dunkel, R.; Treu, J.; Hoffmann, H. M. R. Tetrahedron Asymmetry 1999, 10, 1539; e) Dunkel, R.; Hoffmann, H. M. R. 
Tetrahedron Asymmetry 1999, 10, 8385; f) Wolbers, P.; Hoffmann, H. M. R. Tetrahedron 1999, 55, 1905; g) Misske, A. M.; Hoffmann, H. 
M. R. Chem. Eur. J. 2000, 6, 3313; h) Montaña, A. M.; García, F.; Grima, P. M. Tetrahedron. Lett. 1999, 40, 1375; i) Montaña, A. M.; 
García, F.; Grima, P. M. Tetrahedron. Lett. 1999, 55, 5483; j) Rama Rao, A.V.; Yadav, J.S.; Vidyasagar, V. Chem. Comm. 1985, 55. 
33
 For reviews in [4+3]-cycloaddition, see: a) Hoffmann, H. M. R. Angew. Chem. 1973, 85, 877; b) Noyori, R.; Hayakawa, Y. Org. React. 
1983, 29, 163; c) Hoffmann, H. M .R. Angew. Chem. 1984, 96, 29; d) Mann, J. Tetrahedron 1986, 42, 4611; e) Hosomi, A.; Tominga, Y. 
Comprehensive Organic Synthesis; Trost, B. M.; Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol. 5, p. 593; f) Lautens, M. Top. Curr. Chem. 
Metz, P.; Ed.; Springer: Berlin, 1997, 190, 1; g) Rigby, J. H.; Pigge, F. C. Org. React. 1997, 51, 351. 
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Scheme 6: Synthesis of 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonane 31 by J. Reinecke. 
An alternative route to parent dioxatricycles 34 and 35 was also developed starting from 
ketoolefin 27 (see Scheme 7). Stereoselective reduction of the carbonyl group in oxabicycle 
27 with DIBAH followed by epoxidation furnished tricyclic epoxide 32 in 70% yield over 
two steps. On the other hand, alkylation of 27 with methylmagnesium bromide followed by 
epoxidation led to epoxide 33 in 32% yield over two steps. Both epoxides 32 and 33 
underwent a base-catalyzed intramolecular epoxide opening to give tricyclic oxetanes 34 and 
35 in 82 and 80% yield, respectively. Deoxygenation of hydroxyoxetane 34 was attempted by 
means of radical methodology but oxetane 31 was not isolated. On the contrary, the labile 
oxetane system did not resist the Barton-Mc. Combie reaction conditions. 
Tricyclic oxetane 34 was prepared not only under basic conditions but also under Lewis acid 
catalysis. Intramolecular epoxide opening of epoxy alcohol 32 with BF3·OEt2 proceeded 
unselectively affording tricyclic oxetane 34 and isomeric tetrahydrofuran 36 in 2:1 ratio (see 
Scheme 7). 
Finally, tricyclic oxetane 38 was afforded by inversion of the hydroxyl group at carbon C3 in 
hydroxyketone 34. PCC oxidation of alcohol 34 afforded ketooxetane 37, which was treated 
with BH3 at low temperature giving epimeric alcohol 38 as the major product (38:34 = 3.7:1) 
(see Scheme 7). 
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Scheme 7: Synthesis of substituted 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonanes 34, 35 and 38 by 
J. Reinecke. 
2.1.2 Synthetic Strategy by Heathcock et al. 
The second strategy for the synthesis of the tricyclic substructure of dictyoxetane was 
reported by Heathcock et al. in 1996.28 The method chosen to construct the basic carbon 
skeleton of the target compounds 31 and 45 was a dipolar cycloaddition of a 3-oxidopyrylium 
salt with acrylonitrile. 
The synthesis of intermediate bicyclic ketone 41 started from commercially available 5-
methylfurfural 39, which was treated with methyllithium followed by oxidative rearrangement 
using m-CPBA to give enone 40 in 85% yield. Reaction of acrylonitrile and hemiketal 40 in 
refluxing acetonitrile afforded desired cycloadduct 41 (see Scheme 8). 
O
O
OH
O
O
O
NC
O1) MeLi, THF,
-78°C-rt, 100%
2) m-CPBA, 
DCM, 85%
Acrylonitrile, MsCl,
(i-Pr)2EtN, CH3CN
reflux, 39%
39 40 41
 
Scheme 8: Synthesis of basic carbon skeleton by dipolar cycloaddition of an oxidopyrylium salt and 
acrylonitrile by Heathcock et al. 
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Starting from oxabicyclic ketonitrile 41 oxetane precursors 42 and 44 were prepared 
following two synthetic paths and the key intermediates are highlighted in Scheme 9. On the 
one hand, oxabicyclic alcohol 42 was obtained in 5% yield over eight steps. Treatment of the 
oxetane precursor 42 with NaH in refluxing THF furnished volatile oxatricyclic oxetane 31. 
Although the synthesized compound could not be isolated completely free of residual 
solvents, the 1H NMR spectrum of the product indicated the formation of tricyclic diether 31. 
Because of the high volatility of this compound, the model system was adjusted adding more 
molecular weight. Therefore, oxetane precursor 44 was prepared in 18% yield over eight 
steps. Mesylate 44 was cyclized under the same basic conditions affording oxatricyclic 
oxetane 45 in 88% yield. The synthesis of substituted dioxatricyclic oxetane 45 proceeded in 
better yields than that of the volatile oxetane 31. For this reason, the substituted tricyclic 
oxetanes are preferred for the total synthesis of dictyoxetane. 
O
NC
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HO
MsO
O
O
O
OMs
MeO Bu
MeO OH
O
O
BuMeO
MeO
8 steps
8 steps
NaH, THF, reflux
NaH, THF, reflux
88%
41 42, 5% 31
44, 18% 45
 
Scheme 9: Synthesis of substituted 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonanes 31 and 45 by 
Heathcock et al. 
2.1.3 Synthetic Strategy by J. Wittenberg 
The third strategy for the synthesis of the dioxatricyclic framework of dictyoxetane was 
reported by J. Wittenberg and H. M. R. Hoffmann.29 Deoxygenated and oxygenated 
dioxatricyclononanes were obtained following a shorter synthetic pathway starting from α-O-
benzylated oxabicyclo[3.2.1]ketone rac-49 (Scheme 10). 
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Scheme 10: Synthesis of 2α-benzyloxy-2,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one 49 by J. Wittenberg. 
Much of the research work associated with [4+3] cycloaddition has been focused on 
approaches to generate appropriate oxyallyl cations and a number of useful synthetic methods 
have emerged.33 The classic method developed by H. M. R. Hoffmann34 with a 
polyhalogenated ketone as precursor of the oxyallylcation was used by J. Reinecke to 
construct the starting material of the synthesis of tricyclic oxetanes 31, 34, 37 and 38 as 
mentioned in Section 2.1.1. In the strategy of J. Wittenberg, oxyallyl cations were generated 
from non-halogenated precursors (bis-benzyloxy silyl enol ether) as reported by Albizati et 
al..35 The advantage of this method is the introduction of a α-benzyl ether in the oxabicyclic 
skeletal structure offering a wide range of applications in the synthesis of natural products, 
particularly in the construction of tetrahydropyran units.36 
As outlined in Scheme 10, silyl enol ethers 47 and 48 were prepared from 1,1-bis-benzyloxy-
propan-2-one 46 using LDA and the corresponding trialkyl silyl chloride (kinetic method). 
Treatment of silyl enol ethers 47 and 48 with a catalytic amount of TMSOTf afforded oxyallyl 
cations, which reacted with the 4pi-component. The oxyallyl cation approaches both sides of 
the furan so that the 2α-benzyloxy-8-oxabicyclo[3.2.1]ketone rac-49 is obtained as a 
racemate.37 
                                                 
34
 Hoffmann, H. M. R. Angew. Chem. 1973, 85, 877. 
35
 Murray, D. H.; Albizati, K. F. Tetrahedron Lett. 1990, 29, 4109. 
36
 a) Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem. 1998, 110, 1337; b) Stark, C. B. W.; Pierau, S.; Wartchow, R.; 
Hoffmann, H. M. R. Chem. Eur. J. 2000, 6, 684; c) Misske, A. M.; Hoffmann, H. M. R. Tetrahedron 1999, 55, 4315; d) Beck, H.; Hoffmann, 
H. M. R. Eur. J. Org. Chem. 1999, 2991; e) Gaertzen, O.; Misske, A. M.; Wolbers, P.; Hoffmann, H. M. R. Synlett 1999, 1041; f) Misske, A. 
M.; Hoffmann, H. M. R. Tetrahedron 1999, 55, 4317. 
37
 Hoffmann, H. M. R. Angew. Chemie 1984, 96, 29; Angew. Chemie, Int. Ed. Engl. 1984, 23, 1. 
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In a first strategy, the synthesis of oxatricyclic oxetanes was attempted without modifying the 
carbonyl function at C3 position (see Scheme 11). Epoxidation of oxabicyclic ketone rac-49 
yielded a mixture of desired ketoepoxide 50 and lactone 51. Catalytic hydrogenolysis of 
isolated ketoepoxide 50 led to ketohydroxy alcohol 52. Afterwards the attempted 
intramolecular cyclization of oxetane precursor 52 to oxetane 53 under either basic or acid 
catalysis was not successful. Presumably the presence of the carbonyl group (sp2 carbon 
atom) in the oxabicycle increases the rigidity of the skeletal structure and the ring strain in the 
target molecule 53. 
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Scheme 11: First attempted strategy for the synthesis of oxygenated dioxatricycles by J. Wittenberg. 
Since the synthesis of tricyclic oxetane 53 was not feasible, a more efficient route was 
designed involving the stereoselective reduction of the carbonyl group in oxabicyclic ketone 
rac-49 with DIBAH (see Scheme 12). Oxygenated and deoxygenated oxatricyclic oxetanes 
were then obtained starting from endo-alcohol 54 (see Scheme 12 and Scheme 13). 
For the synthesis of oxygenated tricyclic oxetanes 58, 59 and 60, methyl ether was chosen as 
protecting group for the hydroxy group at carbon C3. Endo-alcohol 54 was converted into 
methyl ether 55 and then epoxidized. Resulting epoxide 56 underwent debenzylation and 
yielded the oxetane precursor 57. Following intramolecular cyclization of epoxy alcohol 57 
proceeded under basic conditions using potassium tert-butoxide in THF. Oxatricyclic 58 was 
afforded in 62% overall yield starting from oxabicyclic ketone rac-49 and in 33% overall 
yield starting from 1,1-bis-benzyloxy-propan-2-one 46. 
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Scheme 12: Synthesis of oxygenated oxatricyclic oxetanes 58, 59 and 60 by J. Wittenberg. 
Swern oxidation of dioxatricyclic oxetane 58 led to tricyclic oxetane 59. The oxetane ring in 
the tricyclic system showed stability upon treatment with Grignard reagents when ketone 59 
was converted stereoselectively into endo-configurated tertiary homo allylic alcohol 60. 
The synthesis of deoxygenated oxatricyclic oxetane 65 was successful following the Barton-
McCombie deoxygenation method, which was already used by J. Reinecke in a similar 
system.27a Deoxygenation was achieved prior to the formation of the oxetane ring by 
conversion of endo-alcohol 54 into S-methylthiocarbonate 61 followed by hydrogenation. 
Deoxygenated benzyl ether 62 was oxidized with m-CPBA and debenzylated to give oxetane 
precursor 64. Under Lewis acid catalysis, epoxy alcohol 64 underwent intramolecular 
cyclization affording oxetane 65 in 72% yield. Starting from 1,1-bis-benzyloxy-propan-2-one 
46, oxatricyclic oxetane 65 was obtained in 18% overall yield, lower than in the case of 
oxygenated oxetane 58. The higher hydrophilicity of deoxygenated oxatricycles as well as the 
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lower molecular weight explain the lower yields in the synthesis of the dioxatricyclic segment 
65.29a 
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Scheme 13: Synthesis of deoxygenated oxatricyclic oxetane 65 by J. Wittenberg  
The four dictyoxetane segments 58, 59, 60 and 65 showed cytostatic activity towards HMO 2 
and HEP G2 cell lines (see Section 2.1.6). 
2.1.4 New Dioxatricycles by S. Proemmel 
In 2002, S. Proemmel and H. M. R. Hoffmann reported progress on the synthesis of the 
dioxatricyclic substructure of dictyoxetane and its functionalization.30 The oxatricyclic 
framework was prepared starting from oxabicyclic ketone rac-49 as in the synthetic approach 
by J. Wittenberg. Pivaloate and benzoate were chosen to protect the hydroxy group at carbon 
C3 as an alternative to the more stable methyl ether, which need harsh conditions to be 
deprotected after the oxetane ring closure and leads to descomposition.29a 
Starting from cycloadduct rac-49, the ketone was reduced stereoselectively with DIBAH and 
the resulting hydroxy group was protected quantitative to afford pivaloate 66 and benzoate 67 
(see Scheme 14). Epoxidation of the homo allylic double bond followed by debenzylation led 
to oxetane precursors 68 and 69. The key intramolecular ring closure of epoxy alcohols 68 
and 69 was carried out under Lewis acid conditions using BF3·OEt2 in good yield. Starting 
from oxabicyclic ketone rac-49, benzoate substituted oxatricyclic oxetane 71 and pivaloate 70 
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were obtained in 38 and 42 % overall yield respectively. The tert-butyl ester as protecting 
group proved to be the best choice for preparing tricyclic oxetanes. 
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Scheme 14: Synthesis of ester substituted oxetanes 70 and 71, dioxatricyclic diol 72 and diketone 73 by 
S. Proemmel. 
After cyclization, the ester was cleaved reductively to tricyclic diol 72. In one-step, double 
oxidation of diol 72 yielded diketone 73. 
Further functionalization of the dioxatricyclic framework was carried out starting from 
pivaloate substituted oxetane 70 (see Scheme 15). Swern oxidation of the hydroxy group at 
carbon C6 afforded keto ester 74, which was reduced to epimeric alcohol 77. Wittig-
olefination of keto ester 74 led to exocyclic olefins 75 and 76. Olefin 75 was subjected to 
reductive cleavage of the pivaloate group and reprotection with TBSCl to give olefin 79, 
which is the starting material for further transformations, like for example, nitrile oxide 
cycloaddition (79→81) or oxidative cleavage to silyl protected keto alcohol 78 followed by 
conversion into alkynyl substituted alcohol 80. Remarkably, the pericyclic reaction as well as 
all the nucleophilic additions to the carbonyl group proceeded selectively from the exo face 
(trans to the oxetane oxygen), which appears to be more accessible. 
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Scheme 15: Functionalization of the dioxatricyclic framework by S. Proemmel. 
Following a similar route, the synthesis of aminated oxetane 84 was carried out starting from 
oxabicyclic ketone rac-49 (see Scheme 16). Reductive amination of the carbonyl group in 
ketone rac-49 was chosen as method to introduce an axial amino group at C3. The resulting 
amine was protected as N-benzamide 82 and then epoxidized and debenzylated to afford N-
benzoyl protected tricyclic precursor 83. Intramolecular cyclization of epoxy alcohol 83 
proceeded under mild conditions in 18% yield. Aminated oxetane 84 was prepared in 5% 
overall yield over five steps, much lower than in the case of oxygenated dioxatricyclic 
oxetanes 70 and 71 because of the lability of the N-benzamide group. 
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Scheme 16:  Synthesis of aminated oxetane 84 by S. Proemmel. 
Attempted synthesis of dioxatricyclic oxetanes with acyl protection of the 3-hydroxy group 
yielded a mixture of bistetrahydrofurans 86 and 87 in 3:2 ratio (see Scheme 17). Under the 
cyclization conditions, the acyl group migrated to the thermodynamically favored equatorial 
position at carbon C2 and the free hydroxy group at carbon C3 underwent a facile 5-exo-tet 
cyclization leading to compounds 86 and 87, which contains a noradamantane skeleton. 
O
OAc
O
HO
O
O
OH
OAc
OAc
O
OH
O
O
O
OBn
4 steps
BF3·OEt2, DCM, 
0°C, 69%
O
O
O
TBSO
O
O
OTBS
O
3  :  2
3 steps
85 86 87
88 89
rac-49
 
Scheme 17: Synthesis of tricyclic acetates 86 and 87 after migration of the acyl group and further 
functionalization by S. Proemmel. 
Amongst dictyoxetane segments 70, 71, 72, 73, 74, 75 and 76, only dioxatricyclic ester 76 
showed cytostatic but not cytotoxic activity towards tumor cells (see Section 2.1.6). 
2.1.5 New Ether Protected Dioxatricycles by M. Vidal Pascual 
Within the research work of M. Vidal Pascual, a series of ether protected oxatricyclic 
segments were prepared.31 Following the synthetic approach by J. Wittenberg, the oxatricyclic 
framework was also constructed by [4+3] cycloaddition using trialkylsilyloxyallyl cations but 
furan was chosen instead of 2,5-dimethylfuran. The resulting oxabicyclo[3.2.1]oct-6-en-3-one 
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rac-90 was the starting material for the synthesis of the dioxatricyclic oxetanes (see Scheme 
18). 
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Scheme 18: Synthesis of oxabicyclo[3.2.1]oct-6-en-3-one rac-90 by [4+3] cycloaddition. 
For the synthesis of oxabicyclic ketone rac-90 two different silyl enol ethers 47 and 48 were 
prepared from 1,1-bis-benzyloxy-propan-2-one 46.38 Triethylsilyl enol ether 47 was prepared 
from 1,1-bis-benzyloxy-propan-2-one 46 by the kinetic method using LDA in THF at –78°C. 
Trimethylsilyl enol ether 48 was prepared either by the kinetic method or by the 
thermodynamic method (triethylamine in DMF at 75°C). In this case, the resulting trimethyl 
silyl enol ether cannot be purified by column chromatography because of its acid sensitivity 
and the crude product was used directly in the [4+3] cycloaddition reaction. The trialkylsilyl 
oxyallyl cation with a pi-donating benzyloxy substituent was generated via treatment of 
triethylsilyl enolether with a catalytic amount of TMSOTf and following [4+3] cycloaddition , 
of the 4pi-component (furan) proceeded smoothly giving 2α-benzyloxy-8-
oxabicyclo[3.2.1]oct-6-en-3-one rac-90. 
A series of ether protected dioxatricyclic segments were obtained following a similar route as 
in the case of J. Wittenberg (see Scheme 19). Starting from oxabicyclic ketone rac-90 
tricyclic oxetanes 101, 102 and 103 were synthesized in 5 steps in 15, 7 and 6% overall yield 
respectively. The absence of methyl groups at the bridgehead carbon atoms and the higher 
hydrophilicity of these compounds may explain the lower yields comparing to their parent 
dioxatricycles prepared from oxabicycle rac-49. Further funtionalization of oxatricyclic 
skeletal structures 102 and 101 afforded ketone 104 and lactone 105. 
                                                 
38
 Vidal, M.; Martínez, C.; Hoffmann, H. M. R. Org. Synth. 2003 (submitted) and references therein. 
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Scheme 19: Synthesis of ether substituted oxatricyclic oxetanes 101, 102, 103 and 104 and lactone 105 
by M. Vidal Pascual. 
Epoxy alcohol 98 and oxetane 101 were tested towards tumor cells and did not show 
cytostatic or cytotoxic activity. 
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2.1.6 Enantioselective Synthesis of Dioxatricyclic Subunits of Dictyoxetane 
The synthesis of enantiopure dioxatricyclic subunits of dictyoxetane was reported by S. 
Proemmel and M. Vidal Pascual.39 The asymmetric [4+3] cycloaddition with chiral oxyallyl 
cations developed by Hoffmann et al.40 offered an efficient method for the enantioselective 
synthesis of oxabicycles. 
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Scheme 20: Diastereoselective asymmetric [4+3]cycloaddition to oxabicycles (+)-107 and (+)-109. 
Enantiomerically pure oxabicycles (+)-107 and (+)-109 were prepared by asymmetric [4+3] 
cycloaddition of furans to chiral silyloxyallyl cation generated from mixed acetal (R)-106 
following a low temperature protocol optimized by C. B. W. Stark (see Scheme 20).40 The 
resulting [4+3] cycloadducts were isolated in high enantiomeric purity. Asymmetric [4+3] 
cycloaddition using furan afforded oxabicyclic diastereomers (2R)-107 and (4S)-108 in a 7:1 
diastereomeric ratio and enantiopure oxabicycle (2R)-107 was isolated in 74% yield and in 
99% enantiomeric purity. In the case of 2,5-dimethylfuran, diastereoselectivity and chemical 
yield were lower owing to the presence of the methyl groups.30,41 Enantiopure oxabicycle 
(2R)-109 was isolated in 40% yield and in >97% enantiomeric purity. 
Enantiomerically pure oxabicyclic ketones (2R)-107 and (2R)-109 were the starting material 
of the enantioselective synthesis of dioxatricyclic segments oxetane (+)-113 and (+)-114. 
Following the same strategy as for the synthesis of methoxy substituted oxetanes 58 and 101, 
dioxatricyclic oxetane (+)-113 and (+)-114 were prepared in 14 and 63% overall yield (see 
                                                 
39
 Proemmel, S. PhD Thesis, Universität Hannover, 2001; Vidal Pascual, M. PhD Thesis, Universität Hannover, 2003. 
40
 a) Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem. 1998, 110, 1337; b) Pierau, S.; Hoffmann, H. M. R. Synlett 1999, 213; 
c) Stark, C. B. W.; Pierau, S.; Wartchow, R.; Hoffmann, H. R. M. Chem. Eur. J. 2000, 6, 684; d) Beck, H.; Stark, C. B. W.; Hoffmann, H. M. 
R. Org. Lett. 2000, 2, 883. 
41
 First diastereoselective asymmetric [4+3] cycloadditions with 2,5-dimethylfuran were carried out by S. Pierau, H. Beck und C. B. W. 
Stark. See: Beck, H.; Stark, C. B. W.; Hoffmann, H. M. R. Org. Lett. 2000, 2, 883. 
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Scheme 21). Higher yields were obtained for more sterically hindered (+)-114, presumably 
because of the stability conferred by the additional methyl groups and lower hydrophilicity of 
the compound. 
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Scheme 21: Synthesis of enantiopure oxatricyclic oxetanes (+)-113 and (+)-114 by M. Vidal Pascual 
and S. Proemmel. 
The anti-tumor activity of enantiopure oxetane (+)-114 was tested but it showed neither 
cytostatic nor cytotoxic activity towards tumor cells. 
2.1.7 Characterization of the Cytostatic and Cytotoxic Activity of Dioxatricyclic 
Segments 
The anti-tumor activity of several dioxatricyclic segments of dictyoxetane was investigated 
considering the pharmacological potential attributed to the strained oxetane ring.42 Five 
dioxatricycles have showed cytostatic activity towards tumor cells (see Scheme 22). 
The cytostatic and cytotoxic activity of these dioxatricyclic segments was tested in vitro, via 
the HMO 2 (human gastric carcinoma), the HEP G2 (human heptocellular carcinoma) and the 
MCF 7 (mamma carcinoma) cell lines.43,44 The antitumor activity was determined according 
to the NCI guidelines.45 
                                                 
42
 For the pharmacological potential of oxetane ring, see: a) Goez, C. E.; Wright, A. D.; König, G. M.; Sticher. O. Phytochem. Anal. 1994, 5, 
68; b) Rao, C. B.; Trimurtulu, G.; Sreedhara, C.; Rao, D. V.; Bobzin, S. C.; Faulkner, D. J. Phytochemistry 1994, 37, 509; c) König, G. M.; 
Wright, A. D. Tetrahedron 1994, 50, 8011; d) König, G. M.; Wright, A. D.; Fronczek, F. R. J. Nat. Prod. 1994, 57, 1529; e) Knops, L.; 
Nieger, M.; Steffan, B.; Steglich, W. Liebigs Ann. 1995, 77; f) Rodrigues, A. D. Tetrahedron 1995, 51, 4571, 4581; g) Corey, E. .; Kania, R. 
S. Tetrahedron Lett. 1998, 39, 741. 
43
 Pharmacological tests were carried out by Prof. W. Beil, Institut für Allgemeine Pharmakologie, Medizinische Hochschule Hannover. 
44
 Cytostatic activity means a preventive action on growth and proliferation of tumor cells. Cytotoxic effect means an attack and destroying 
action in the tumor cells. 
45
 Grever, M. R.; Schepartz, S. A.; Chabner, B. A. Semin. Oncol. 1992, 19, 622. 
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Scheme 22: Dioxatricyclic compounds with cytostatic activity towards tumor cells. 
The data obtained from the concentration-extinction curves of the pharmacological assays of 
dioxatricycles 58, 59, 60 and 65 are listed in Table 1. 
Compound Carcinoma type GI50a TGI50b LC50c 
58 HMO 2 3.0 57 >100 
 HEP G2 <0.1 45 >50 
59 HMO 2 <1.0 72 >100 
 HEP G2 <0.1 35 >50 
60 HMO 2 <1.0 54 >100 
 HEP G2 <0.1 30 >50 
65 HMO 2 4.0 50 >100 
 HEP G2 0.1 30 >50 
76 HMO 2 >50 >50 >50 
 
HEP G2 13 >50 >50 
 
MCF 7 10 >50 >50 
5-fluorouracil HMO 2 1.2 35 >50 
 
HEP G2 0.15 50 >50 
cis-platinum HMO 2 0.1 2.5 40 
 
HEP G2 0.5 30 >50 
Table 1: Antitumor activity (µmol/l) measured towards HMO 2, HEP G2 and MCF 7 cells. a) Drug 
concentration causing 50% growth inhibition; b) drug concentration causing 100% growth inhibition; c) drug 
concentration causing 50% reduction of the cells present at time point zero, i.e. at 24 h. 
The internal limiting values for the evaluation of cytotoxicity based on standard cytostatic 
agents (5-fluorouracil or cis-platinum) are outlined in Table 2. Comparison between Table 1 
and Table 2 indicates that all five substances 58, 59, 60, 65 and 76 showed anti-tumor 
activity. Four of these dictyoxetane segments, 58, 59, 60 and 65, showed cytostatic activity 
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towards HMO 2 and HEP G2 cell lines comparable to 5-fluorouracil, which is a well known 
metabolite capable of entering the synthesis and function of nucleic acids, similar to AZT, an 
anti-AIDS drug. The most potent substance towards the HMO 2 cell lines, dioxatricyclic 59, 
inhibited cell growth by 68% at 1µmol/l. On the other hand, dioxatricyclic ester 76 showed 
cytostatic activity towards HEP G2 and MCF 7. 
Evaluation of 
cytotoxicity 
 
good GI50 < 1 µmol/L + TGI < 5 µmol/L 
satisfactory GI50 < 5 µmol/L + TGI < 10 µmol/L 
weakly efficient GI50 < 10 µmol/L or TGI < 50 µmol/L 
inefficient GI50 > 10 µmol/L  
Table 2: Internal limiting values for the evaluation of cytotoxicity based on standard cytostatic agents (5-
fluorouracil or cis-platinum). 
Although the activity of these dioxatricyclic segments is lower than of the structurally related 
taxol, both compounds contain a functionalized oxetane ring and their biogenesis are 
related.46 
The anti-tumor activity shown by the above mentioned oxetanes demonstrates the 
pharmacological potential of the dioxatricyclic substructure of dictyoxetane, which is, 
moreover, easily available following an efficient synthetic route. 
Variation of substituents in the dioxatricyclic framework is essential to provide more 
information to understand the pharmacological activity of this class of substances. Therefore, 
the synthesis and functionalization of new dioxatricyclic oxetanes and aza-analogues of the 
natural product dictyoxetane was one of the goals of the present work. 
                                                 
46
 a) Kobayashi, J.; Shigemori, H. Heterocycles 1998, 47, 1111, 1126; b) Reinecke, J.; Hoffmann, H. M. R. Chem. Eur. J. 1995, 1, 3682. 
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2.2 Aza-analogues of Dictyoxetane 
2.2.1 Azetidines 
Although the chemistry of azetidines has been developed almost simultaneously with the 
rapid growth of heterocyclic chemistry in the past decades, azetidines are still a rare class of 
compounds.47 Medicinal and pharmacological properties of azetidines have been covered 
properly.48 Most notable advances have been reported in the synthesis of azetidin-2-ones (ß-
lactams) than in azetidine chemistry. 
Azetidines are not especially labile even relatively stable towards basic conditions and 
nucleophiles. An evidence for their stability is that many routes leading to azetidines employ 
such conditions. 
The most important method for the synthesis of azetidines is the cyclization of open-chain 
compounds, most generally by formation of the C-N bond. Few azetidines have been obtained 
by cycloaddition methods, by rearrangement of larger rings or by expansion of aziridines. The 
important developments of the ß-lactam chemistry in recent decades have provided several 
routes for the synthesis of azetidin-2-ones. As a consequence, many methods for the reduction 
of the carbonyl group of the ß-lactam to azetidine have also emerged.47 
The chemistry of azetidines and its derivatives have been comprehensively reviewed.47 
2.2.2 Azetidine Ring in the Dioxatricyclic Framework of Dictyoxetane 
The synthesis of aza-analogues of the dioxatricyclic subunit of Dictyoxetane with an azetidine 
ring substituting the oxetane ring has not been accomplished until now. Such an intricate 
oxazatricyclic skeletal type has not been encountered in natural or unnatural compounds.49 
Therefore, the introduction of an azetidine ring in the tricyclic skeletal structure constitutes an 
important synthetic challenge and also, an access to potential pharmacological activity. 
                                                 
47
 a) Davies, D. E.; Storr, R. C. Comprehensive Heterocyclic Chemistry; Katritzky, A. R.; Rees, C. W. Eds.; Pergamon Press: Oxford, 1984; 
Vol. 7, p. 237-362.; b) Moore, J. A. The Chemistry of Heterocyclic Compounds; Weissberger, A.; Taylor, E. C., Eds.; Wiley:Chichester, 
1983; Vol. 42. 
48
 Testa, E.; Wittgens, A.; Maffii, G.; Bianchi, G. Research Progress in Organic-Biological and Medicinal Chemistry; Gallo, U.; Santamaria, 
L., Eds.; Società Editoriale Farmaceutica:Milan, 1994; Vol. 1. 
49
 Beilstein on-line search. 
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2.2.2.1  Attempted Synthesis by S. Proemmel 
The synthesis of tricyclic azetidines was attempted by S. Proemmel following a similar route 
to that of oxetanes (Scheme 23).39 Starting from cycloadduct rac-49, epoxy alcohol 57 was 
synthesized as reported by J. Wittenberg.29 Swern oxidation led to epoxy ketone 115 in 70% 
yield. Attempted reductive amination of epoxy ketone 115 with methylamine and sodium 
cyanoborohydride led exclusively to epoxy alcohol 57, by-product from the competing 
reduction. On the other hand, attempted Borch reduction followed by protection with Boc 
group led to a mixture of epoxy alcohol 57 in higher ratio than desired amine 116. Attempted 
cyclization using tert-butylmagnesium chloride did not afford tricyclic azetidine 117 whereas 
the reaction was less disappointing using methylmagnesium chloride; the azetidine was not 
characterized, though. 
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Scheme 23: Attempted synthesis of tricyclic azetidines by S. Proemmel. 
The difficulties of the synthesis of primary epoxy amines using common reductive amination 
methods exemplify the hindered environment of the carbonyl group in the oxatricyclic epoxy 
ketones. The steric hindrance and electrophilicity of the epoxy ketone 115 possibly makes the 
imine intermediate formation difficult and, consequently, the competing reduction of the 
ketone is faster. In order to improve the results of the reductive amination, additives or step-
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wise protocols should be employed instead of the common methods, which are less 
appropriate for sluggish reactions such as those involving tricyclic epoxy ketone 115. 
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3. Conceptual Formulation 
As part of one of the research projects in the work group of Prof. H. M. R. Hoffmann, the 
present work deals with the synthesis of new dioxatricyclic subunits of dictyoxetane and their 
analogous oxazatricyclononanes. 
The first aim of the present work was the synthesis of new dioxatricyclic oxetanes starting 
from 2α-benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one. The introduction of different ester 
functions in the oxabicyclic skeletal structure was chosen as a promising alternative to 
improve the overall yield and allow an easier deprotection. As a broader goal, emphasis was 
put on the shortening of the synthetic route towards dioxatricyclic compounds. 
The present work was also concerned with the development of an efficient strategy for the 
synthesis of higher functionalized dioxatricyclic structures. For this purpose, three 
possibilities were considered: functionalization of ester substituted oxetanes, introduction of 
an isoxazoline ring in the oxatricyclic skeletal structure and attachment of aryl and alkyl 
groups directly to the oxetane ring system. 
Finally, the main aim was the development of a valuable synthetic route towards aza-
analogues of the dioxatricyclic subunit of dictyoxetane. The synthesis of the oxazatricyclic 
compounds and their functionalization provide access not only to potential pharmacologically 
active compounds but also to versatile precursors of a wide variety of derivatives including 
azasugars. 
Because of the pharmacological potential of the dioxatricyclic subunits of dictyoxetane and its 
aza-analogues, the biological activity of new dioxatricyclononanes and oxazatricyclononanes 
was tested providing information to understand the structure-activity relationship of the 
oxatricyclic segments. 
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Results and Discussion 
4. Synthesis of New Dioxatricyclic Subunits of Dictyoxetane 
As described in Chapter 2, the biological activity shown by some dioxatricyclic subunits of 
dictyoxetane50 stressed the importance of the synthesis of new dioxatricycles containing the 
skeletal structure 2,7-dioxatricyclo[4.2.1.03.8]nonane (see Scheme 24). 
The first aim of the present work was the synthesis of new dioxatricyclic oxetanes from meso-
oxabicycle rac-90. The introduction of different ester groups at carbon C3 offered the 
possibility of milder deprotection after ring closure and better overall yields (see Section 4.1). 
On the other hand, considering the dioxatricyclic framework of dictyoxetane with no 
functionality at carbon C3, the synthesis of deoxygenated dioxatricyclic oxetane 119 was 
carried out starting from meso-oxabicycle rac-90 (see Section 4.2). The shortening of the 
synthetic route towards dioxatricyclic oxetanes was also investigated by means of Lewis acids 
(see Section 4.4). 
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Scheme 24: General synthetic strategy to obtain new dioxatricyclic oxetanes starting from meso-
oxabicycles rac-49 and rac-90. 
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 See Chapter 2. 
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A second aim of the present work was the synthesis of higher functionalized dioxatricyclic 
structures starting from meso-oxabicycles rac-49 and rac-90. For this purpose, a further 
functionalization of ester substituted oxetane 118 was studied starting by oxidation of the 
hydroxyl group at C6 (see Section 4.3). The introduction of an isoxazoline ring at carbon C3 
in the oxatricyclic skeletal structure 121 and 122 was also investigated since a wide variety of 
open chain compounds are accessible by cleavage of the N-O bond (see Section 4.5). Finally, 
attachment of aryl and alkyl groups directly to the oxetane ring led to the synthesis of 
valuable C2-arylated and alkylated dioxatricyclic oxetanes 120 (see Section 4.6). 
4.1 Synthesis of Tricyclic Oxetanes with an Ester Function at Carbon C3 
As mentioned in Chapter 2, oxygenated tricyclic oxetanes are synthesized following a short 
route, which involves protection of the hydroxyl group at C3 position from unwanted 
reactions (see Scheme 25). 
The low overall yield of the synthesis of ether substituted dioxatricyclic oxetanes starting 
from meso-oxabicycle rac-9051 as well as the reported difficulties to cleave the ether function 
after ring closure52 stressed the importance of an alternative synthesis of dioxatricyclic 
substructure 10 without methyl groups at the bridgehead carbon atoms. Consequently, the use 
of alternative protecting groups to the more stable ethers was considered in the present work. 
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Scheme 25: Synthetic strategy to oxygenated dioxatricyclic structures. 
Protection of the 3-hydroxyl group with silyl ethers proved to be inappropriate in the 
synthesis of tricyclic oxetanes by J. Wittenberg. Even a bulky TBDMS-group shows a 1,2-
migration tendency as long as an alkoxy anion is generated in the bicyclic vicinal diol under 
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 a) Wittenberg, J. PhD Thesis, Universität Hannover, 1998; b) Wittenberg, J.; Beil, W.; Hoffmann, H. M. R. Tetrahedron Lett. 1998, 39, 
8259. 
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the reaction conditions.52 In contrast to silyl ethers, the use of an ester as protecting group for 
the hydroxyl group offers the alternative to a more efficient synthetic pathway. 
The synthesis of oxygenated dioxatricyclic oxetanes 124 with an ester function at carbon C3 
was accomplished following the efficient synthetic pathway outlined in Scheme 26, which has 
been explained in detail in Section 2.1.50 Silyl enolether 48 of 1,1-Bis-benzyloxy propanone 
46 underwent a trimethylsilyltriflate-catalyzed [4+3]-cycloaddition with furan affording 
meso-oxabicycle rac-90.53 Diastereoselective reduction with DIBAH of cycloadduct rac-90 
provided exclusively endo-alcohol 125, which was protected afterwards using different ester 
functions. Epoxidation of the homoallylic double bond proceeded stereoselectively to afford 
epoxide 127. Mild catalytic hydrogenolysis of epoxy ester 127 led to ester 128, which are 
substituted precursors of the dioxatricyclic dictyoxetane segments. Finally, the key four-
membered ring closure to oxetane 118 was carried out with BF3⋅OEt2 in DCM. 
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Scheme 26: Proposed synthetic route to prepare dioxatricyclic oxetanes with an ester function at C3. 
4.1.1 Pivaloate as Protecting Group 
The synthesis of oxygenated dioxatricyclic oxetanes with an ester was first accomplished 
using pivaloate as protecting group for the hydroxyl function at carbon C3. Compared to other 
commonly used ester protecting groups, pivaloates do not show any tendency for migration 
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and are more stable. Thus, pivaloates are slow to deprotect in contrast to acetates and their 
cleavage may require strongly basic reagents. Nevertheless, deprotection of the pivaloate 
group in similar dioxatricycles proceeded in good to high yield by using DIBAH in THF.54 
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Scheme 27: Synthesis of oxetane 132 with pivaloate as protecting group at carbon C3. 
Following the above mentioned route for the synthesis of dioxatricycles, racemic axial alcohol 
125 was quantitavely protected as its pivaloate 129 under standard conditions adding a 
catalytic amount of 4-dimethylaminopyridine (DMAP),55 which increases the rate of acylation 
by a factor of 104. The homoallylic double bond was then oxidized to exo-epoxide 130 with 
m-CPBA in DCM at 0 °C. Afterwards, the benzyl ether group was cleaved by catalytic 
hydrogenolysis using 10% Pd/C as catalyst. The debenzylation reaction time was faster in 
ethyl acetate than in methanol. The following key ring closure of epoxy alcohol 131 was 
carried out with BF3⋅OEt2 in DCM in good yield (see Scheme 27). 
The conformational aspects of the key cyclization to oxetane 132 are illustrated in Scheme 28. 
The conversion of epoxy alcohol 131 into oxetane 132 is a cycloisomerization, in which a 
four-membered ring is formed at the expense of a three-membered ring. A conformational 
change in epoxy alcohol 131 must precede the reaction. The six-membered oxacyclic ring has 
to populate a minor boat 133, which brings the hydroxyl group sufficiently close for a 
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stereoelectronically favoured formation of the new oxetane C-O bond. After formation of the 
tricyclic oxetane, the bulky substituent adopts a less hindered equatorial position in an 
oxacyclohexane boat 132. Therefore, pivaloyl protection is advantageous to force formation 
of oxetane 132 from epoxy alcohol 131. 
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Scheme 28: Conformational aspects of the key cyclization to oxetane 132. 
Summarizing, the synthesis of pivaloate substituted dioxatricyclic oxetane 132 proceeded 
smoothly over four steps in a 40% overall yield without unwanted by-products. Furthermore, 
the absence of acyl migration as well as a forcing effect in the formation of the oxetane ring 
showed the advantages of the pivaloyl protection. 
4.1.2 Benzoate as Protecting Group 
The synthesis of ester substituted dioxatricyclic oxetanes was further studied using benzoate 
as protecting group for the hydroxyl group. Benzoates esters are less readily hydrolyzed than 
acetates and not as slow as pivaloates to be cleaved. Moreover, the tendency for benzoate 
migration to adjacent hydroxyls, in contrast to that of acetates, is not nearly as strong,56,57 
although they can be forced to migrate under a strong driving force, e. g. to a 
thermodynamically more stable position.58,59 In view of these advantages, the synthesis of a 
dioxatricyclic oxetane with a benzoate protecting group was promising. 
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Scheme 29: Synthesis of oxetane 138 with a benzoate group at C3 position. 
The synthesis towards desired oxetane 138 started with quantitative conversion of racemic 
alcohol 125 to benzoate 134 using BzCl and DMAP. Alkene 134 was oxidized with m-CPBA 
in excellent yield and the resulting epoxy bicycle 135 was afterwards debenzylated under H2 
atm with Pd/C as catalyst. The hydrogenolysis was completed after 1 day and changing the 
solvent (EA, MeOH or EtOH) did not alter the reaction time. Upon treatment of epoxy 
alcohol 136 with BF3⋅OEt2, a mixture of desired oxetane 138 and dioxatricycle 137 was 
obtained in a 2:1 ratio in 60% yield (see Scheme 29). Dioxatricycle 137 resulted from the 
migration of the benzoate group to the more stable equatorial position at carbon C2 followed 
by a 5-exo-tet cyclization. Compounds 137 and 138 were not separable by column 
chromatography. 
The synthesis of benzoate protected dioxatricyclic oxetane 138 was less efficient than in the 
case of pivaloyl protection since the benzoate group showed a tendency to migrate and the 
overall yield (34%) was lower than that of pivaloate (40%). 
4.1.3 Acetate as Protecting Group 
The next step was the synthesis of an oxygenated dioxatricyclic oxetane with a methyl ester 
group at carbon C3 which would also favor a later enzymatic resolution. Acetate is probably 
the most employed of all the ester protecting groups and a common substrate in enzymatic 
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reactions. Deprotection of acetates proceed under mildly basic conditions, by acid catalyzed 
solvolysis (transesterification) or by enzymatic hydrolysis using high stereoselective and 
substrate selective esterases (lipases) with the added benefit that racemic or meso-substrate 
can often be resolved with excellent enantioselectivity.60 The synthesis of a dioxatricyclic 
oxetane with an acetate group at C3 would offer not only the possibility of a milder 
deprotection of the hydroxyl group at carbon C3 but also a valuable later enzymatic 
hydrolysis of the meso-compounds in order to determine their absolute configuration. 
Following the same synthetic route as for the preceding ester substituted oxetanes, racemic 
alcohol 125 was converted to acetate 139 and then treated with m-CPBA to obtain epoxide 
140 in good yield. Hydrogenolytic debenzylation with a catalytic amount of 10% Pd/C 
yielded a mixture of desired product 142 and epoxy alcohol 141, resulting from the 1,2-
migration of the acyl group to the equatorial position, in a 3:1 ratio. Changing the solvent 
(EA, MeOH or EtOH) did not alter the ratio of products 142 and 141. Compounds 142 and 
141 were not separable by column chromatography and, therefore, the mixture of both epoxy 
alcohols was treated with BF3⋅OEt2 leading to dioxatricycles 143 and 144 in a 5:2 ratio 
without traces of desired oxetane (see Scheme 30). Dioxatricycles 143 and 144 were not 
separable by column chromatography either. 
Similarly to the reported migration of the benzoate group (see Section 4.1.2), the axial acetate 
in epoxy alcohol 142 migrated to the adjacent equatorial position. Moreover, in the case of 
acetate protection, the acyl migration occurred not only under Lewis acid conditions 
(BF3·OEt2) but also under the acidic conditions of the hydrogenolytic debenzylation. After 
cis-migration of the acyl group to the thermodynamically favoured equatorial position at 
carbon C2, the free hydroxyl group at carbon C3 underwent a facile 5-exo-tet cyclization 
leading to compounds 143 and 144, which contain the skeletal structure of thromboxan A2 
analogues (TXA2).61 
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Scheme 30: Synthetic route towards dioxatricycles 144 and 143 using acetate as protecting group. 
In view of the foregoing results, the synthesis of acetate substituted dioxatricyclic oxetanes as 
substrates for enzymatic resolution failed because of the acyl migration tendency. In Chapter 
5, other alternatives for determination of the absolute configuration of dioxatricyclic 
compounds are outlined. 
4.1.4 Summary of the Synthesized Ester Substituted Dioxatricyclic Oxetanes and 
Comparison with Similar Dioxatricyclic Substructures 
Starting from meso-oxabicycle rac-90, the synthesis of oxygenated dioxatricyclic oxetanes 
132 and 138 with pivaloate and benzoate as protecting groups was accomplished offering a 
milder deprotection after ring closure. Tert-butylester proved to be the best choice for 
preparing tricyclic oxetane compared to benzoate and acetate since pivaloate did not show any 
tendency for migration of the acyl function. Furthermore, pivaloate substituted dioxatricyclic 
oxetane 132 was obtained starting from meso-oxabicycle rac-90 over five steps in 32% 
overall yield, better than that of benzoate 138 (27%) (see Scheme 31). 
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Scheme 31: Comparison of different dioxatricyclic oxetanes from meso-oxabicycles rac-49 and rac-90. 
Comparing the synthesis of ester-substituted dioxatricyclic oxetanes 132 and 138 from meso-
oxabicycle rac-90 to that of ester-substituted dioxatricyclic oxetanes 70 and 71 from meso-
oxabicycle rac-49, dioxatricycles 132 and 138 without methyl groups at the bridgehead 
carbon atoms are obtained in lower overall yield than oxetanes 70 and 71.54 The methyl 
groups confer more stability to the skeletal structure and also increase the lipophilicity and 
molecular weight of the compounds, thus increasing the yield. 
Moreover, the benzoate group showed a migration tendency under Lewis acid-catalyzed 
cyclization conditions in the synthesis of dioxatricyclic 138, while benzoate 71 was obtained 
in good yield without by-products resulting from intramolecular transesterification. For both 
cases, the use of pivaloate is more advantageous in terms of yield and stability. 
In the case of methoxy substituted oxetanes, dioxatricyclic 58 is prepared from meso-
oxabicycle rac-49 in 62% overall yield over five steps63 while the corresponding pivaloate 
substituted oxetane 70 is synthesized in 42% overall yield from the same meso-oxabicycle 
rac-49. Consequently, the use of methyl ether as protecting group is more efficient for the 
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synthesis of oxatricyclic oxetanes starting from meso-oxabicycle rac-49. On the contrary, 
methoxy substituted oxetane 97 is prepared in 15% overall yield while pivaloate substituted 
oxetane 131 is synthesized in 32% overall yield from meso-oxabicycle rac-90. Therefore, the 
synthesis of dioxatricyclic oxetanes starting from meso-oxabicycle rac-90 is clearly more 
successful using pivaloate than methyl ether62 as protecting group, as outlined in Scheme 31. 
Summarizing, protection of the hydroxyl group at carbon C3 with pivaloate proved to be the 
best choice for the synthesis of oxygenated dioxatricyclic oxetanes starting from meso-
oxabicycle rac-90. In addition, pivaloyl protection is not only advantageous to force 
formation of the oxetane ring but it also opens the possibility of milder deprotection of the 3-
hydroxyl group after cyclization. 
4.2 Synthesis of C3-Deoxygenated Tricyclic Oxetanes 
Looking carefully at the dioxatricyclic framework of dictyoxetane, there is a non 
functionalized carbon atom at C3 position. On the other hand, most of the previously reported 
dioxatricyclic oxetanes have a protected hydroxyl group at carbon C3. Therefore, the 
synthesis of deoxygenated dioxatricyclic analogues is very interesting. 
A deoxygenated 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonan-9ß-ol was synthesized by J. 
Wittenberg63 from 2α-benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one following 
the deoxygenation method already used by J. Reinecke in a similar dioxatricyclic system.64 
In the present work, the synthesis of a deoxygenated 2,7-dioxatricyclo[4.2.1.03,8]nonan-9ß-ol 
from 2α-benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-90 was attempted to complete the 
series of deoxygenated dioxatricyclic analogues. 
As reported by J. Reinecke in similar tricyclic systems,64 deoxygenation in the presence of a 
labile oxetane ring is not feasible because of radical fragmentation or decomposition of the 
substrate under the reaction conditions. Therefore, deoxygenation at C3 position must be 
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achieved prior to the formation of the oxetane ring by conversion of the hydroxyl group into 
S-methylthiocarbonate followed by Barton-McCombie hydrogenation.65  
Following the synthetic path outlined in Scheme 32, racemic alcohol 125 was converted 
quantitatively to S-methylthiocarbonate 144, which underwent a Barton-McCombie 
deoxygenation affording simplified oxabicycle 145. In two steps the deoxygenated compound 
145 was obtained in an excellent overall yield (86%), unexpected better than the similar 2α-
benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-ene, in which methyl groups provide 
stability to the compound and lower its hydrophilicity. Afterwards, alkene 145 was 
epoxidized with m-CPBA and debenzylated to epoxy alcohol 147 in good yield. 
Stereoselective cyclization with BF3⋅OEt2 in DCM afforded tricyclic hydroxyl oxetane 119 
and dioxatricycle 148 in a 2:5 ratio in very poor yield. Compounds 119 and 148 were not 
separable by column chromatography. 
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Scheme 32: Synthesis of C3-deoxygenated dioxatricyclic oxetane 119. 
The increasing hydrophilicity of these deoxygenated dioxatricycles along the synthetic route 
raises the risk of losses during the work-up and lowers consequently the yield of oxetane 119. 
In addition, the conformational aspects of the cyclization reaction explain a weaker driving 
                                                 
65
 Barton, D. H. R.; McCombie, S. W. J. Chem. Soc. Perkin Trans I 1975, 1574. 
4. Synthesis of New Dioxatricyclic Subunits of Dictyoxetane 41 
 
force for the formation of the oxetane ring compared to the corresponding oxygenated 
dioxatricyclic oxetanes.  
As outlined in Scheme 33, the six-membered ring of both epoxy alcohols 131 and 147 
changes to a minor boat, in which the hydroxyl function occupies the ideal axial position to 
attack the epoxide and form the new oxetane C-O bond. Simultaneously, in epoxy 133 the 
ester group at C3 moves from the axial position to the most favorable equatorial position 
lowering the energy difference between chair conformation 131 and boat transition state 133, 
while in deoxygenated dioxatricycle this effect does not occur. Deoxygenated epoxy alcohol 
147 changes to minor boat dioxatricycle 149 where the hydroxyl group is in axial position but 
there is no lowering of energy due to an additional substituent at carbon C3, so that the energy 
difference between chair and boat conformers is proportionally bigger for the deoxygenated 
oxatricycle. In contrast to similar deoxygenated oxetanes, the absence of additional methyl 
groups at the bridgehead carbon atoms in deoxygenated oxetane 119 reduces its stability and, 
consequently, the formation energy difference between oxetane 119 and furan 148 appears to 
be lowered. Attack at the farther side of the epoxide leading to a more stable furan ring also 
takes place. 
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Scheme 33: Key cyclization to dioxatricyclic oxetanes 132 and 119 and dioxatricycle 148. 
The synthesis of a deoxygenated oxatricyclic oxetane 119 from meso-oxabicycle rac-90 
completes the series of deoxygenated dioxatricyclic analogues. Deoxygenated oxetane 119 is 
rather hydrophilic which raises the risk of losses during the work-up. Compared to 
oxygenated oxatricycles, a weaker driving force was observed for the formation of the 
oxetane ring in the case of deoxygenated dioxatricycle. In addition the more stable 
dioxatricycle 148 was obtained together with the oxetane. All these factors are responsible for 
the low yield of oxetane 119. 
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The intramolecular cyclization of epoxy alcohol 147 may proceed in higher selectivity by 
base-catalyzed cyclization using potassium tert-butoxide, which however does not activate the 
epoxide ring in contrast to Lewis acids. Such an increase of selectivity was obtained by J. 
Reinecke in an intramolecular epoxide opening by using potassium tert-butoxide instead of 
BF3·OEt2.66 
4.3 Functionalization of the Oxetane Skeletal Structure 
In view of the high biological activity of some dioxatricycles,50 the functionalization of 
dioxatricyclic skeletal structure without “non natural” methyl groups at carbons C1 and C5 
constitutes a valuable access to potential pharmacological active derivatives. For this purpose, 
the oxidation of free hydroxy group at carbon C6 of the oxatricyclic oxetane 131 was chosen 
as starting point for further functionalization. 
Following an efficient strategy, similar to the reported by S. Proemmel,54 functionalization of 
oxatricyclic ketone 150 would provide a series of tricyclic oxetanes (see Scheme 34). 
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Scheme 34: Synthetic strategy for functionalization of the dioxatricyclic skeletal structure of ketone 150. 
4.3.1 Studies towards Oxidation of the β-Hydroxyl Group at Carbon C6 
The first step towards new derivatives of the oxetane skeletal structure was the oxidation of 
the hydroxyl group of oxatricyclic oxetane 131. Pivaloate 132 was chosen as starting material 
because pivaloyl protection proved to be the best choice for the synthesis of dioxatricyclic 
oxetanes without methyl groups at the bridgehead carbon atoms.67 
The oxidation of the hydroxyl group of oxatricyclic oxetane 131 was attempted using 
different methods. As summarized in Table 3, PCC68 did not generate the desired ketone 
while Swern69 and Parikh-Doering70 oxidations afforded the desired tricyclic ketone 150 in 
good yield. 
Tricyclic ketone 150 is moisture sensitive and acetal 151 is progressively formed, so that both 
compounds coexist and are not separable by column chromatography. 
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Entry Conditions Yield [%] 
1 (COCl)2, DMSO, Et3N, -78°C → rt, 16 h 66 
2 SO3·Py, DMSO, Et3N, 0°C, 24 h 83 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 72 h - 
Table 3: Oxidation conditions to afford ketone 150. 
After oxidation of the 6β-hydroxyl group, the resulting caged ketone 150 contains a high ring 
strain (sp2 carbon atom). Nucleophilic attack on the carbonyl group releases this strain by 
forming acetal 151 (sp3 carbon atom), which explains the moisture sensitivity of ketone 150. 
Therefore the oxidation of the 6-hydroxyl group is not recommendable as starting point for 
the functionalization of oxetane 131. A better alternative would be the protection of the 6-
hydroxyl group in oxetane 131 before further functionalization of the dioxatricyclic skeletal 
structure. 
Further functionalization of dioxatricyclic oxetane 131 was not studied in the framework of 
the present work. 
4.4 Attempts to a Short and Efficient Synthetic Route towards Dioxatricyclic 
Oxetanes 
As summarized in Section 4.1.4, the synthetic strategy towards dioxatricyclic subunits of 
dictyoxetane starting from meso-oxabicycles rac-49 and rac-90 offers a straightforward route 
to a series of versatile compounds containing the skeletal structure 2,7-
dioxatricyclo[4.2.1.03.8]nonane. Examining this route carefully, the idea of shortening the 
number of synthetic steps was offered by the possibility that epoxide 153 could be 
debenzylated and undergo an intramolecular cyclization in a one-step reaction by using an 
appropriate Lewis acid (see Scheme 35). 
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The reactant of choice was boron trichloride, a Lewis acid capable of selective cleavage of 
ether and acetal protecting groups. Like many other Lewis acids, BCl3, has been extensively 
used as a reagent for the cleavage of a wide variety of ethers, different acetals, and certain 
types of esters.71 The reagent is less reactive than boron tribromide for ether cleavage; 
however the chloride ion is also nucleophilic and capable of attacking the primary benzyl 
carbon. The type and extent of deetherification can be controlled by the ratio of the substrate 
to BCl3 as well as by variation of the reaction temperature. The transition state is 
predominantly SN1 in character, as evidenced by partial racemization of chiral ethers71 and the 
rearrangement of allyl phenyl ethers to allylphenols.72 When methoxy groups are ortho to a 
carbonyl group, the reaction is accelerated by the formation of a chelate between boron and 
the carbonyl oxygen atom.73 
The synthesis of oxygenated tricyclic oxetanes involves protection of the hydroxyl group at 
carbon C3 from side reactions (see Scheme 35). Esters were chosen as protecting groups in 
epoxide 153 for a selective Lewis acid catalyzed cleavage of the benzyl ether group at C2-
position. 
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Scheme 35: Attempted shortening of the synthetic route towards dioxatricyclic oxetanes 154. 
4.4.1 Benzoate Protection at Carbon C3 
Synthesis of oxygenated dioxatricyclic oxetane 154 from epoxide 153 using BCl3 was first 
attempted using benzoate as protecting group (see Scheme 36). Epoxide 155 was synthesized 
starting from racemic axial alcohol 54 over two steps in 62% overall yield as reported by S. 
Proemmel.54 Treatment of epoxide 155 with BCl3 in DCM at –78°C afforded desired oxetane 
71 together with dioxatricycles 156 and 157 in a 1:7:3.5 ratio. The three compounds were 
                                                 
71
 a) Bhatt, M.; Kulkarni, S. U. Synthesis 1983, 249; b) Greene, T. W. Protective Groups in Organic Synthesis; Wiley: New York, 1981. 
72
 a) Gerrard, W.; Lappert, M. F.; Silver, H. B. Proc. Chem. Soc. 1957, 19; b) Borgulya, J.; Madeja, R.; Fahrni, P.; Hansen, H.-J.; Schmid, 
H.; Barner, R. Helv. Chim. Acta 1973, 56, 14. 
73
 a) Dean, R. B.; Goodchild, J.; Houghton, L. E.; Martin, J. A. Tetrahedron Lett. 1966, 4153.; b) Arkley, V.; Attenburrow, J.; Gregory, G. I.; 
Walker, T. J. Chem. Soc. 1962, 1260; c) Barton, D. H. R.; Bould, L. ; Clive, D. L. J.; Magnus, P.D.; Hase, T. J. Chem. Soc. 1971, 2204. 
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separable by column chromatography. The yield of the deprotection/cyclization reaction was 
high (88%) but the migration of the benzoate group to the adjacent equatorial position lead to 
oxetane 71 as minor product of the reaction. 
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Scheme 36: Treatment of epoxide 155 with BCl3 to afford dioxatricycles 156, 157 and 71. 
The tendency for benzoate migration to adjacent hydroxyls is not strong but it can be forced 
into a thermodynamically more stable position as illustrated by the benzoate migration en 
route to N-acetyl neuraminic acid.58 In this case the migration was thermodynamically driven 
by the greater stability of the equatorial benzoate in the product. A similar driving force 
appeared in the case of epoxide 155: after debenzylation at C2 position, the axial benzoate 
migrated to the adjacent equatorial hydroxyl group and the resulting epoxy alcohol entered 
into facile 5-exo-tet cyclization to dioxatricycles 156 and 157 in a 2:1 ratio. The formation of 
desired oxetane 71 is thermodynamically and kinetically disfavoured, as illustrated in Scheme 
37. 
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Scheme 37: Formation of dioxatricycles 155 and 156 is thermodynamically and kinetically favoured in 
contrast to the synthesis of dioxatricyclic oxetane 71. 
4.4.2 Pivaloyl Protection at Carbon C3 
In view of the migration tendency of the benzoate group, synthesis of oxygenated 
dioxatricyclic oxetanes using BCl3 was attempted with more stable pivaloate protecting 
group. Starting from racemic axial alcohol 54, epoxide 160 was obtained over two steps in 
70% overall yield as reported by S. Proemmel.54 Treatment of epoxide 160 with one 
equivalent of BCl3 at –78°C afforded desired oxetane 70 in poor yield and in the presence of 
unreacted substrate. Changing the ratio of substrate to BCl3 as well as the reaction 
temperature in order to optimize the reaction was attempted without success (see Table 4). 
However, by addition of two equivalents of Lewis acid the reaction proceeded in good yield 
(86%) giving a mixture of desired oxetane 70 and dioxatricycle 161 in a 1.2:1 ratio. 
Dioxatricycle 161 results from cleavage of the pivaloate group and 5-exo-tet cyclization of the 
resulting hydroxy epoxide. 
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Entry BCl3 [eq] Conditions Total Yield [%] Ratio of 70:161 
1 1 -78°C → rt, 16 h 33a 1:0 
2 2.2 -78°C, 16 h 86 1.2:1 
Table 4: Attempted reaction conditions to obtain selectively desired dioxatricyclic oxetane 70. a) Epoxide 160 
recovered unreacted. 
Nevertheless, starting from racemic alcohol 54, dioxatricyclic oxetane 70 was obtained in 
three steps with an overall yield of 33%, lower than the four-steps synthesis of pivaloate 70 by 
catalytic hydrogenolysis and Lewis acid-catalyzed cyclization using BF3·OEt2 (41% overall 
yield). 
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Scheme 38: Shorter synthetic route towards oxetane 70. 
4.4.3 Synthesis of Dioxatricycles as TXA2-Analogues by 5-exo-tet Cyclization 
In view of the reactivity of BCl3, the synthesis of 2,6-dioxatricyclo[3.3.1.03,7]nonanes was 
attempted by a tandem deetherification-cyclization reaction of methoxy substituted epoxide 
56. 
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Starting from meso-oxabicycle 54, methoxy substituted epoxide 56 was synthesized over 
three steps as reported by J. Wittenberg.63 Resulting epoxide 56 was treated with the Lewis 
acid and, as expected, benzyl ether remained unaffected while methyl ether was cleaved and 
the free hydroxyl group attacked the epoxide affording dioxatricycles 161 and 165 in a 2:1 
ratio in excellent yield (see Scheme 39). 
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Scheme 39: Synthesis of dioxatricycles 161 and 165 containing a noradamantane structure by one-step 
reaction using BCl3. 
2,6-Dioxatricyclo[3.3.1.03,7]nonanes such as 156 and 157 contain a similar skeletal structure 
as thromboxane A2-analogues (TXA2) 163 and 164 synthesized by K. G. Bowers and J. Mann 
(see Scheme 40).74 
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Scheme 40: Thromboxane A2-analogues 163 and 164 synthesized by K. G. Bowers and J. Mann. 
As outlined in Scheme 41, this new approach, similar to the synthetic route towards 
dioxatricyclic oxetanes,75 provides a facile access to 2,6-dioxatricyclo[3.3.1.03,7]nonanes as 
TXA2-analogues starting from 2α-benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one 
in four steps in an overall yield of 89%. 
                                                 
74
 a) Bowers, K. G.; Mann, J. Tetrahedron Lett. 1985, 26, 4411; b) Bowers, K. G.; Mann, J.; Walsch, E. B.; Howarth, O. W. J. Chem. Soc. 
Perkin Trans. 1 1987, 1657. 
75
 See Chapter 2 and Section 4.1. 
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Scheme 41: Synthetic route to dioxatricycles 161 and 165 as TXA2-analogues. 
4.4.4 Outlook for a Short Synthetic Route towards Dioxatricyclic Oxetanes 
The above reported capability of BCl3 for a selective cleavage of methyl ether in the presence 
of a benzyl ether group may be used for a more efficient route towards dioxatricyclic 
oxetanes. A promising alternative would be the treatment with BCl3 of a C3-pivaloate 
substituted epoxide with a methyl ether group at C2, instead of a benzyl ether, as outlined in 
Scheme 42. In this case, the selectivity of the Lewis acid towards both protecting groups: 
pivaloate and methyl ether would be studied. The synthesis of this C2-methoxy substituted 
epoxide should start from a methylated silyl enol ether. 
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Scheme 42: Promising alternative for a shorter synthetic route to dioxatricyclic oxetanes. 
4.5 Studies towards Dioxatricyclic Oxetanes with an Isoxazoline Ring at C3 Position 
Another aim of the present work was the introduction of a new functionality into the 
dioxatricyclic structures starting from meso-oxabicycles rac-49 and rac-90 (see Scheme 43).  
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Scheme 43: Synthetic strategy to dioxatricyclic oxetanes 121 and 122 including a 3-bromo-2-isoxazoline ring. 
Among the known 1,3-dipolar cycloaddition reactions, the formation of an isoxazoline ring 
from an olefin and a nitrile oxide has been shown to be particularly useful in organic 
synthesis. This heterocycle is stable toward several reagents, so transformations can be carried 
out on pendant groups. Furthermore, 3-bromo-2-isoxazoline derivatives have been used in 
many natural product syntheses and have also proved to be efficient precursors for a wide 
variety of open chain scaffolds, including γ-amino alcohols,76 ß-hydroxy ketones,77 β-hydroxy 
esters,78 β-hydroxy ketones,79 1,3-butadienes and β-hydroxy nitriles,80 as outlined in Scheme 
44. Moreover, the moderate rigidity of the five-membered ring and the heteroatom lone pairs 
have made isoxazolines been attractive candidates for stereocontrolled transformations. 
Incorporation of a bromoisoxazoline ring at C3 position by 1,3-dipolar cycloaddition81 results 
in a tetracyclic system and offers a wide range of possibilities for further functionalization. 
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 a) Burri, K. F; Cardone, R. A.; Chen, W. Y.; Rosen, R. J. Am. Chem. Soc. 1978, 100, 7069; b) Müller, I.; Jäger, V. Tetrahedron Lett. 1982, 
23, 4777; c) Kozikowski, A. P. Acc. Chem. Res. 1984, 17, 410; d) Jäger, V.; Müller, I.; Schohe, R.; Frey, M.; Ehrler, R.; Häfele, B.; Scröter, 
B. Lect. Heterocycl. Chem. 1985, 8, 79; e) Wade, P.A.; Rao, J. A.: Bereznak, J. F.; Yuan, C.-k. Tetrahedron Lett. 1989, 30, 5969; f) Wade, P. 
A.; Price, D. T. Tetrahedron Lett. 1989, 30, 1185. 
77
 Kanemasa, S.; Tsuge, O. Heterocycles 1990, 30, 719. 
78
 Curran, D. P.; Scanga, S.; Fenk, C. J. J. Org. Chem.. 1984, 49, 3474. 
79
 a) Kozikowski, A. P.; Stein, P. D. J. Am. Chem. Soc. 1982, 104, 4023; b) Curran, D. P. J. Am. Chem. Soc. 1982, 104, 4024; c) Curran, D. 
P. J. Am. Chem. Soc. 1983, 105, 5826. 
80a) Wade, P.A.; Hinney, H. R. J. Am. Chem. Soc. 1979, 101, 1319; b) Kozikowski, A. P.; Adamczyk, M. J. Org. Chem. 1983, 48, 366; c) 
Wade, P.A; Bereznak, J. F. J. Org. Chem. 1987, 52, 2973. 
81
 For recent reviews of [3+2]-cycloadditions, see: a) Tufariello, J. 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; John Wiley & 
Sons: Chichester, 1984; Vol. 2, p. 83; b) Torssell, K. B. G. Nitrile Oxides, Nitrones and Nitronates in Organic Synthesis; VCH: Weinheim, 
1988; c) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863. 
4. Synthesis of New Dioxatricyclic Subunits of Dictyoxetane 52 
 
O
N
3-Bromo-2-isoxazolines
R1 NH2
OH
R2
γ-Amino alcohols
R1 OR3
OH
R2
β-Hydroxy esters
O
R1 CN
OH
R2
ß-Hydroxy nitriles
R1 R3
OH
R2
β-Hydroxy ketones
O
R1
1,3-Butadienes
R1 R3
R2
O
α,β−Unsaturated ketones
R1
OH
R2
R3
NOH
α,β− and β,γ-Unsaturated 
oximes
R1
BrR2
168
169 170
175
174 173
171
172
 
Scheme 44: 3-Bromo-2-isoxazolines are precursors of a wide variety of open-chain scaffolds through 
cleavage of the N-O bond. 
A similar route compared to that of the oxygenated dioxatricyclic oxetanes was chosen for the 
synthesis of dioxatricyclic oxetanes with an isoxazoline ring attached at C3 position (see 
Scheme 45). The introduction of the bromoisoxazoline ring at carbon C3 should proceed by 
facile 1,3-dipolar cycloaddition of bromonitrile oxide to an alkene. Therefore, starting 
oxabicyclic ketones rac-49 and rac-90 should be converted by Wittig reaction into dialkenes 
176 and 177. The methylenation of ketones rac-49 and rac-90 should be achieved prior to 
epoxidation of the endocyclic double bond in order to avoid the competing oxidation of the 
ketone to lactone.82 In addition, 1,3-dipolar cycloaddition should precede the formation of the 
labile oxetane ring. 
With this background in mind, the synthetic route towards oxatricyclic oxetanes 121 and 122 
should start by methylenation of oxabicyclic ketones rac-49 and rac-90. Dialkenes 176 and 
177 should be converted into epoxides 178 and 179 in two steps. Afterwards, debenzylation 
of epoxides 178 and 179 would led to oxetane precursors 166 and 167, which should undergo 
an intramolecular cyclization to highly functionalized oxetanes 121 and 122. 
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 See Section 2.1.3. 
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Scheme 45: Synthetic path to dioxatricyclic oxetanes 121 and 122 containing an isoxazoline ring. 
The question which remained open was the pathway between dialkenes 176 and 177 and 
epoxides 178 and 179 (see Scheme 46). For this purpose, two strategies were studied. The 
first possibility should start with a site selective 1,3-dipolar cycloaddition of bromonitrile 
oxide with the exocyclic double bond in dialkenes 176 and 177 followed by epoxidation of 
endocyclic double bond to obtain epoxides 178 and 179. The second strategy would involve a 
site selective epoxidation of the 1,2-disubstituted double bond of oxabicyclic 176 and 177 
preceding the 1,3-dipolar cycloaddition of bromonitrile oxide to the exocyclic double bond at 
carbon C3. Further considerations about the reactivity of both double bonds as well as the 
feasibility of the mentioned two strategies are presented in later chapters. 
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Scheme 46: Two strategies for the synthesis of epoxides 178 and 179 with an isoxazoline ring at C3. 
4.5.1 Conversion of Oxabicyclic Ketones to Dialkenes by Wittig Reaction 
The starting point of the synthetic route towards oxatricyclic oxetanes 121 and 122 with a 
bromoisoxazoline ring at C3 position is the synthesis of an oxabicyclic dialkene with an 
exocyclic double bond at carbon C3 (see Scheme 45). 
Harmata et al.83 reported the synthesis of similar methylenated oxabicycles by [4+3] 
cycloaddition (see Scheme 47).  
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Scheme 47: [4+3]-Cycloaddition of allylic acetals by Harmata et al. 
The yields of these [4+3] cycloaddition reactions are good except from the reaction of 
diisopropoxy acetal with 2,5-dimethylfuran, which do not proceed because of apparent steric 
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 Harmata, M.; Jones, D. E. J. Org. Chem. 1997, 62, 1578. 
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effect. The presence of methyl, ethyl or isopropyl ether in the cycloadduct would cause 
difficulties by ether cleavage to obtain the convenient precursor for an intramolecular 
cyclization to desired oxetane. Such alkyl ethers need drastic conditions for cleavage 
compared to benzyl ether, which is easily removed under mild conditions. Therefore, Harmata 
et al.‘s methylenated oxabicycles 185 were not considered as an efficient starting material for 
the synthesis of new dioxatricyclic oxetanes. Moreover, the synthesis of a similar benzyl 
substituted allylic acetal would involve a longer synthetic path than that of meso-oxabicycles 
rac-49 and rac-90. Instead, introduction of a methylene group into oxabicycles rac-49 and 
rac-90 proceeded by Wittig reaction in high yield affording desired olefins 176 and 177 as 
reported below. 
O
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Ph3P=CH2
Ph3P=CH21)
2)
rac-49 177
 
Entry Ph3P+Me Br- 
[eq] 
Deprot. Cond.a Ketone 
[eq] 
Wittig Cond.a Yield 
[%] 
1 1.2 2.2 eq n-BuLi, 0°C, 30 min  1 16 h, -78°C → rt 12b 
2 1.3 1.3 eq n-BuLi, rt, 3 h 1 2 d, rt 18b 
3 1.3 1.3 eq t-BuOK, rt, 15 h 1 15 h, rt 26b 
4 2.7 2.5 eq t-BuOK, reflux, 30 min 1 16 h, reflux 99 
Table 5: Reaction conditions for the generation of ethylenetriphenylphosphorane and following Wittig reaction 
with oxabicycle rac-49. a) THF was the solvent used; b) unreacted ketone was recovered. 
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Entry Ph3P+Me Br- 
[eq] 
Deprot. Cond.a Ketone 
[eq] 
Wittig Cond.a Yield 
[%] 
1 1.2 2.2 eq n-BuLi, 0°C, 30 min  1 16 h, -78°C→ rt 5b 
2 1.3 1.3 eq n-BuLi, rt, 3 h 1 2 d, rt 12b 
3 1.3 1.3 eq t-BuOK, rt, 15 h 1 15 h, rt 17b 
4 2.7 2.5 eq t-BuOK, reflux, 30 min 1 16 h, reflux 80 
Table 6: Reaction conditions for the generation of ethylenetriphenylphosphorane and following Wittig reaction 
with oxabicycle rac-90. a) THF was the solvent used; b) unreacted ketone was recovered. 
Methyltriphenylphosphonium bromide was used to prepare the corresponding ylide upon 
treatment with n-butyllithium or potassium tert-butoxide. The use of n-butyllithium to 
generate the ylide gave olefin 177 in 12 to 18% yield and olefin 176 in 5 to 12% yield, which 
was increased to 26% for 177 and 17% for 176 when the ylide was generated with potassium 
tert-butoxide at room temperature, as suggested by Schlosser and Christmann84 (see Table 5 
and Table 6). Best results were obtained by treatment of methyltriphenylphosphonium 
bromide with potassium tert-butoxide under reflux conditions to afford 177 in 99% yield and 
176 in 80% yield.  
Summarizing, the Wittig reaction proceeded well to generate an exocyclic double bond at C3 
position in good to high yield. In the case of oxabicyclic 176, without the bridgehead methyl 
groups, the olefination reaction proceeded in 80% yield. With additional stabilizing methyl 
groups, dialkene 177 was obtained in quantitative yield. In view of these results, oxabicyclic 
ketones rac-49 and rac-90 proved to be efficient starting materials for the synthetic route to 
dioxatricyclic oxetanes with a bromoisoxazoline ring at C3.  
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 a) Schlosser, M.; Christmann, K. F. Angew. Chem. 1964, 76, 683. 
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4.5.2 Site Selective 1,3-Dipolar Cycloaddition of Bromonitrile Oxide to 
Oxabicyclic Dialkenes 
The next step towards the synthesis of dioxatricyclic oxetanes with an isoxazoline ring at C3 
position was investigating the feasibility of a site selective 1,3-dipolar cycloaddition of the 
bromonitrile oxide to the exocyclic double bond in oxabicycles 176 and 177; particularly, the 
chemoselective attack of the dipole to the endocyclic or exocyclic double bond. Addition of 
bromonitrile oxide may occur on the terminal double bond or on the 1,2-disubstituted alkene 
depending on the dipolarophilic activity of both double bonds. The convenient 
regioselectivity of the 1,3-dipolar cycloaddition for the synthesis of dioxatricyclic oxetanes 
120 and 121 is outlined in Scheme 48. 
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Scheme 48: Illustrated site selective 1,3-dipolar cycloaddition to oxabicyclic dialkenes  176 and 177. 
In following sections 4.5.2.1 and 4.5.2.2, different aspects related to the dipolarophilic activity 
of double bonds and different selectivities of 1,3-dipolar cycloaddition are explained to 
anticipate the regioselectivity and stereoselectivity of the 1,3-dipolar cycloadditions of 
bromonitrile oxide to oxabicyclic dialkenes 176 and 177. 
4.5.2.1 Reactivity of Nitrile Oxides in 1,3-Dipolar Cyclodditions 
Relative rates of cycloadditions of nitrile oxides to various dipolarophiles85 have revealed 
characteristic features of reactivity in 1,3-dipolar cycloadditions. Both n- and pi-conjugation 
have a strong promoting effect on the reactivity and a general retardation is observed in 
disubstituted alkenes, principally owing to steric factors compared to unsubstituted 
dipolarophiles. Moreover, 1,2-disubstitution in alkenes decreases the addition rates more than 
1,1-disubstitution in dipolarophiles. 
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Electronic, steric and ion-pairing effects influence mainly the reactivity of dipolarophiles. 
Beyond these contributions, there are also some additional factors, which affect the ground-
state energy of molecules and thus their reactivity, like strain, aromaticity, hydrogen-bonding 
or solvent effects. 
The frontier molecular orbital (FMO) theory offers a satisfactory interpretation of the 
electronic contribution in the dipolarophilic activity and its dependence on the frontier orbital 
(FO) energies of the pi-components. The reactivity of the 1,3-dipole with the double bond is 
mainly determined by the interaction between Highest Occupied Molecular Orbital (HOMO) 
and low Lowest Unoccupied Molecular Orbital (LUMO). The stabilization energy is 
associated with this interaction and is inversely proportional to the energy difference between 
the interacting orbitals.  
The FMO theory can predict the effect of substituents on reactivity: electron-donating 
substituents raise the FO energies, while conjugating substituents raise the HOMOs and lower 
the LUMOs. Both donor and acceptor substituents increase the reactivity by a LUMO(dipole)- 
or a HOMO(dipole)-controlled cycloaddition, respectively. Besides, alkyl substitution 
decrease the reactivity mainly because of steric effects and the dipolarophilic activity 
decreases more in 1,2-disubstituted than in 1,1-disubstituted dipolarophiles.86 
Steric effects derive from increases of repulsion or from secondary orbital interactions, which 
reduce the overlap between the interacting orbitals. These secondary interactions are not 
considered in the FO predictions, nor are the changes in the flexibility of the dipolarophiles, 
which affect the energy of activation through the deformation energy, and their importance is 
apparently pre-eminent in the reduced dipolarophilic activity of 1,2-cis-disubstituted alkenes. 
Special attention must be paid to cyclic dipolarophiles like norbornene, cyclopentene, 
bicyclo[2.2.2]octene or cyclohexene,87 in which ring strain can only account partially for their 
high reactivity. A satisfactory rationalization in terms of deformation energies and staggering 
of forming bonds with respect to allylic bonds has been provided.88 Calculations show that 
C=C bonds of cyclic dipolarophiles with diastereotopic faces are considerably deformed away 
from planarity.88a For example, in norbornene, the olefinic C-H bonds are bent in the endo 
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 Boyd, E. C.; Paton, R. M. Tetrahedron Lett. 1993, 34, 3169. 
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direction by 3.4°, and only a small expenditure of energy is required to effect the 10° cis 
bending to achieve the cycloaddition transition state geometry. Similar deformations have 
been found in molecules such as norbornadiene, bicyclopentene, and Dewar benzene.89 In 
these molecules, the deformations always take place in direction of staggering of the olefinic 
carbon substituents with the allylic bond which is most nearly eclipsed with the pi orbital. 
Thus, the capability of the reactant for deformation toward the cis-bent geometry correlates 
the reactivity of cyclic dipolarophiles. Furthermore, in addition reactions to pi systems, the 
staggering of the forming bonds with the allylic bond is highly favoured88b and this tendency 
for staggering directs the geometry of the dipolarophile in the transition state. For instance, 
the high reactivity of norbornene can then also be partly attributed, aside from their easy 
deformation, to the fact that the forming bonds in the exo addition are almost perfectly 
staggered with the bonds to the bridgehead carbons. 
Additional increased reactivity can be adequately explained in part by the reduction in strain 
caused by the conversion of the olefin into a saturated product. 
The rates of 1,3-dipolar cycloadditions are barely influenced by the nature of solvents but 
selectivities (regioselectivity, stereoselectivity, site selectivity and periselectivity) may be 
significantly altered, even reversed upon a change of solvent. 
4.5.2.2 Regioselectivity and Stereoselectivity of 1,3-Dipolar Cyclodditions with 
Nitrile Oxides 
1,3-Dipolar cycloadditions of nitrile oxides to alkenes can afford two regioisomers of the 2-
isoxazoline, in which the relative configuration between the 4- and 5-substituents is 
determined by the geometry of the alkene (see Scheme 49). 
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Scheme 49: 1,3-Dipolar cycloaddition of nitrile oxides can afford two regioisomers. 
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 Fusco, F.; Garanti, L.; Zecchi, G. Tetrahedron Lett. 1974, 269. 
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Generally, nitrile oxides react with terminal alkenes to give the 5-isomer of the isoxazoline, 
i.e. the nitrile oxide carbon atom attacks the terminal carbon atom of the alkene. The 
sensitivity of the cationic carbon of the bromonitrile oxide to steric effects is greater than that 
of the oxygen, which favors the sterically less hindered 5-substituted isomer in the 1,3-dipolar 
cycloaddition with a terminal double bond. Mixtures of regioisomers are usually obtained 
with 1,2-disubstituted alkenes. Consequently, addition of bromonitrile oxide to 1,1-
disubstituted alkene in oxabicycles 176 and 177 would mostly afford 5-substituted 
regioisomers 182 and 183, while in the case of addition to the symmetrically 1,2-substituted 
double bond, a mixture of regioisomers 186 and 187 would be obtained (see Scheme 50). 
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Scheme 50: Illustrated 1,3-dipolar cycloaddition reaction of bromonitrile oxide to oxabicyclic 176 and 177. 
When the two faces of the double bond are nonequivalent, the attack of the 1,3-dipole may 
occur on the same side as the perturbing substituent or on the opposite one. In such cases, the 
1,3-dipolar cycloaddition proceeds under facial stereoselectivity. Several examples of facial 
selectivity have been reported in 1,3-dipolar cycloadditions of nitrile oxides to bicyclic 
systems.90 These stereoselectivities seem to be a consequence of the geometry of the 
dipolarophiles. 
                                                 
90
 a) Flige, W.; Huisgen, R. Liebigs. Ann. Chem. 1973, 2038; b) Sasaki, T.; Hayakawa, K.; Manabe, T.; Nishida, S. J. Am. Chem. Soc. 1981, 
103, 565; c) Anderson, P. S.; Christy, M. E.;  Engelhardt, E. L.; Lundell, G. F.; Ponticello, G. S. J. Heterocycl. Chem. 1977, 14, 213; d) De 
Micheli, C.; Gandolfi, R.; Oberti, R. J. Org. Chem. 1980, 45, 1209. 
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Addition of bromonitrile oxide to the 1,2-disubstituted alkene in oxabicycles 176 and 177 
would occur exclusively on the exo face, as observed in 1,3-dipolar cycloadditions to 
[3.2.1]oxabicyclic alkenes.91 In the 1,1-disubstituted double bond in oxabicycles 176 and 177, 
the two faces of the pi system are not equivalent either, so addition of the 1,3-dipole may 
occur under facial stereoselectivity affording bromoisoxazolines 182 and 183 in different ratio 
(see Scheme 50). 
4.5.2.3 Attempted Site Selective 1,3-Dipolar Cycloddition of Bromonitrile Oxide to 
Oxabicyclic Dialkenes 
1,3-Dipolar cycloadditions of bromonitrile oxide to oxabicyclic olefins 176 and 177 were 
attempted following two optimized procedures successfully used in [3.2.1]oxabicycles.91 The 
first one involves the use of DBU as base and acetonitrile as solvent while the second method 
proceeds using KOH as base in THF with aliquat336. 
The nitrile oxide of choice for the 1,3-dipolar cycloaddition to oxabicyclic dialkenes 176  and 
177 was bromonitrile oxide. The most widely used method to generate nitrile oxides is the 
dehydrohalogenation of the halogenated aldoxime,92 which can be effected by action of 
bases93 or silver salts, or by thermal dissociation of the halides (see Scheme 51). 
Dibromoformaldoxime (DBF) was chosen as the precursor for the nitrile oxide since the 
synthesis of dichloro derivatives is complicated and affords lower yields.94, 95 Generation of 
bromonitrile oxide was carried out in situ adding slowly a base to an ice cold solution of 
dibromoformaldoxime96b and dipolarophile in order to keep a low stationary concentration of 
nitrile oxide, thus preventing its dimerization.92, 96 
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 Martínez Lamenca, C. Master Thesis, University of Hannover, 2000. 
92
 Grundmann, C.; Grünanger, P., The nitrile oxides; Springer-Verlag: Berlin, 1978. 
93
 Beltrame, P.;  Veglio, C.; Simonetta, M. J. Chem. Soc. 1967, 867. 
94
 Halling, K.; Thomsen, I.; Torssell, K. B. G. Liebigs Ann. Chem. 1989, 985. 
95
 a) Stevens, V.; Polniaszek, R. P. Tetrahedron 1983, 39, 743.; b) De Amici, M.;. De Michaeli, C.; V. Misani, V. Tetrahedron. 1990, 46, 
1975. 
96a) R. Huisgen, Angew. Chem. Int. Ed. Engl. 1963, 2, 565.; b) N. Sewald, K. Burger, Liebigs Ann. Chem. 1992, 947. 
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Scheme 51: Dehydrohalogenation of dibromoformaldoxime by action of bases. 
Attempted 1,3-dipolar cycloaddition of bromonitrile oxide to oxabicyclic dialkenes did not 
give the desired oxabicycles 182 and 183. Instead, bromonitrile oxide attacked oxabicyclic 
olefins 176 and 177 stereospecifically from the exo face97 of the 1,2-disubstituted double bond 
to give both regiosisomers 186 and 187 in almost equivalent ratio. No traces of 1,3-dipolar 
cycloaddition to the terminal alkene at C3 were detected, even when a significant excess of 
dipole was added to the reaction. 
As summarized in Table 7, 1,3-dipolar cycloaddition of bromonitrile oxide to dialkene 176 
led to regioisomers 188 and 189 in 66 to 77% yield without either by-products or recovered 
dipolarophile. Regioisomers 188 and 189 were separable by column chromatography. In the 
case of dialkene 177, addition of bromonitrile oxide provided azatricycles 190 and 191 in 32 
to 58% yield with recovered unreacted dipolarophile and longer reaction times were needed. 
Regioisomers 190 and 191 were not separable by column chromatography. 
Best results were obtained using KOH as ionic base in THF. When phase transfer catalyst 
methyltrioctylammonium chloride (aliquat336) was added, the reaction was finished in 
shorter time (no increase of product was observed when the reaction mixture was stirred for 
longer time), though yields were smaller. In dialkene 177, the steric hindrance of the two 
methyl substituents at the bridgehead carbon atoms decreases its dipolarophilic activity, 
which explains the lower yield compared to the 1,3-dipolar cycloaddition to less hindered 
double bond of dialkene 176. 
 
                                                 
97
 Different nomenclature is used to describe the diastereotopic attacks: syn-anti/endo-exo. In [3.2.1]oxabicycles, the diastereotopic faces are 
described as endo and exo, where endo refers to the side cis to the larger bridge of the oxabicycle and exo to the trans one. 
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Entry R 
DBF 
[eq] 
Base Conditions 
Total 
Yield 
[%] 
Ratio of 
188:189 
(190:191) 
1 H 2+2a 2.2 eq KOH Aliquat336, THF, 0°C → rt, 5 h 66 4:5 
2 H 2+2b 2.2 eq KOH THF, 0°C → rt, 2 d 77 4:5 
3 H 2.5+2b 3 eq DBU CH3CN, 0°C → rt, 3 d 73 4:5 
4 Me 2+2a 2.2 eq KOH Aliquat336, THF, 0°C → rt, 16 h 35 3:4 
5 Me 2+2b 2.2 eq KOH THF, 0°C → rt, 4 d 58c 1:1 
6 Me 2.5+2b 3 eq DBU CH3CN, 0°C → rt, 4 d 32c 3:4 
Table 7: Attempted 1,3- dipolar cycloaddition reactions of bromonitrile oxide to 176 and 177. a) Addition of 2 
eq of DBF after 2 h reaction time; b) addition of 2 eq of DBF after 16 h reaction time; c) additionally 20% 
dipolarophile was recovered. 
As a result of the symmetry of the 1,2-disubstituted double bond in both oxabicycles 176 and 
177, a mixture of two regioisomers is obtained. ß-Substituents in dialkenes 176 and 177 
(benzyl ether at C2 position) are too far from the double bond to exert an outstanding 
electronic or steric effect on the regioselectivity of the cycloaddition. Additionally, in 
oxabicycle 177 the methyl groups at α-position decrease the dipolarophilic activity but do not 
influence the regioselectivity of the 1,3-dipolar cycloaddition.  
As observed in 1,3-dipolar cycloadditions to [3.2.1]oxabicyclic alkenes,91 addition of 
bromonitrile oxide to the 1,2-disubstituted alkenes proceed under facial selectivity. 
Summarizing the above described results, the 1,2-disubstituted double bond in oxabicyclic 
dialkenes shows higher dipolarophilic activity than the 1,1-disubstituted pi system towards 
bromonitrile oxide under the attempted conditions. The strain of the 1,2-disubstituted double 
bond in oxabicyclic 176 and 177 increases its reactivity but it is not the only effect for a 
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satisfactory rationalization of the observed reactivity. As in other cyclic dipolarophiles,98 
deformation energies and staggering of forming bonds with respect to allylic bonds may also 
have an important influence on its dipolarophilic activity. Thus, these contributions in terms 
of deformation energies and tendency for staggering should be further studied with ab initio 
calculations. 
4.5.3 Alternative Approach for the Synthesis of Dioxatricyclic Oxetanes with an 
Isoxazoline Ring 
In view of the results of the attempted 1,3-dipolar cycloadditions (see Section 4.5.2.3), the 
synthetic route towards higher functionalized oxetanes 121 and 122 was reexamined. In a 
second strategic route, site selective epoxidation of oxabicyclic dialkenes 176 and 177 should 
provide dipolarophiles 181 and 182 for a later 1,3-dipolar cycloaddition with bromonitrile 
oxide. Debenzylation and following cyclization should lead to desired oxetanes 121 and 122, 
as outlined in Scheme 53. 
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Scheme 52: Alternative synthetic strategy to generate isoxazolines rings attached to dioxatricyclic oxetanes. 
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4.5.4 Attempted Site Selective Epoxidation of Oxabicyclic Dialkenes 
The second synthetic approach starts with a site selective epoxidation of dialkenes 176 and 
177 on the endocyclic bond to form dioxatricyclic 180 and 181, as precursors of 1,3-dipolar 
cycloaddition. The reactivity of alkenes towards epoxidation increases with substitution of the 
double bond because of the electron-releasing effect of alkyl groups.99 In the presence of two 
double bonds in one molecule, epoxidation takes place selectively at the more electron-rich 
double bond and a high chemoselectivity is observed. A widely used reagent in selective 
epoxidations is m-CPBA, thus it was chosen for the attempted chemoselective oxidations of 
dialkenes 176 and 177. 
As outlined in Scheme 53, epoxidation took place non-selectively on both double bonds of 
oxabicyclic dialkenes 176 and 177 forming a mixture of epoxides and diepoxides in high 
yield. Changing the ratio of the substrate to m-CPBA as well as the solvent (DCM or 
H2O/THF)100 did not improve either yield or ratio of desired epoxides 180 and 181 (see Table 
8). All diepoxides 196, 197, 198 and 199 and epoxides 180, 181, 194 and 195 were separable 
with difficulty by column chromatography. 
Comparing the ratios of the obtained epoxides, certain selectivities may be observed in the 
case of dialkene 176: m-CPBA reacts preferably with the exocyclic double bond. In the case 
of dialkene 177, the attack of m-CPBA is nearly the same on both double bonds. Possibly, the 
methyl groups at the bridgehead carbon atoms limit free movement of the benzyl group at 
carbon C2 to the “north” part of the molecule, thus increasing the steric hindrance of the 
exocyclic bond. As a result, both exocyclic and endocyclic double bonds of dialkene 177 react 
similarly with m-CPBA. This steric effect does not occur in dialkene 176, in which the benzyl 
group moves more freely due to the absence of the methyl groups and the exocyclic bond is 
less sterically hindered compared to that in dialkene 177. 
                                                 
99
 McDonald, R. N.; Steppel, R. N.; Dorsey, J. E. Org. Synth. 1970, 50, 15.  
100
 Different epoxidation conditions using m-CPBA in DCM or in THF/H20 (1:1) and with different ratios of substrate/ m-CPBA were carried 
out on micro scale and have not been included in Table 8. m-CPBA was too reactive and  unwanted mixtures of epoxides and diepoxides 
were always obtained. 
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Scheme 53: Epoxidation of dialkenes 176 and 177 with m-CPBA afforded a mixture of epoxides and diepoxides. 
Entry R 
m-CPBA 
[eq] 
Conditions 
Total Yield 
[%] 
Ratio of 
180:194:196:198 
(181:195:197:199) 
1 H 1 DCM, 0°C → rt, 16 h 75 2:7:14:15 
2 H 1.25 DCM, 0°C → rt, 16 h 93 2:7:9:9 
3 Me 1 DCM, 0°C → rt, 16 h 94 3:2:3:2 
4 Me 1.25 DCM, 0°C → rt, 16 h 96 2:1:5:3 
Table 8: Some attempted regioselective epoxidation conditions of dialkenes 176 and 177 with m-CPBA. 
Although attempted site selective epoxidation to dialkenes 176 and 177 was inefficient, 
desired epoxides 180 and 181 were isolated and used as dipolarophiles in a 1,3-dipolar 
cycloaddition with bromonitrile oxide (see Section 4.5.5). Therefore, the synthesis of 
dioxatricyclic oxetanes with an isoxazoline ring at C3 was further investigated. 
4.5.5 Attempted 1,3-Dipolar Cycloaddition of Bromonitrile Oxide to Oxabicyclic 
Epoxy Alkenes 
Epoxides 180 and 181 were utilized for the next step of the second synthetic route towards 
highly functionalized oxetanes with an isoxazoline ring at C3. For this purpose, the optimized 
protocol for 1,3-dipolar cycloaddition, described in Section 4.5.2.3, was followed without 
success. Only unreacted oxabicyclic olefines 180 and 181 were isolated, even if the reaction 
mixture was heated to reflux or excess of 1,3-dipole or phase transfer catalyst were added (see 
Table 9). 
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Entry R 
DBF 
[eq] 
Base Conditions Total Yield [%]b 
1 H 2+2a 2.2 eq KOH Aliquat-336, THF, 0°C → rt n.r. 
2 H 2+2a 2.2 eq KOH THF, 0°C → rt n.r. 
3 H 2.5+2a 3 eq DBU CH3CN, 0°C → rt n.r. 
3 Me 2+2a 2.2 eq KOH Aliquat-336, THF, 0°C → rt n.r. 
4 Me 2+2a 2.2 eq KOH THF, 0°C → rt n.r. 
5 Me 2.5+2a 3 eq DBU CH3CN, 0°C → rt n.r. 
Table 9:  Attempted 1,3-dipolar cycloaddition reactions of bromonitrile oxide to epoxy alkene 180 and 181. a) 
Addition of 2 eq after 16 h reaction time; b) unreacted epoxides 180 and 181 were recovered. 
Further 1,3-dipolar cycloaddition conditions could be attempted such as change of solvent or 
use of different nitrile oxides. However, the low observed dipolarophilic activity of the 
exocyclic double bond of epoxides 180 and 181 indicates an sterically hindered environment, 
which impedes the addition of bromonitrile oxide. 
4.5.6 Summary and Conclusions of Attempted Synthesis of Oxatricyclic Oxetanes 
with an Isoxazoline Ring at C3 Position 
For the synthesis of dioxatricyclic oxetanes with an isoxazoline ring at C3 position, two 
strategic routes were studied starting from meso-oxabicycles rac-49 and rac-90 In first place, 
conversion of the ketone function into a double bond proceeded by Wittig reaction in 
excellent yield affording the dipolarophile for a later 1,3-dipolar cycloaddition. In the 
following steps, the reactivity of both double bonds played an important role. On the one 
hand, a site selective 1,3-dipolar cycloaddition to the exocyclic double bond failed since the 
endocyclic alkene showed higher dipolarophilic activity towards bromonitrile oxide than the 
exocyclic double bond, which coincides with the high reactivity shown by other cyclic 
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dipolarophiles.101 On the other hand, attempted site selective epoxidation of oxabicyclic 
dialkenes on the endocyclic double bond provided a mixture of epoxides and diepoxides. 
Furthermore, attempted 1,3-dipolar cycloaddition of bromonitrile oxide with desired epoxides 
180 and 181 was not successful under the studied conditions.  
The study of other nitrile oxides as well as different reaction conditions for 1,3-dipolar 
cycloaddition to the 1,1-disubstituted double bond or the optimization of a selective 
epoxidation of the endocyclic double bond of oxabicyclic dialkenes leave the door open for 
the future synthesis of oxetanes with an isoxazoline ring at C3. 
A more promising alternative strategy would be the debenzylation of epoxides 180 and 181 
without reduction of the exocyclic double bond before attempting the 1,3-dipolar 
cycloaddition (see Scheme 54). In the absence of the benzyl group at carbon C2, the steric 
hindrance of the 1,1-disubstituted alkene would diminish, thus facilitating the addition of the 
bromonitrile oxide to the exocyclic double bond and releasing the ring strain (sp2 carbon 
atom). 
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Scheme 54: Alternative for the introduction of an isoxazoline ring in the oxatricyclic skeletal structure. 
4.6 Synthesis of C2-Arylated and Alkylated Oxatricyclic Oxetanes using Grignard 
Reagents 
The synthesis of dioxatricyclic oxetanes with an additional aryl or alkyl group at carbon C2 
was the next goal of the present work completing a series of higher functionalized 
dioxatricyclic structures (see Scheme 55). The attachment of an alkyl or aryl group should be 
achieved prior to the intramolecular cyclization to oxetane ring. The method of choice for the 
                                                 
101
 See Section 1.5.2.1. 
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introduction of an aryl or alkyl group at C2 position was the addition of an organometallic 
compound to the carbonyl group. 
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Scheme 55: Retrosynthesis of dioxatricyclic oxetanes with alkyl or aryl groups at C2 starting 
from meso-oxabicycles rac-49 and rac-90. 
Starting from meso-oxabicycles rac-49 and rac-90, epoxy alcohol 205 is easily accessible 
following the route towards precursors of dioxatricyclic oxetanes.102 Then, epoxy alcohol 205 
should be first oxidized to epoxy ketone 204 and treated with an organometallic reagent 
affording a tertiary alcohol 206, which is the precursor of alkylated dioxatricyclic oxetane 120 
(see Scheme 56). 
Organomagnesium compounds can function as a strong base and a Lewis acid.103 Therefore, 
after nucleophilic attack to the carbonyl group, these organometallic reagents can catalyze the 
intramolecular cyclization of tertiary alcohol 206 to desired oxetane ring. In addition, 
competing reactions would be minimize because of their lower reactivity compared to the 
corresponding organolithium compounds. 
                                                 
102
 See Section 2.1 and Section 4.1. 
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 a) Wakefield, B. L. In Comprehensive Organometalic Chemistry ; Wilkinson, G.; Stone, F. G. A.; Abel. E. W., Eds.; Pergamon: Oxford, 
1982, Chapter 44; b) Nützel, K. J. Organomet. Chem. 1973, 13/2a, 47; c) Raston, C. L.; Salem, G. The Chemistry of the Metal-Carbon Bond 
Hartley, F. R.; Ed.; Wiley: Chichester, 1987; Vol. 4, Chapter 2; d) Kharasch, M.; Reinmuth, O. Grignard Reactions of Non-metallic 
Substances;  Prentice-Hall: New York, 1954; e) Ioffe, S. T.; Nesmeyanov, A. N. The Organic Compounds of Magnesium, Beryllium, 
Calcium, Strontium and Barium; North-Holland: Amsterdam, 1967. 
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Scheme 56: Synthetic route to dioxatricyclic oxetanes with alkyl or aryl groups at C2 starting 
from meso-oxabicycles rac-49 and rac-90. 
As outlined in Scheme 56, epoxy alcohol 205 was synthesized starting from meso-oxabicycles 
rac-49 and rac-90 in four steps following the developed route towards precursors of 
dioxatricyclic oxetanes. The synthesis of pivaloate and benzoate substituted epoxy alcohols 
from meso-oxabicycle rac-90 was already described in Section 4.1, while the synthesis of 
pivaloate and benzoate substituted epoxy alcohols from meso-oxabicycle rac-49 was carried 
out as reported by S. Proemmel.104 Methoxy substituted epoxy alcohols from meso-
oxabicycles rac-49 and rac-90 were prepared as described by J. Wittenberg105 and M. Vidal 
Pascual.106 
4.6.1 Oxidation of Epoxy Alcohols 
The first step towards the synthesis of arylated or alkylated dioxatricyclic oxetanes was the 
oxidation of the 2-endo-hydroxyl group to afford the required ketone 204 for a later reaction 
with Grignard reagents. Starting from epoxy alcohol 205, different oxidation methods and 
protecting groups at carbon C3 were chosen to obtain desired epoxy ketone 204 (see Scheme 
56). 
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 Proemmel, S.; Wartchow, R.; Hoffmann, H. M. R. Tetrahedron 2002, 58, 6199. 
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 Wittenberg, J.; Beil, W.; Hoffmann, H. M. R. Tetrahedron Lett. 1998, 39, 8259. 
106
 Vidal Pascual, M. PhD Thesis, University of Hannover, 2003. 
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PCC oxidation proved to be the best choice because of excellent yields, absence of by-
products and several practical advantages: inexpensive reagent, straightforward reaction, mild 
conditions, easy work-up procedure and no need of chromatographic purification (compounds 
are obtained in high purity). 
4.6.1.1 Oxidation of Pivaloate 160 
In the case of pivaloate protected epoxy alcohol 160, ketone 207 was obtained in excellent 
yield under the attempted oxidation conditions except for Parikh-Doering oxidation (see Table 
10). 
OPiv
O
O
O
OPiv
O
OH
O
Oxidation Conditions
(see Table below)
160 207
 
Entry Conditions Yield [%] 
1 (COCl)2, DMSO, Et3N, -78°C → rt - rt, 2.5 h 91 
2 SO3·Py, DMSO, Et3N, 0°C, 24 h 47 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 99 
4 Dess-Martin Periodinane, DCM, rt, 2 h 92 
Table 10: Attempted oxidations of epoxy alcohol 160. 
4.6.1.2 Oxidation of Pivaloate 131 
The oxidation of epoxy alcohol 131 using DMP or PCC led exclusively to ketone 208 in 
excellent yield. Swern and Parikh-Doering oxidations afforded desired ketone 208 together 
with ketone 209, in which the pivaloate function is in equatorial position (see Table 11). 
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Entry Conditions 
Total Yield 
[%] 
Ratio of products 
208:209 
1 (COCl)2, DMSO, Et3N, -78°C → rt, 2 h 90 1:2 
2 SO3·Py, DMSO, Et3N, 0°C, 24 h 60 1:1 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 95 100% 208 
4 Dess-Martin Periodinane, DCM, rt, 4 h 89 100% 208 
Table 11: Attempted oxidations of epoxy alcohol 131. 
Under Swern and Parikh-Doering oxidation conditions the pivaloate function at C3 adopts the 
thermodynamically favoured equatorial position. This inversion of the carbon center at carbon 
C3 proceeds by keto-enol-tautomerism under the basic conditions (triethylamine) (see 
Scheme 57). 
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Scheme 57: Keto-enol-tautomerism of epoxy ketone 208. 
4.6.1.3 Oxidation of Benzoate 155 
Benzoate protected epoxy alcohol 155 was oxidized exclusively to ketone 210 using either 
PCC or DMP in quantitative yield, while Swern and Parikh-Doering oxidations afforded again 
a mixture of ketones 210 and 211 (see Table 12). Moreover, under Swern oxidation 
conditions 16% of deprotected epoxy ketone was obtained because of the basicity of the 
reaction medium. 
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Entry Conditions 
Total Yield 
[%] 
Ratio of products 
210:211 
1 (COCl)2, DMSO, Et3N, -78°C → rt, 2.5 h 53a 4:1 
2 SO3·Py, DMSO, Et3N, 0°C, 24 h 95 1:5 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 99 100% 210 
4 Dess-Martin Periodinane, DCM, rt, 4 h 95 100% 210 
Table 12: Attempted oxidations of epoxy alcohol 155. a) Obtention of additional 16% of deprotected ketone. 
4.6.1.4 Oxidation of Benzoate 136 
PCC oxidation of benzoate protected epoxy alcohol 136 led to desired epoxy ketone 212 in 
excellent yield while the other three oxidation methods afforded a mixture of epoxy ketones 
212 and 213 in lower yield (see Table 13). In constrast to the methylated analogue 155, DMP 
oxidation of epoxy alcohol 136 gave a mixture of both diastereomers after epimerisation. 
OBz
O
O
O
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Oxidation Conditions
(see Table below)
OBz
O
O
O
136 212 213
 
Entry Conditions 
Total Yield 
[%] 
Ratio of products 
212:213 
1 (COCl)2, DMSO, Et3N, -78°C → rt, 16 h 24 1:3 
2 SO3·Py, DMSO, Et3N, 0°C, 16 h 72 1:1 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 95 100% 212 
4 Dess-Martin Periodinane, DCM, rt, 16 h 54 3:1 
Table 13: Attempted oxidations of epoxy alcohol 136. 
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4.6.1.5 Oxidation of Methyl Ether 56 
Epoxy methyl ether 56 was oxidized to ketone 214 under different oxidation conditions. The 
best results were obtained using PCC or DMP as summarized in Table 14. No inversion 
tendency to the equatorial position was observed using the less electron attracting ether 
function. 
OMe
O
O
O
OMe
O
OH
O
Oxidation Conditions
(see Table below)
56 214
 
Entry Conditions Yield [%] 
1 (COCl)2, DMSO, Et3N, -78°C → rt, 2.5 h 50 
2 SO3·Py, DMSO, Et3N, 0°C, 24 h 30 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 95 
4 Dess-Martin Periodinane, DCM, rt, 2 h 99 
Table 14: Attempted oxidations for epoxy alcohol 56. 
4.6.1.6 Oxidation of methyl ether 94 
O-Methyl protected epoxy alcohol 94 was not stable under Swern and Parikh-Doering 
oxidation conditions and the desired epoxy ketone 215 was only obtained using PCC or DMP 
in good yield. 
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(see Table below)
94 215
 
Entry Conditions Yield [%] 
1 (COCl)2, DMSO, Et3N, -78°C → rt, 2.5 h - 
2 SO3·Py, DMSO, Et3N, 0°C, 24 h - 
3 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 56 
4 Dess-Martin Periodinane, DCM, rt, 2 h 57 
Table 15: Attempted oxidations for epoxy alcohol 94. 
4.6.1.7 Oxidation of Deoxygenated Epoxy Alcohol 147 
Finally, the oxidation of deoxygenated epoxy alcohol 147 using DMP occurred in higher yield 
compared to PCC oxidation. 
O
O
O
O
OH
O
Oxidation Conditions
(see Table below)
147 216
 
Entry Conditions Yield [%] 
1 PCC, NaOAc, 4 Å MS, DCM, rt, 1 h 58 
2 Dess-Martin Periodinane, DCM, rt, 16 h 77 
Table 16: Attempted oxidation for deoxygenated alcohol 147. 
4.6.2 Synthesis of C2-Arylated and Alkylated Oxatricyclic Oxetanes using 
Grignard Reagents 
The next step of the synthetic route towards new arylated and alkylated dioxatricyclic 
oxetanes was the introduction of an aryl or alkyl group at carbon C2 by chemoselective and 
exo-selective addition of a Grignard reagent to the carbonyl function of different epoxy 
ketones. It was anticipated that, after addition of Grignard reagents, the resulting tertiary 
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alcohols could undergo immediately intramolecular cyclization to oxetane ring, because of the 
Lewis acidic character of the organomagnesium compounds.103 In other words, C2-arylated 
and alkylated would be synthesized by a tandem Grignard reagent-mediated addition-
cyclization reaction. 
The relative reactivity of a series of carbon nucleophiles may be assessed to a first 
approximation by comparing the pKa values of their conjugate acids. The weakest acids 
produce the strongest conjugate bases, i.e. the most reactive nucleophiles. Table 17 presents a 
list of representative systems ranked in order of increasing acidity. 
Compound Structure pKa 
Methane CH3-H 60 
Ethene CH2=CH-H 45 
Benzene 
H
 43 
Ethyne HC≡C-H 25 
Water HO-H 15.7 
Table 17:  Values of pKa’s of a selection of representative systems. 
Hydrocarbons are very weak acids, implying that the corresponding carbanions will be strong 
bases. Considering the Grignard reagents used in the above studied synthesis of alkylated 
dioxatricyclic oxetanes, vinyl magnesium bromide is the most reactive followed closely by 
phenylmagnesium bromide while ethynylmagnesium halides are weaker. 
4.6.2.1 Synthesis of Oxatricyclic Oxetanes with a Phenyl Group at Carbon C2 
The attachment of an aryl group at carbon C2 of the oxatricyclic skeletal structure was first 
attempted by treatment of pivaloate substituted epoxy ketones 207 and 208 with 
phenylmagnesium bromide (see Scheme 58). In general, pivaloate ester could be attacked by 
the nucleophilic Grignard reagent but the steric hindrance of the phenyl carbanion as well as 
the shielding effect of the methyl groups of the pivaloate ester diminished this competing 
reaction. Epoxy ketones 207 and 208 reacted indeed with phenylmagnesium bromide to afford 
exclusively desired dioxatricyclic oxetanes 217 and 218 without affecting the pivaloate group 
at carbon C3. 
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Scheme 58:  Synthesis of dioxatricyclic oxetanes 217 and 218 using phenylmagnesium bromide. 
The same tandem strategy was applied for methoxy substituted epoxy ketone 214, which 
provided a mixture of arylated endo-hydroxy epoxide 219 and dioxatricyclic oxetane 220 in a 
5:2 ratio in 66% yield (see Scheme 59). 
The obtained alkylated α-configured hydroxy epoxide 219 could undergo a base-catalyzed 
intramolecular cyclization to desired oxetane 220 using potassium tert-butoxide in THF, as in 
the synthesis of similar methoxy-substituted dioxatricyclic oxetanes.52,63 
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Scheme 59: Synthesis of dioxatricyclic oxetane 220 using phenylmagnesium bromide. 
4.6.2.2 Synthesis of Oxatricyclic Oxetanes with an Ethynyl Group at Carbon C2 
In view of the satisfactory results using phenylmagnesium bromide in the synthesis of 
arylated dioxatricyclic oxetanes, the use of other Grignard reagents was further investigated. 
Epoxy ketones 207 and 208 were also treated with ethynyl magnesium halides to afford a 
mixture of desired oxetane and endo-hydroxy epoxide. Yields and ratio of products are 
summarized in Table 18. Treatment of epoxy ketones with ethynyl magnesium bromide 
yielded desired oxetane in higher ratio than using ethynyl magnesium chloride, the former 
being more reactive than the later. 
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Entry R Conditions 
Total Yield 
[%] 
Ratio of  
221:222 
(223:224) 
1 H EthynylMgBr, THF, -30°C → rt, 16 h 25 0:1 
2 H EthynylMgCl, THF, -30°C → rt, 16 h 65 5:1 
3 Me EthynylMgBr, THF, -30°C → rt, 16 h 55 1:4 
4 Me EthynylMgCl, THF, -30°C → rt, 16 h 34 2:7 
Table 18: Attempted reaction conditions using ethynylmagnesium halides for the synthesis of dioxatricyclic 
oxetanes 222 and 224. 
The obtained alkylated α-configured hydroxy epoxides 221 and 223 underwent Lewis acid-
catalyzed intramolecular cyclization to desired oxetanes 222 and 224 in 56 and 61% yield, 
respectively, as outlined in Scheme 60. 
OPiv
O
O
R R
OH
BF3·OEt2
DCM, 0°C-rt
OPiv
O
O
HO
RR
222: R = H (56%)
224: R = Me (61%)
221: R = H
223: R = Me
 
Scheme 60: Lewis acid-catalyzed intramolecular cyclization using BF3⋅OEt2 in THF to 
dioxatricyclic oxetanes 222 and 224. 
4.6.2.3 Synthesis of Oxatricyclic Oxetanes with a Vinyl Group at Carbon C2 
Treatment of epoxy ketone 207 with the more reactive vinyl magnesium bromide led to 
oxetane 225 in low yield and unwanted by-product 226, which results from the cleavage of 
the pivaloate at carbon C3 (see Scheme 61). To explain these results, the reactivity and the 
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conformational aspects of the addition of Grignard reagents to epoxy ketones are carefully 
examined in the next section. 
OPiv
O
O
O
OPiv
O
O
HO
MgBr
THF, -30°C-rt,
4 h
OH
O
O
HO
207 225, 42% 226
 
Scheme 61: Tandem addition-cyclization reaction by using vinylmagnesium bromide afforded 
dioxatricyclic oxetane 225 and by-product 226. 
4.6.2.4 Reactivity Considerations in the Synthesis of Alkylated Dioxatricyclic 
Oxetanes 
The above reported results of the addition of different Grignard reagents to dioxatricyclic 
epoxy ketones agree with the relative reactivity of organomagnesium compounds. Weaker 
ethynylmagnesium halides reacted with epoxy ketones leading to a mixture of endo-hydroxy 
epoxide and desired oxetane. As mentioned in Section 4.6.2.2, addition of ethynylmagnesium 
chloride provided the oxetane in lower yield than that of ethynyl magnesium bromide because 
of the lower reactivity of the chloride compared to the bromide. Pivaloate ester was 
unaffected by these Grignard reaction conditions because of the lower basic character of these 
halides and the high stability of the pivaloate protecting group. 
In the case of more reactive phenylmagnesium bromide, C2-arylated dioxatricyclic oxetane 
was obtained exclusively without cleavage of the pivaloate ester. In contrast, addition of 
slightly more reactive vinylmagnesium bromide proceeded in lower yield because desired 
oxetane was obtained together with by-products resulting from the pivaloate cleavage. The 
fact that this competing side reaction did not occur using similarly reactive phenylmagnesium 
bromide can be explained by the steric hindrance of the phenyl group in comparison to the 
vinyl group. Sterically hindered phenyl carbanion adds only to the accessible and more 
reactive ketone rather than to the stable pivaloate ester whose carbonyl group is shielded from 
nucleophilic attack by methyl groups. In contrast, less sterically hindered vinyl group is able 
to add partially to the electrophilic carbonyl group of pivaloate. 
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4.6.2.5 Mechanistic Considerations in the Synthesis of C2-Alkylated Dioxatricyclic 
Oxetanes 
Mechanistic and conformational aspects of the Grignard reaction to epoxy ketones and later 
intramolecular cyclization towards dioxatricyclic oxetanes are outlined in Scheme 62. The 
addition of the organomagnesium compound to the ketone proceeds with facial selectivity on 
the less hindered side of the carbonyl group through a complex formation between both 
substrates. Afterwards, a conformational change in resulting tertiary endo-hydroxy epoxide 
230 must precede the cyclization. The six-membered oxacyclic ring changes to a minor boat 
231, in which the hydroxyl function moves to axial position for a stereoelectronically 
favoured formation of the new oxetane C-O bond. Simultaneously, the protecting group at C3 
(methyl ether or pivaloate ester) and the aryl or alkyl group at C2 move from axial positions 
to thermodynamically favoured equatorial positions, lowering the energy difference between 
chair conformation 230 and boat transition state 231. After formation of the tricyclic oxetane 
232, the bulky substituents at carbons C3 and C2 occupy less hindered equatorial positions in 
an oxacyclohexane boat. Thus, conformational analysis shows a driving force for the 
formation of arylated or alkylated oxetanes despite the steric hindrance of the substituents. 
Besides, additional methyl groups at the bridgehead carbons increase the stability of 
dioxatricyclic oxetane structure. 
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Scheme 62: Addition of Grignard reagents to epoxy ketones and intramolecular cyclization to 
alkylated oxetanes. 
4. Synthesis of New Dioxatricyclic Subunits of Dictyoxetane 81 
 
4.6.3 Summary and Conclusions of the Synthesis of C2-Alkylated and Arylated 
Dioxatricyclic Oxetanes 
Following a short and valuable route a series of arylated and alkylated dioxatricyclic oxetanes 
was synthesized. Starting from versatile meso-oxabicycles rac-49 and rac-90, epoxides 56, 
131 and 160 were obtained over four steps in good yield. The conversion of the endo-
hydroxyl group into ketone was attempted with different oxidants (PCC, Swern, Parikh-
Doering and DMP). PCC oxidation proved to be the best method to prepare epoxy ketones 
207, 208 and 214. Afterwards, the introduction of aryl and alkyl groups at carbon C2 was 
accomplished by a Grignard reagent-mediated addition/cyclization tandem reaction of epoxy 
ketones 207, 208 and 214. Moreover, dioxatricyclic oxetanes 222 and 224 could be obtained 
by Lewis acid-catalyzed cyclization of isolated tertiary alcohols. 
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Scheme 63:  Synthesis of alkylated and arylated dioxatricyclic oxetanes. 
4.7 Summary of new Synthesized Dioxatricyclic Oxetanes 
The biological activity shown by some dioxatricyclic subunits of dictyoxetane107 stressed the 
importance of the synthesis of new dioxatricycles starting from meso-oxabicycles rac-49 and 
rac-90. 
Starting from 2α-benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one, dioxatricyclic oxetanes with 
different ester functions at C3 position were synthesized as an alternative to the more stable 
ether protecting group. Tert-butylester was the best choice for preparing tricyclic oxetanes 
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4. Synthesis of New Dioxatricyclic Subunits of Dictyoxetane 83 
 
compared to benzoate and acetate groups since pivaloate did not show any tendency for 
migration. Furthermore, the synthesis of dioxatricyclic oxetanes proved to be clearly more 
successful using a pivaloate ester than an ether function108 at C3 position in absence of 
stabilizing methyl groups at the bridgehead carbons. 
The possibility of reducing the number of steps in the synthetic route towards dioxatricyclic 
oxetanes by tandem Lewis acid-catalyzed debenzylation-cyclization reaction was 
investigated. Treatment of different oxatricyclic epoxides with BCl3 afforded a mixture of 
oxetanes and unwanted dioxatricycles as a result of pivaloate cleavage or migration of the 
benzoate group. Nevertheless, the reactivity of BCl3 opened a new synthetic access to 2,6-
dioxatricyclo[3.3.1.03,7]nonanes as TXA2-analogues starting from meso-oxabicycle rac-49. 
Attempted synthesis of a new deoxygenated oxatricyclic oxetane starting from meso-
oxabicycle rac-90 led only to a mixture of desired oxetane 119 and dioxatricycle 148 in poor 
yield. 
Starting from oxabicyclic dialkenes, the synthesis of higher functionalized oxetanes with a 
bromoisoxazoline ring at C3 was studied. Whereas a site selective 1,3-dipolar cycloaddition 
to the 1,1-disubstituted double bond of the oxabicyclic dialkene was unsuccessful, attempted 
site selective epoxidation of the 1,2-disubstituted alkene provided a mixture of epoxides. 
Nevertheless, other nitrile oxides as well as different reaction conditions for the 1,3-dipolar 
cycloaddition to the 1,1-disubstituted double bond as well as the optimization of a 
regioselective epoxidation should be further investigated. 
An efficient route to higher functionalized dioxatricyclic oxetanes with alkyl and phenyl 
groups at C2 position was accomplished starting from versatile meso-oxabicycles rac-49 and 
rac-90. The introduction of alkyl and phenyl groups proceeded by stereoselective tandem 
addition-cyclization reaction upon treatment of epoxy ketones with different Grignard 
reagents. 
In summary, the synthetic strategy towards dioxatricyclic subunits of dictyoxetane starting 
from oxabicycles rac-49 and rac-90 offers a valuable and straightforward route to a series of 
versatile compounds containing the skeletal structure 2,7-dioxatricyclo[4.2.1.03.8]nonane with 
potential biological activity. 
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Scheme 64: Overview of the new dioxatricycles starting from oxabicycles rac-49 and rac-90. 
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5. Attempted Enzymatic Resolution of Tricyclic Subunits of Dictyoxetane 
Until now only the relative configuration of dictyoxetane has been established.109 The 
determination of the absolute configuration of this natural product is essential not only for the 
understanding of its biological activity but also for a more comprehensive approach of its 
biogenesis in Dictyota dichotoma. Furthermore, the anti-tumor activity shown by some 
reported dioxatricycles110 stresses the interest for the stereochemistry of dioxatricyclic 
subunits of dictyoxetane. 
As reported in Section 4.1.3, the direct synthesis of acetate protected dioxatricyclic oxetanes 
for enzymatic resolution failed because of the acyl migration tendency. In the present chapter, 
determination of the absolute configuration of new oxabicyclic and dioxatricyclic segments 
was attempted after enzymatic resolution of acetate protected meso-compounds. 
In recent years, esterases and lipases with high stereoselectivity and substrate selectivity have 
been exploited for transformations which would otherwise be difficult to achieve using 
“standard” synthetic methodology. For instance, the enzymatic desymmetrization of meso 
substrates has recently become a powerful tool in the de novo synthesis of enantiomerically 
pure compounds.111  
One of the most promising enzymes in terms of substrate specificity and stereoselectivity is 
the lipase PS from Pseudomonas cepacia (Amano).112 One example of lipase PS catalyzed 
hydrolysis is the enzymatic desymmetrization of meso-diacetates meso-233 and meso-235 by 
T. Lampe.113 Benzyl ether meso-233 and meso-235 were desymmetrized with >98% e.e. upon 
the action of lipase PS in a 4:1 mixture of 0.5 molar phosphate buffer and toluene at pH 7. 
The corresponding 2,4,6-trifunctionalized C-glycosides (-)-234 and (-)-236 were obtained in 
high chemical yield and excellent optical purity (see Scheme 65). 
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Scheme 65: Desymmetrization of meso-diacetates meso-233 and meso-235 with Lipase PS by T. Lampe. 
Lipase PS catalyzed hydrolysis of deoxygenated dioxatricycle rac-237 was attempted by S. 
Proemmel114 under standard conditions without success (see Scheme 66). Presumably the 
acetate group may not reach the reactive center of the lipase PS because of the steric 
hindrance of dioxatricycle rac-237. Enzymatic hydrolysis of meso-acetate rac-240 using 
different lipases (PS, PV, PPL) also failed owing to the proximity of the acetate group to the 
sterically hindered carbon skeleton. 
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Scheme 66: Attempted enzymatic hydrolysis of acetates rac-237 and rac-240 by S. Proemmel. 
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Despite the disappointing results of the attempted enzymatic hydrolysis of dioxatricycle rac-
237 and oxabicycle rac-240 by S. Proemmel, the enzymatic resolution of dioxatricyclic meso-
compounds was investigated in the present work. 
Meso-alcohols rac-131 and rac-68 were first converted quantitatively into meso-acetates rac-
243 and rac-246. Racemic acetates rac-243 and rac-246 were then subjected to the conditions 
for lipase PS catalyzed enzymatic hydrolysis optimized by T. Lampe. After one week no 
products of hydrolysis were observed and both reactions were quenched (see Scheme 67). 
The acetate group in both pivaloates rac-243 and rac-245 may not reach the reactive center of 
the lipase PS owing to steric hindrance of the dioxatricyclic structure. The absence of the 
methyl groups at the bridgehead carbon atoms in pivaloate rac-243 does not improve the 
results of the attempted enzymatic hydrolysis comparing to more sterically hindered pivaloate 
rac-245. The access of the acetate group to the reactive center of the lipase PS is hindered in 
both cases. 
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Scheme 67: Attempted enzymatic hydrolysis of racemic acetates rac-131 and rac-68. 
Enzymatic resolution was also attempted with a dioxatricyclic oxetane system. For this 
purpose, meso-pivaloate rac-131 was acetylated quantitatively and meso-acetate rac-247 was 
subjected to lipase PS catalyzed enzymatic hydrolysis. After one week the reaction was 
quenched without products of hydrolysis (see Scheme 68). 
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Scheme 68: Attempted enzymatic hydrolysis of meso-acetate rac-247. 
In view of the failed enzymatic resolution of the caged dioxatricyclic rac-243, rac-245 and 
rac-247, the meso-oxabicycle rac-139 was used as a model compound for further 
investigation. After acetylation of meso-oxabicycle rac-90, resulting meso-acetate rac-139 
was treated with lipase PS under hydrolysis conditions without success (see Scheme 69). The 
proximity of the acetate group to the shielding benzyl ether group in the oxabicyclic structure 
possibly makes the approach to the reactive center of the lipase difficult. 
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Scheme 69: Attempted enzymatic hydrolysis of meso-acetate rac-139. 
Further attempts on the synthesis of enantiopure dioxatricycles were not carried out in the 
framework of the present work. 
5.1 Outlook 
Regarding the reported results, oxabicyclic and oxatricyclic compounds are sluggish 
substrates for enzymatic resolution because of the proximity of the acetate group to the 
sterically hindered skeletal structure. An alternative to these sterically congested 
meso-acetates would be the synthesis of the meso-allyl ester rac-250, where the acetate group 
is in farther distance from the skeletal structure. 
5. Attempted Enzymatic Resolution of Tricyclic Subunits of Dictyoxetane 89 
 
O
O
OPiv
O
O
HO
OPiv
O
O
OPiv
OAc
steps Enzymatic resolution
rac-250rac-132 (+)-251
OAc
 
Scheme 70: Proposed synthesis of less sterically hindered meso-allyl ester rac-250 for enzymatic resolution. 
Another valuable alternative reported by S. Proemmel and M. Vidal Pascual is the synthesis 
of enantiomerically pure oxatricyclic structures using asymmetric [4+3]-cycloaddition of 
enantiopure silylenolether, as mentioned in Section 2.1. 
Other methods for enantioselective synthesis include the use of chiral reagents. The synthetic 
route towards tricyclic compounds offers several possibilities for the use of chiral reagents. 
For instance, meso-oxabicycle rac-90 could be converted into a diastereomeric mixture using 
(R)-(+)-N-amino-(methoxymethyl)-pyrrolidine (RAMP) (see Scheme 71). 
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Scheme 71: Proposed obtention of a diastereomeric mixture using (R)-(+)-N-amino-
(methoxymethyl)-pyrrolidine (RAMP). 
The conversion of meso-tricyclic ketone rac-255 into a diastereomeric mixture in a later step 
of the synthetic route should be even more advantageous (see Scheme 72). 
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Scheme 72: Proposed obtention of a diastereomeric mixture using (R)-(+)-N-amino-
(methoxymethyl)-pyrrolidine (RAMP). 
As outlined in Scheme 71 and Scheme 72, several alternatives for the synthesis of enantiopure 
dioxatricyclic subunits of dictyoxetane remain open for further investigation. 
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6. Synthesis of Aza-analogous Tricyclic Systems 
The second major aim of the present work was the synthesis of aza-analogues of the 
dioxatricyclic subunit of dictyoxetane with an azetidine ring substituting the oxetane ring (see 
Scheme 73). As described in Chapter 1, the azetidine ring system represents an unusual 
substructure of several relevant classes of drugs and has also been identified as a structural 
feature in some natural products with significant biological activity. Therefore, the 
introduction of an azetidine ring in the tricyclic skeletal structure constituted not only an 
important synthetic challenge but also offered an access to potential pharmacologically active 
compounds. 
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Scheme 73: Oxazatricyclic system 258 is analogous to the dioxatricyclic subunit of dictyoxetane. 
The synthetic route towards oxatricyclic azetidines was designed starting from meso-
oxabicycles rac-49 and rac-90 , which already contain two of the three rings of the skeletal 
structure 7-oxa-2-aza-tricyclo[4.2.1.03.8]nonane (see Scheme 74). The key reaction of the 
synthetic strategy is the introduction of an endo-amine function at C2 position to afford the 
appropriate precursors 260 for the key intramolecular cyclization to tricyclic azetidine 259. 
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Scheme 74: Synthetic strategy towards oxatricyclic azetidines. 
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6.1 Synthetic Strategy towards Tricyclic Azetidines by Reductive Amination 
The synthesis of oxatricyclic azetidines containing the skeletal structure 7-oxa-2-aza-
tricyclo[4.2.1.03.8]nonane was approached following the synthetic pathway outlined in 
Scheme 75. In this strategy, the method of choice for the introduction of an endo-amino group 
was the reductive amination115 of a ketone function, one of the most useful routes to 
synthesize amines. 
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Scheme 75: Synthetic strategy for the synthesis of tricyclic azetidines starting from meso-
oxabicycles rac-49 and rac-90. 
Starting from meso-oxabicycles rac-49 and rac-90, epoxy alcohols 205 were obtained over 
four steps in good yield.116 The α-configurated hydroxyl group of these oxatricyclic structures 
was protected with either pivaloate ester or methyl ether because both protecting groups 
showed already high stability towards Grignard reagents in the synthesis of C2-alkylated 
                                                 
115
 For reviews on reductive amination see: a) Emerson,W. S. Org. Reactions, Wiley; 1948, 4, 174; b) Lane, C. F. Synthesis, 1975, 135; c) 
Hutchins, R.O.;Hutchins, M. K. In Comprehensive Organic Synthesis, Trost, B. M.; Fleming, I., Eds.; Pergamon Press: Oxford, 1991, Vol. 8, 
25; d) Baxter, E.W.; Reitz, A. B. Org. Reactions,Wiley, 2002, 59, 1. 
116
 The synthesis of pivaloate substituted epoxy alcohol 131 was already described in Section 4.1 and pivaloate 160 and methyl ether 56 were 
synthesized following reported methods by J. Wittenberg and S. Proemmel, as  mentioned in Section 4.6. 
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dioxatricyclic oxetanes.117 Synthesized versatile epoxy alcohols 205 were then oxidized with 
PCC to afford the epoxy ketones 204.118 
Epoxy ketones 204 were then converted to tricyclic azetidines in two steps: reductive 
amination and intramolecular cyclization. For the reductive amination of epoxy ketones two 
possibilities were investigated: the introduction of a primary endo-amine and the introduction 
of a secondary endo-N-alkylamine. 
The synthesis of primary epoxy amines was not successful using common reductive 
amination methods, as it is reported in Section 6.2. The synthesis of secondary epoxy endo-N-
alkylamines showed difficulties that took many attempts and a great deal of effort to 
overcome. The examined reductive amination procedures are thoroughly discussed in Section 
6.3. Under the optimized reaction conditions reductive amination of epoxy ketones afforded 
desired secondary epoxy amines in good yield without affecting the epoxide ring. Once 
synthesized, secondary epoxy amines underwent an intramolecular cyclization leading to the 
desired oxatricyclic azetidines 259 (see Section 6.4). 
6.2 Attempted Synthesis of Primary Epoxy Amines 
Following the route towards tricyclic azetidines, the synthesis of primary epoxy amines was 
first studied using pivaloate substituted epoxy ketones 208 and 207 as starting material. 
Reductive amination of these epoxy ketones was attempted following common methods in 
order to afford primary amines 261 and 262. Once synthesized, primary epoxy amines should 
be protected using Boc. Intramolecular cyclization of resulting N-Boc-protected epoxy amines 
263 and 264 would lead to desired oxatricyclic azetidines 265 and 266 (see Scheme 76). 
                                                 
117
 See Section 4.6.2. 
118
 As reported in Section 4.6.1, PCC oxidation proved to be the best choice. 
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Scheme 76: Attempted synthesis of Boc-protected primary amines 263 and 264, precursors of 
azetidines 265 and 266. 
As outlined in Table 19, the synthesis of primary amines by reductive alkylation of ammonia 
was unsuccessful using standard methods. The most popular reductive amination in recent 
years, the Borch reduction,119 uses sodium cyanoborohydride as reductant and a large excess 
of ammonium acetate. Treatment of epoxy ketones 208 and 207 under these Borch conditions 
afforded exclusively epoxy alcohols 131 and 160, resulting from the competing reduction of 
the carbonyl function (see entries 1 and 3, Table 19). Addition of 3Å molecular sieves to 
promote imine formation by absorbing water did not alter the results. Use of titanium (IV) 
isopropoxide prior to addition of NaBH3CN was also unsuccessful and only the epoxy alcohol 
was obtained (see entries 2 and 4, Table 19). Presumably, the formation of the iminium 
intermediate upon exposure of the epoxy ketone to ammonium acetate is so slow that the 
ketone function is reduced faster by NaBH3CN to the corresponding epoxy alcohol. 
                                                 
119
 a) Borch, R. F.; Bernstein, M. D.; Durst, H. P. J. Am. Chem. Soc. 1971, 93, 2897; b) Borch, R. F. Org. Synth. 1972, 52, 124; c) Borch, R. 
F.; Hassid, A. I. J. Org. Chem. 1972, 37, 1673. 
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Entry R Conditions Yield [%] 
1 H NH4OAc, NaBH3CN, MeOH, rta 25% Epoxy alcohol 
2 H NH4OAc, NaBH3CN, Ti(Oi-Pr)4, MeOH, rt,  29% Epoxy alcohol 
3 Me NH4OAc, NaBH3CN, MeOH, rta 40% Epoxy alcohol 
4 Me NH4OAc, NaBH3CN, Ti(Oi-Pr)4, MeOH, rt 50% Epoxy alcohol 
Table 19: Attempted reductive amination conditions for the synthesis of primary endo-amines 261 and 262. a) 
Addition of 3 Å molecular sieves. 
Attempted reductive amination reactions using ammonium acetate and NaBH3CN with 
different additives, e. g. 3 Å molecular sieves and titanium (IV) isopropoxide, were not 
successful. Nevertheless, the synthesis of primary epoxy amines remains open for further 
investigation. Recent literature examples report alternative methods for the conversion of 
ketones to primary amines. For instance, the synthesis of 3-endo-tropanamine by a modified 
palladium catalyzed reduction of tropanone in an aqueous/alcoholic medium with ammonium 
formate salt as nitrogen and hydrogen source.120 
6.3 Synthesis of Secondary Epoxy Amines 
In view of the disappointing results of the synthesis of primary epoxy amines, the introduction 
of a secondary endo-amino group in different epoxy ketones was next attempted. 
                                                 
120
 a) Allegretti, M.; Berdini, V.; Cesta, M. C.; Curti, R.; Nicolini, L.; Topai, A. Tetrahedron Lett. 2001, 42, 4257; b) Berdini, V.; Cesta, M. 
C.; Curti, R.; D'Anniballe, G.; Di Bello, N.; Nano, G.; Nicolini, L.; Topai, A.; Allegretti, M. Tetrahedron 2002, 58, 5669. 
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Scheme 77: Reductive amination of epoxy ketones by reductive amination affording epoxy N-
methylamines, precursors of tricyclic azetidines. 
Reductive amination is dependent not only on the reactivity of the carbonyl function but also 
on the basicity of the amine. A ketone generally reacts with a more basic amine in the absence 
of factors such as steric hindrance. Thus sterically hindered epoxy ketones will preferentially 
react with a more basic and small amine than with a less basic or more sterically hindered 
one. Therefore, the amine of choice for the first attempted synthesis of secondary amines was 
methylamine. 
The synthesis of secondary epoxy N-methylamines was first attempted by reductive amination 
of pivaloate substituted epoxy ketones 208 and 207 using several procedures. Once optimized, 
the reductive amination conditions were also applied for the conversion methoxy substituted 
epoxy ketone 214. 
6.3.1 Synthesis of C3-Pivaloate Substituted Epoxy N-Methylamines 
6.3.1.1 Synthesis of C3-Pivaloate Substituted Epoxy N-Methylamines using 
NaBH3CN 
The first reductive amination method for the one-pot conversion of epoxy ketones 207 and 
208 to primary amines was the Borch reduction.119 This protocol involves sodium 
cyanoborohydride as the reductant and a fivefold excess amount of methylamine to prevent 
the product amine from undergoing further reaction with the carbonyl compound. Besides, 
methylamine HCl salt is used as the starting material in order to achieve the optimal pH for 
reduction of the intermediate iminium species (pH 5-7). 
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Entry R Conditions 
Total Yieldf  
of 263+265+267 
(264+266+268) 
[%] 
Ratio of 
263:265:267 
(264:266:268) 
Yield of 
Alcohol 
131/160 
[%] 
1 H Direct reaction, 3 da, c 30 0:3:1: 28 
2 H Stepwise reac., 3 Å MS, 3 db, c 48 2:5:4 0 
3 H TiCl4d complex mixture of products 
4 H Ti(Oi-Pr)4e complex mixture of products 
5 Me Direct reaction, 3 da, c 18 0:3:2 53 
6 Me Stepwise reac., 3 Å MS, 3 db, c 22 0:2:1 7 
7 Me TiCl4d complex mixture of products 
8 Me Ti(Oi-Pr)4e complex mixture of products 
Table 20: Reductive amination conditions using NaBH3CN. a) Direct reaction: reductant was added at the same 
time as the epoxy ketone and amine; b) stepwise reaction: reductant was added after 16 h; c) addition of 3Å 
molecular sieves; d) amine and ketone are stirred in TiCl4/MeOH for 16 h followed by addition of NaBH3CN; e) 
amine and ketone are stirred in Ti(Oi-Pr)4/EtOH for 16 h followed by addition of NaBH3CN; f) products were 
separated by column chromatography. 
As indicated by entries 1 and 5 in Table 20, direct reductive amination of epoxy ketones 208 
and 207 using NaBH3CN and 3Å molecular sieves afforded a mixture of endo-N-
methylamine, azetidine and undesirable epoxy alcohol. The compounds could be separated by 
column chromatography. Better yields and lower competing reduction of the ketone function 
were obtained when the reaction was carried out stepwise121,122 (see entries 2 and 6 in Table 
20). In this case, the epoxy ketones were stirred with an excess amount of methylamine in the 
presence of the dehydrating agent (3Å molecular sieves) to allow the preformation of the 
intermediate imine prior to addition of the reductant. Under these conditions, less hindered 
epoxy ketone 208 was partially converted to exo-amine 263 in contrast to the more sterically 
                                                 
121
 Mićović, I. V.; Roglic, G. M.; Dosen-Mićović, L.; Kirićojević, V. D.; Popović, J. B. J. Chem. Soc., Perkin Trans. 1 1996, 2041. 
122
 The reductive amination is termed as direct when a mixture of the carbonyl compound and the amine is treated with proper reducing agent 
in a single operation. A stepwise or indirect reaction involves the preformation of the intermediate imine followed by reduction in a separate 
step. 
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hindered epoxy ketone 207, in which the introduction of the amino group at the axial position 
did not occur. 
Competing reduction of the ketone function to alcohol is more significant for sterically 
hindered epoxy ketone 207. Moreover, reductive amination of epoxy ketone 207 proceeded in 
lower yields and higher stereoselectivity than less sterically hindered epoxy ketone 208. These 
facts show the remarkable steric effect of the methyl groups at the bridgehead carbon atoms. 
Presumably, the formation of the imine intermediate upon exposure of epoxy ketone 207 to 
the amine is slower owing to this steric effect, thus lowering the yield of the reductive 
amination but increasing its stereoselectivity. 
In order to improve yields and ratio of the reductive amination of epoxy ketones 207 and 208, 
the use of titanium (IV) additives was next investigated. These Lewis acids facilitate the imine 
formation in reductive amination reactions with sodium cyanoborohydride because they form 
a complex with the carbonyl oxygen, thereby increasing the electrophilicity of the carbonyl 
carbon. Moreover Lewis acids can act as water scavengers and may also coordinate with the 
intermediate imine increasing its electrophilicity.123 Their use has been reported for 
particularly sluggish reactions, such as those involving weakly electrophilic carbonyl groups, 
poorly nucleophilic amines or sterically congested reactive centers. 
Reductive amination of epoxy ketones 208 and 207 was then carried out by treatment of the 
ketone with stoichiometric amounts of methylamine and titanium (IV) chloride124 during 16 h 
followed by addition of NaBH3CN. A complex mixture of products was obtained (see entries 
3 and 7 in Table 20). The high reactivity of TiCl4 as well as the use of an equimolar ratio of 
ketone and amine would explain the obtained results. Use of titanium (IV) isopropoxide125 
with stoichiometric amounts of methylamine and epoxy ketone followed by treatment with 
NaBH3CN led also to a complicated mixture of products (see entries 4 and 8 in Table 20). 
Although titanium (IV) isopropoxide is less reactive than titanium (IV) chloride and more 
compatible with acid-sensitive functional groups,125,126 side reactions as the bisalkylation of 
primary amines are promoted when ketone and amine are added in equimolar ratio. 
                                                 
123
 For mechanistic aspects of reductive amination reactions in the presence of Ti(OiPr)4, see Section 6.6. 
124
 Barney, C. L.; Huber, E. W.; McCarthy, J. R. Tetrahedron Lett. 1990, 31, 5547. 
125
 Mattson, R. J.; Pham, K. M.; Leuck, D. J.; Cowen, K. A. J. Org. Chem. 1990, 55, 2552. 
126
 Seebach, D.; Hungerbuhler, E.; Naef, R.; Scnurrenberger, P.; Weidmann, B.; Zueger, M. Synthesis 1982, 138. 
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In some of the attempted reductive amination reactions, azetidines 267 and 268 were already 
isolated (see entries 1, 2, 5 and 6 in Table 20). Presumably the intramolecular cyclization of 
the endo-amino group takes place catalyzed by the reaction conditions and the long reaction 
times. 
Summarizing the results in Table 20, the introduction of an endo-amino group at epoxy 
ketones 207 and 208 was accomplished using one of the most common hydride reagents for 
this conversion: NaBH3CN. Nevertheless, the low yields as well as the formation of by-
products stressed the importance of a further optimization of this conversion. 
6.3.1.2 Synthesis of C3-Pivaloate Substituted Epoxy N-Methylamines using 
NaBH(OAc)3 
Another commonly used reductant is sodium triacetoxyborohydride,127 a mild and selective 
hydride reagent128 with a high degree of tolerance for a variety of functional groups. 
NaBH(OAc)3 has also the advantage of reducing aldehydes but not ketones if the reaction is 
conducted in an aprotic solvent such as DCM, 1,2-dichlorethane (DCE), THF or 
acetonitrile.129 
Attempted reductive amination using NaBH(OAc)3 involved 1,2-dichlorethane as solvent and 
a fivefold excess of methylamine as an acid salt to promote reductive amination. Under these 
reaction conditions conversion of epoxy ketone 208 afforded epoxy N-methylamines 263 and 
265 in 34% yield in a 3:4 ratio (see entry 1 in Table 21). In the case of epoxy ketone 207, a 
2:5 mixture of endo-amine 266 and azetidine 268 was obtained in 21% yield (see entry 2 in 
Table 21). 
                                                 
127
 a) Abdel-Magid, A. F.; Maryanoff, C. A.; Carson, K. G. Tetrahedron Lett. 1990, 31, 5595; b) Abdel-Magid, A. F.; Maryanoff, C. A. 
Synlett 1990, 537.; c) Abdel-Magid, A. F.; Maryanoff, C. A. In ACS Symp. Ser.; Abdel-Magid, A. F., Ed. American Chemical Society: 
Washington, DC, 1996; Vol. 641, pp. 201-216; d) Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. J. Org. 
Chem. 1996, 61, 3849. 
128
 The mildness of the reagent has been attributed to both steric and the electron withdrawing effects of the acetoxy groups which stabilize 
the boron-hydrogen bond. Gribble, G. W. Eastman Organic Chemical Bulletin 1979, 51, 1. 
129
 Gribble, G. W.; Ferguson, D. C. J. Chem. Soc., Chem. Commun. 1975, 535. 
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Entry R Conditions 
Azaprod. 
Yield [%]a 
Ratio of 
263:265:267 
(264:266:268) 
1 H 5 eq MeNH2.HCl, NaBH(OAc)3, DCE, rt, 7 d 34 3:4:0 
2 Me 5 eq MeNH2.HCl, NaBH(OAc)3, DCE, rt, 7 d 21 0:2:5 
Table 21: Reductive amination conditions using NaBH(OAc)3. a) Products were separated by column 
chromatography. 
The low solubility of the methylamine hydrochloride in the reaction solvent (DCE) explains 
the low yields and the long reaction times for the reported reductive amination using 
NaBH(OAc)3.  
6.3.1.3 Synthesis of C3-Pivaloate Substituted Epoxy N-Methylamines using NaBH4 
Other commonly used reductive amination methods include the use of sodium borohydride in 
combination with different additives. Amongst these procedures, stepwise reductive 
amination using NaBH4 and titanium (IV) isopropoxide has been developed as an efficient 
and mild alternative to the other current methods.130,127d. However, since sodium borohydride 
also reduces aldehydes and ketones, it is important to ensure that imine formation is 
completed prior to addition of the reducing agent. 
Following this efficient protocol, epoxy ketones 208 and 207 were treated with titanium (IV) 
isopropoxide prior to addition of NaBH4. The solvent of choice was methanol, in which imine 
formation is faster relative to THF or 1,2-dichloroethane, as demonstrated by Abdel-Magid et 
al.127d Besides, a mixture of methylamine hydrochloride and triethylamine was employed as 
                                                 
130
 a) Bhattacharyya, S.; Chatterjee, A.; Williamson, J. S. Synlett 1995, 1079; b) Bhattacharyya, S. J. Org. Chem. 1995, 60, 4928; c) 
Bhattacharyya, S. J. Org. Chem. 1995, 60, 4928. 
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the convenient source of nucleophilic methylamine; this requires no special handling 
techniques and obviates the use of excess gaseous amine.130b 
Reductive amination of epoxy ketone 208 afforded a mixture of endo-amine 265, exo-amine 
263 and azetidine 267 in 44% yield (see entry 1, Table 22). In the case of epoxy ketone 207 
equatorial amine 266 was exclusively isolated in 70% yield when the reaction was quenched 
two hours after addition of the reductant, as indicated by entry 2 in Table 22. In contrast, 
when the reaction mixture was stirred for a longer time, though reduction was completed, a 
mixture of endo-amine 266 and azetidine 268 was obtained in a 1:12 ratio in 78% yield (see 
entry 3 in Table 22). This fact confirms the suggestion that intramolecular cyclization of the 
endo-epoxy amine to azetidine already occurs catalyzed by the reaction conditions. 
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Entry R Conditions 
Total 
Yield 
[%]c 
Ratio of 
263:265:267 
(264:266:268) 
1 H MeNH2.HCl, NaBH4, Ti(Oi-Pr)4, MeOH, rt, 18 ha 44 2:3:2 
2 Me MeNH2.HCl, NaBH4, Ti(Oi-Pr)4, MeOH, rt, 18 ha 70 100% 266b 
3 Me MeNH2.HCl, NaBH4, Ti(Oi-Pr)4, MeOH, rt, 2 da 78 0:1:12b 
Table 22: Reductive amination conditions using NaBH4. a) Amine and ketone were stirred in Ti(OiPr)4/MeOH 
for 16 h followed by addition of reductant; b) epoxy exo-amine 264 was isolated in traces and therefore it has not 
been included in the total yield; c) products were separated by column chromatography. 
In order to study the influence of the reaction time, several experiments were carried out. On 
the one hand, changing the work-up procedure did not alter the results, which indicates that 
the formation of the azetidine ring takes place before the reaction is quenched. On the other 
hand, increasing considerably the amount of titanium (IV) isopropoxide led to lower yields 
and complementary addition of 3Å molecular sieves did not improve results either. Most 
significant was the influence of the reaction times, as indicated by entries 2 and 3 in Table 22. 
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The reductive amination of epoxy ketone 207 using sodium borohydride and titanium (IV) 
isopropoxide proceeded in good yield. In contrast, moderate yields were obtained for the 
conversion of epoxy ketone 208, presumably because of its lower stability towards NaBH4. 
6.3.1.4 Synthesis of C3-Pivaloate Substituted Epoxy N-Methylamines using BH3⋅py 
The next alternative for the synthesis of epoxy endo-N-methylamines 265 and 266 was the use 
of borane-pyridine complex,131 developed for reductive aminations because it typically 
reduces imines and iminium salts preferentially relative to carbonyl groups.132, 133 As reactions 
with borane-pyridine complex run significantly faster in methanol than in other solvents,131 
attempted reductive aminations were carried out in this solvent. 
In a first in situ reaction, equimolar amounts of epoxy ketone 208 and methylamine were 
treated with borane-pyridine complex in the presence of 4Å molecular sieves affording a 
mixture of endo-amine 265, exo-amine 263 and azetidine 267 in 20% yield (see entry 1, Table 
23). Increasing the amount of methylamine to two equivalents led to slightly higher yields 
(see entry 2, Table 23). Better yields were obtained with a fivefold excess of methylamine and 
allowing the preformation of the imine intermediate prior to addition of the reducing agent 
(see entry 3, Table 23). 
Direct reductive amination of epoxy ketone 207 with borane-pyridine complex and 4 Å 
molecular sieves afforded azetidine 268 in 12% yield (see entry 5 in Table 23). Comparing 
entries 3 and 5 in Table 23, reductive amination of epoxy ketone 208 proceeded in higher 
yield under the same conditions than the conversion of epoxy ketone 207 owing to the steric 
effect of the methyl groups. 
A new protocol was developed combining titanium (IV) isopropoxide, as an efficient catalyst 
for the imination of epoxy ketones 207 and 208, with borane-pyridine complex as a mild 
selective reductant. Following reductive amination of epoxy ketone 208 yielded a mixture of 
exo-amine 263, endo-amine 265 and azetidine 267 (see entry 4 in Table 23). In this case, the 
reaction mixture was stirred for a longer time, although reduction was already completed 
some hours after addition of the reductant. In contrast, epoxy ketone 207 was converted 
                                                 
131
 Bomann, M. D.; Guch, I. C.; DiMare, M. J. Org. Chem. 1995, 60, 5995. 
132
 Pelter, A.; Rosser, R. M.; Mills, S. J. Chem. Soc., Perkin Trans. 1 1984, 37, 1309. 
133
 Hutchins, R. O.; Learn, K.; Mazer, B.; Pytlewski, D.; Pelter, A. Org. Prep. Proced. Int. 1984, 16, 335. 
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exclusively into equatorial amine 266 in 69% yield when the reaction was quenched 4 hours 
after addition of the reductant (see entry 6 in Table 23). 
OPiv
O
NHMe
O
OPiv
O
O
O
R R R R
OPiv
O
NHMe
O
R R
OPiv
O
N
HO Me
R R
Reaction Conditions
(see Table below)
208: R = H
207: R = Me
263: R = H
264: R = Me
265: R = H
266: R = Me
267: R = H
268: R = Me
 
Entry R Conditions 
Total 
Yield 
[%]c 
Ratio of 
263:265:267 
(264:266:268) 
1 H 1 eq MeNH2.HCl, BH3·py, MeOH, rt, 2 da, c 20 1:9:1 
2 H 2 eq MeNH2.HCl, BH3·py, MeOH, rt, 2 da, c 33 1:5:1 
3 H 5 eq MeNH2.HCl, BH3·py, MeOH, rt, 2 db, c 73 1:1:1 
4 H 5 eq MeNH2.HCl, BH3·py, Ti(OiPr)4, MeOH, rt, 2 dd 74 2:1:3 
5 Me 2 eq MeNH2.HCl, BH3·py, MeOH, rt, 3 da, c 12 100% 268 
6 Me 5 eq MeNH2.HCl, BH3·py, Ti(OiPr)4, MeOH, rt, 20 hd 69 100% 266 
Table 23: Reductive amination conditions using BH3·py. a) Direct reaction; b) stepwise reaction: reductant was 
added after 16 h; c) addition of 4Å molecular sieves; d) amine and ketone were stirred in Ti(OiPr)4/MeOH for 16 
h followed by addition of reductant; e) products were separated by column chromatography. 
As indicated by entries 4 and 6 in Table 23, the reductive amination procedure combining 
borane-pyridine complex and titanium (IV) isopropoxide proceeded in good yields. This 
protocol proved to be the best choice to synthesize desired epoxy endo-N-methylamines 
compared to the preceding attempted procedures. 
6.3.1.5 Summary of the Synthesis of C3-Pivaloate Substituted Epoxy N-
Methylamines 
Following the route towards tricyclic azetidines, the synthesis of secondary epoxy N-
methylamines was first attempted by reductive amination of pivaloate substituted epoxy 
ketones with methylamine. For this purpose, several procedures were carried out in search of 
an optimized protocol which promoted the formation of the imine intermediate, in order to 
diminish competing reactions. 
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The first attempted method was the Borch reduction of epoxy ketones 207 and 208 with a 
fivefold excess amount of methylamine as an acid salt. Under this reaction conditions the 
synthesis of epoxy N-methylamines was accomplished in low yields and with the obtention of 
the epoxy alcohols resulting from the competing reduction of the ketone function. 
Another attempted procedure was the direct reductive amination of epoxy ketones 207 and 
208 using NaBH(OAc)3 in DCE. In this case, the low solubility of the methylamine 
hydrochloride in the reaction solvent led to the desired N-methylamines in low yields and 
after long reaction times. 
Reductive amination of the epoxy ketones was also carried out using sodium borohydride and 
titanium (IV) isopropoxide. The conversion of sterically hindered epoxy ketone 207 led 
stereoselectively to the epoxy endo-amine in 70% yield or to a 1:12 mixture of epoxy endo-
amine 266 and azetidine 268 in 78% yield depending on the reaction time. In contrast, 
moderate yields were obtained for the conversion of epoxy ketone 208, presumably because 
of its lower stability towards NaBH4. 
Direct reductive amination of the epoxy ketones using milder borane-pyridine complex and 
4Å molecular sieves proceeded in low yields. Better results were obtained when the reaction 
was carried out stepwise and with a fivefold excess of methylamine. Under these conditions, 
conversion of less sterically hindered epoxy ketone 208 afforded a 1:1:1 mixture of endo-
amine 265, exo-amine 263 and azetidine 267 in 73% yield. 
An efficient protocol was developed combining titanium (IV) isopropoxide as catalyst and 
borane-pyridine complex as a mild selective reductant. Following this procedure, epoxy 
ketone 207 was converted exclusively into equatorial amine 266 in 69% yield. In the case of 
epoxy ketone 208, a mixture of exo-amine 263, endo-amine 265 and azetidine 267 was 
obtained in 74% yield in a 2:1:3. Comparing all the attempted procedures, combination of 
borane-pyridine complex and titanium (IV) isopropoxide proved to be the best choice for the 
synthesis of pivaloate substituted epoxy endo-N-methylamines. 
Pivaloate ester showed stability not only towards all the attempted reductive amination 
conditions but also to the work-up procedures and methylamines were accessible without 
cleavage of the protecting group. The steric hindrance of the pivaloate ester, whose methyl 
groups shield the carbonyl group from nucleophilic attack, explains this great stability. 
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The steric effect of the methyl groups at the bridgehead carbon atoms has an influence on the 
formation of the imine intermediate and on the stereoselectivity of the reductive amination. 
This steric effect impedes the formation of the intermediate imine, thus lowering the yield of 
the reaction in the absence of an efficient catalyst. The competing reduction to alcohol 
proceeds faster and undesired epoxy alcohols are obtained in higher ratio than in the reductive 
amination of less sterically hindered epoxy ketone 208. The different steric hindrance of both 
epoxy ketones 207 and 208 also have an influence on the stereoselectivity of the reductive 
amination. In the case of epoxy ketone 207, reductive amination led selectively to epoxy 2α-
configurated amine 266, resulting from an axial attack of hydride reagent on the intermediate 
imine. In contrast, epoxy ketone 208 underwent reductive amination affording both epoxy 
exo-N-methylamine and epoxy endo-N-methylamine with moderated selectivity. 
Under the reductive amination conditions, tricyclic azetidines 267 and 268 were already 
isolated. Tricyclic azetidine 268 was afforded almost exclusively when the reaction mixture 
was stirred for a longer time, though reduction of the imine intermediate was completed. 
Presumably, the intramolecular cyclization of the endo-amino group takes place catalyzed by 
the reaction conditions and the long reaction times. 
6.3.2 Synthesis of C3-Methoxy Substituted Epoxy N-Methylamines 
After the synthesis of pivaloate substituted epoxy endo-N-methylamines, reductive amination 
of methoxy substituted epoxy ketone 214 was attempted. For this purpose, three of the most 
efficient procedures for the reductive amination of epoxy ketone 214 were carried out as 
summarized in Table 24. 
Stepwise reductive amination of epoxy ketone 214 using sodium borohydride and titanium 
(IV) isopropoxide afforded azetidine 270 in 27 % yield (see entry 1 in Table 24). Better yields 
were obtained by treatment of the epoxy ketone and a fivefold excess of methylamine with 
borane-pyridine complex and 4Å molecular sieves (see entry 2 in Table 24). As for the 
synthesis of pivaloate substituted aza-products, the most efficient method proved to be the 
combination of borane-pyridine complex and titanium (IV) isopropoxide affording tricyclic 
azetidine 270 in 51% yield (see entry 3 in Table 24). 
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Entry Conditions Yield [%] 
1 2 eq MeNH2.HCl, NaBH4, Ti(Oi-Pr)4, MeOH, rt, 20 hc 27 
2 5 eq MeNH2.HCl, BH3·py, MeOH, rt, 1 da, b 46 
3 2 eq MeNH2.HCl, BH3·py, Ti(Oi-Pr)4, MeOH, rt, 20 hc 51 
Table 24: Reductive amination conditions using NaBH4 and BH3·py. a) Stepwise reaction; b) addition of 4Å 
molecular sieves; c) amine and ketone were stirred in Ti(Oi-Pr)4/MeOH for 16 h followed by addition of 
reductant. 
As can be seen in Table 24, all attempted reductive amination reactions afforded exclusively 
tricyclic azetidine 270 and the corresponding epoxy amine could not be isolated even if the 
reaction was quenched directly after addition of the hydride reagent. This fact shows that the 
intramolecular cyclization of the methoxy substituted epoxy α-configurated amine is highly 
favoured and proceeds catalyzed by the reaction conditions. Consequently, the synthesis of 
methoxy substituted azetidine 270 proceeded through a stereoselective one-pot reductive 
amination/cyclization tandem reaction starting from epoxy ketone 214 in 51% yield. 
6.3.3 Synthesis of Pivaloate Substituted Epoxy N-Ethylamines 
Since the synthesis of epoxy endo-N-methylamines was accomplished successfully, the 
introduction of a different secondary amino group in the oxatricyclic structure was next 
attempted. Considering the steric hindrance and electrophilicity of the epoxy ketones, the 
amine of choice was ethylamine, which is slightly more sterically hindered than methylamine. 
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Entry R Conditions 
Amine 
Yield [%]e 
Alcohol 
Yield [%]e 
1 H EtNH2.HCl, NaBH3CN, MeOH, rt, 4 da, b 21 40 
2 H EtNH2.HCl, BH3·py, MeOH, rt, 2 da, c 24 0 
3 Me EtNH2.HCl, NaBH3CN, MeOH, rt, 4 da, b 0 50 
4 Me EtNH2.HCl, NaBH4, Ti(Oi-Pr)4, MeOH, rt, 2 dd 12 0 
Table 25: Reductive amination conditions. a) Direct reaction; b) addition of 3Å molecular sieves; c) addition of 
4Å molecular sieves; d) amine and ketone were stirred in Ti(Oi-Pr)4/MeOH for 16 h followed by addition of 
NaBH4; e) products were separated by column chromatography. 
The first attempted method was the Borch reduction using NaBH3CN, a fivefold excess 
amount of ethylamine as an acid salt and 3Å molecular sieves. Under these conditions epoxy 
ketone 208 was converted into desired ethylamine 271 in low yield (21%) together with 
undesired epoxy alcohol 131 (see entry 1 in Table 25). In the case of more sterically hindered 
epoxy ketone 207, epoxy alcohol 160 was exclusively obtained without traces of the aminated 
tricycle 272 (see entry 3 in Table 25). 
In order to improve yields and lower competing reactions, the use of pyridine-borane complex 
and 4 Å molecular sieves was attempted. Following this direct protocol, epoxy ketone 208 
was converted selectively into epoxy ethylamine 271 in 24% yield and no by-products were 
isolated (see entry 2 in Table 25). 
In the case of more sterically hindered epoxy ketone 207, titanium (IV) isopropoxide was 
used to promote the imine formation prior to addition of the hydride reagent. This reductive 
amination procedure afforded desired ethylamine 272 in 12% yield and without by-products 
(see entry 4 in Table 25). 
The formation of the imine intermediate upon exposure of sterically hindered epoxy ketones 
to the amine is a reversible and slow reaction. The steric hindrance and electrophilicity of the 
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carbonyl group as well as the chain length and basicity of the amine influence the imine 
formation. The lower yields of the reductive amination of epoxy ketones 207 and 208 with 
ethylamine compared to methylamine exemplify the influence of the basicity and chain length 
of the amine. 
Since the synthesis of epoxy endo-N-ethylamines was not extensively studied in the 
framework of the present work, optimization of this conversion remains open. For instance, 
better yields could be obtained combining pyridine-borane complex and titanium (IV) 
isopropoxide with a larger excess of ethylamine. 
6.3.4 Mechanistic Aspects of the Synthesis of Epoxy N-Alkylamines 
The mechanism of reductive aminations depends on the reducing agent and additives 
employed. A reasonable mechanism for the reductive amination of epoxy ketone 273 would 
involve condensation of the carbonyl group and amine to give a carbinol amine, followed by 
dehydration to form an imine 274 (see Scheme 78). Under weakly acidic or neutral reaction 
conditions the imine would be protonated to form an iminium ion.134 Subsequent reduction of 
the imine intermediate or of the iminium ion would led to epoxy N-alkylamine 276.119 
However, some reports provide evidence suggesting a direct reduction of the intermediate 
carbinol amine in some reactions to provide the target amine directly.135 
The attack of the hydride may occur on both diastereotopic faces of the epoxy ketones with 
different selectivity owing to steric effects. As reported in the preceding chapters, reductive 
amination of epoxy ketone 208 led to both epoxy exo-amine and epoxy endo-amine with 
moderated selectivity. In the case of sterically hindered epoxy ketones 207 and 214, reductive 
amination proceeded with higher selectivity affording almost exclusively epoxy α-
configurated amine, resulting from an axial attack of hydride reagent on the intermediate 
imine. 
                                                 
134
 The formation of imines or iminium ions has been reported as possible intermediates in reductive amination reactions in catalytic 
hydrogenation methods, see: a) Emerson, W. S. Org. React. 1984, 4, 174 and references therein. It has also been proposed in hydride 
methods, see: b) Schellenberg, K. A. J. Org. Chem. 1963, 28, 3259. 
135
 Tadanier, J.; Hallas, R.; Martin, J. R.; Stanastek, R. S. Tetrahedron 1981, 37, 1309. 
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Scheme 78: Proposed mechanism for the reductive amination of epoxy ketone 273 leading to 
epoxy N-alkylamine 276. 
In the presence of the titanium (IV) isopropoxide, reductive amination of epoxy ketones is 
possibly proceeding through coordination of the Lewis acid with the carbonyl compound and 
the amine. In one possible mechanism, the formation of an intermediate 
aminocarbinolatotitanium (IV) complex 280 has been proposed,125,136 which is then reduced 
either directly or via transient iminium species137 to afford alkylated amine 276 (see Scheme 
79). 
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Scheme 79: Possible mechanism of reductive aminations in the presence of titanium (IV) 
isopropoxide through formation of an intermediate aminocarbinolatotitanium (IV) complex 
280. 
6.4 Intramolecular Cyclization of Epoxy N-Methylamines to Tricyclic Azetidines 
The last step of the synthetic strategy towards tricyclic azetidines was the intramolecular 
cyclization of the intermediate epoxy endo-amines 265 and 266 to afford desired azetidines 
267 and 268. Since reductive amination of methoxy substituted epoxy ketones afforded 
directly the tricyclic azetidine, intramolecular cyclization towards tricyclic azetidine was only 
studied for isolated pivaloate substituted epoxy endo-amines 265 and 266 (see Scheme 80). 
                                                 
136
 a) Reetz, M. T. Organotitanium Reagents in Organic Synthesis; Springer-Verlag: Berlin, 1986; 107; b) Takahashi, H.; Tasubuki, T.; 
Higashiyama, K. Synthesis 1988, 238; c) Imwinkelried, R.; Seebach, D. Helv. Chim. Acta 1984, 67, 1496. 
137
 Hine, J.; Yeh, C. Y. J. Am. Chem. Soc. 1967, 89, 2669. 
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Scheme 80: Intramolecular cyclization of epoxy endo-N-methylamines 265 and 266 to afford 
tricyclic azetidines 267 and 268. 
The dual character of Grignard reagents, which can act as a strong base and a Lewis acid, has 
been used to promote intramolecular cyclization reactions. In the synthesis of Thienamycin 
284 by Merck,138 a Grignard-mediated cyclization of N-methylsilyl-dibenzylaspartate 282 
using tert-butylmagnesium chloride afforded ß-lactam intermediate 283 (see Scheme 81). 
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Scheme 81: Grignard-mediated cyclization to ß-lactam 283 in the synthesis of Thienamycin by Merck. 
A recent example of Grignard reagent-mediated intramolecular cyclization is the synthesis of 
oxazatricycles 287, 288, 289 and 290 containing the tropanone skeletal structure (see Scheme 
82).139 
                                                 
138
 Salzman, T. N.; Ratcliffe, R. W.; Christensen, B. G.; Bouffard, F. A.; J. Am. Chem. Soc. 1980, 102, 6161. 
139
 a) Proemmel, S. PhD Thesis, Universität Hannover, 2001; b) Vidal Pascual, M. PhD Thesis, Universität Hannover, 2003. 
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Scheme 82: Grignard-mediated cyclization in the synthesis of scopoline by M. Vidal Pascual. 
Base-catalyzed intramolecular cyclization reactions have also been reported in the synthesis 
of ß-lactams. In the total synthesis of the quinone antibiotic (±)-Naphthyridinomycin,140 key 
tricyclic intermediates 292 and 296 were prepared by base-catalyzed intramolecular (see 
Scheme 83). Treatment of epoxy amide 291 with potassium tert-butoxide led to a mixture of 
desired lactam 292 and isomeric lactam 293 in a 1:1 ratio in 92% yield. Better regioselectivity 
was obtained when N-methyl epoxide 294 was subjected to the same cyclization conditions 
affording desired lactam 295 in 82% yield. In this cyclization, less than 5% undesired tricyclic 
lactam 296 was detected. The greater electron withdrawing capability of the Cbz-N function 
apparently disfavours epoxide cleavage at the desired, nearest carbon.140 
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Scheme 83: Synthesis of ß-lactams 292 and 296, key intermediates in the total synthesis of (±)-
Naphthyridinomycin. 
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 Evans, D. A.; Biller, S. A. Tetrahedron Lett. 1985, 26, 1907. 
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6.4.1 Intramolecular Cyclization of C3-Substituted Epoxy N-Methylamines 
In order to accomplish the synthesis of tricyclic azetidines, different conditions for the 
intramolecular cyclization of epoxy α-configurated amines 265 and 266 were tried out, as 
indicated in Table 26. 
OPiv
O
NHMe
O
R R
OPiv
O
N
HO Me
R R
Reaction Conditions
(see Table below)
267: R = H
268: R = Me
265: R = H
266: R = Me
 
Entry R Conditions 
Total Yield 
[%] 
1 H t-BuOK, THF, rt, 2 da, c n.r. 
2 H VinylMgBr, THF, 0°C → rt, 4 h 71 
3 Me BF3·OEt2, DCM, 0°C → rt n.r. 
4 Me t-BuOK, THF, rt, 2 da, c n.r. 
5 Me VinylMgBr, THF,0°C → rt, 4 h 83 
6 Me PhMgBr, THF, 0°C → rt, 4 h 82 
7 Me EthynylMgBr, THF, 0°C → rt, 2 d 34a 
8 Me EthynylMgCl, THF, 0°C → rt  n.r. 
Table 26: Attempted reaction conditions for intramolecular cyclization of 2-endo-amino epoxides. a) 20% 
Amine was additionally recovered unreacted. 
As indicated by entries 1 and 4 in Table 26, attempted base-catalyzed cyclization of epoxy 
endo-N-methylamines 265 and 266 using potassium tert-butoxide did not afford the desired 
azetidines 267 and 268. Attempted cyclization of epoxy endo-amine 266 using Lewis acid 
BF3·OEt2 was also unsuccessful (see entry 3 in Table 26). In contrast, epoxy endo-amines 265 
and 266 underwent Grignard-mediated intramolecular cyclization in better yield without 
cleavage of the pivaloate group. Using vinylmagnesium bromide tricyclic azetidines 267 and 
268 were obtained in 71 and 83% yield, respectively (see entries 2 and 5 in Table 26). Upon 
treatment with more sterically hindered phenylmagnesium bromide, intramolecular 
cyclization of epoxy endo-amine 266 afforded azetidine 268 in 82% yield (see entry 6 in 
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Table 26). Cyclization of epoxy endo-amine 266 catalyzed by less reactive ethynylmagnesium 
bromide led to azetidine 268 in 34% yield and additional 20% of epoxy endo-amine 266 was 
recovered unreacted (see entry 7 in Table 26). On the other hand, epoxy endo-amine 266 was 
recovered unreacted using ethynylmagnesium chloride (see entry 8 in Table 26). 
The synthesis of oxatricyclic azetidines was accomplished by Grignard-mediated 
intramolecular cyclization of pivaloate substituted epoxy endo-amines 265 and 266 in good 
yield. Moreover, the pivaloate group showed high stability towards the reaction conditions 
and azetidines 267 and 268 were obtained without cleavage of the protecting group. 
6.4.2 Mechanistic and Conformational Aspects of the Intramolecular Cyclization 
Two proposed mechanisms for the Grignard-mediated intramolecular cyclization of epoxy N-
methylamines 265 and 266 are outlined in Scheme 84 and in Scheme 85. The 
organomagnesium compound can act as a strong base and a Lewis acid. Therefore, after 
deprotonation of the endo-amino group, the magnesium atom possibly coordinates with the 
oxygen atoms in the epoxy N-methylamine. 
In a first proposed mechanism, the magnesium carbon atom may coordinate with the oxygen 
atom at carbon C3, with the nitrogen atom of the amino group and with the oxygen atom of 
the vicinal protected hydroxy group. The five-membered ring resulting from this coordination 
may populate two conformations. Afterwards, the six-membered oxacyclic ring changes to a 
boat, in which the amino function moves to axial position for a favoured formation of the new 
azetidine C-N bond. Simultaneously, the protecting group at C3 (methyl ether or pivaloate 
ester) moves from axial position to thermodynamically favoured equatorial position, which 
lowers the energy difference between chair conformation and boat transition state. In this boat 
transition state, the magnesium atom possibly coordinates with the nitrogen atom of the amino 
group and the oxygen atom of the epoxide ring. This coordination favours the intramolecular 
cyclization affording the tricyclic azetidine. After formation of the tricyclic azetidine, the 
bulky substituents at C3 occupy less hindered equatorial positions in an oxacyclohexane boat. 
Additional methyl groups at the bridgehead carbons increase the stability of oxazatricyclic 
structure. 
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Scheme 84: First proposed mechanism for the synthesis of tricyclic azetidines by Grignard-
mediated intramolecular cyclization. 
In a second proposed mechanism, the magnesium atom may coordinate with both bridgehead 
oxygen atom and epoxide oxygen atom simultaneously activating the epoxide towards the 
attack from the deprotonated amine. Afterwards, the six-membered oxacyclic ring 299 
changes to a boat, in which the amino group moves to axial position for a favoured formation 
of the new azetidine C-N bond. As in the preceding mechanism, a decrease in the energy 
difference between chair conformation 299 and boat transition state 300 occurs when the 
protecting group at C3 (methyl ether or pivaloate ester) moves from axial position to 
thermodynamically favoured equatorial position. Afterwards, the coordination of the 
magnesium atom with the epoxide oxygen favours the intramolecular cyclization to desired 
tricyclic azetidine 259. 
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Scheme 85: Second proposed mechanism for the synthesis of tricyclic azetidines by Grignard-
mediated intramolecular cyclization. 
6.5 Summary of the Synthesis of Epoxy Amines and Tricyclic Azetidines 
The major aim of the present work was the synthesis of aza-analogues of the dioxatricyclic 
subunit of dictyoxetane. The introduction of an azetidine ring in the tricyclic skeletal structure 
constituted an important synthetic challenge which was accomplished following an efficient 
and valuable route. 
The synthetic route towards oxatricyclic azetidines was designed starting from meso-
oxabicycles rac-49 and rac-90, which already contain two of the three ring of the 
oxazatricyclic skeletal structure. In four steps meso-oxabicycles rac-49 and rac-90 were 
converted into versatile epoxy alcohols with pivaloate and methyl ether as protecting groups. 
Afterwards, epoxy ketones were converted into the azetidine precursors by reductive 
amination. For this purpose, two possibilities were studied: the synthesis of primary epoxy 
amines and secondary epoxy N-alkylamines. 
The synthesis of primary epoxy amines was not successful using common reductive 
amination methods. The synthesis of secondary epoxy N-methylamines was first attempted by 
reductive amination of pivaloate substituted epoxy ketones 207 and 208 and methylamine. 
This conversion showed difficulties because of the steric hindrance and electrophilicity of the 
epoxy ketones. Several procedures were examined to promote the formation of the imine 
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intermediate. Under the optimized reaction conditions reductive amination of epoxy ketones 
afforded desired epoxy endo-N-methylamines in good yield and without cleavage of the 
pivaloate group. Synthesized epoxy endo-N-methylamines underwent Grignard-mediated 
intramolecular cyclization leading to the desired oxatricyclic azetidines in good yields. The 
same efficient reductive amination conditions were also applied for the conversion of 
methoxy substituted epoxy ketone 214. In this case, epoxy ketone afforded directly azetidine 
270. The introduction of different amino group was also attempted by reductive amination of 
pivaloate substituted epoxy ketones 207 and 208 with ethylamine but the reaction proceeded 
in low yields. Therefore, methylamine proved to be the best choice for synthesis of tricyclic 
azetidines. In the following chapters the synthesis of the three synthesized tricyclic azetidines 
is described starting from meso-oxabicycles rac-49 and rac-90. 
6.5.1.1  Synthesis of Pivaloate Substituted Azetidine 267 
Starting from meso-oxabicycle rac-90, pivaloate substituted epoxy alcohol 131 was 
synthesized in 57% yield over four steps. Oxidation of epoxy alcohol 131 with PCC afforded 
epoxy ketone 208 in 95% yield under mild conditions and easy work-up procedures. 
Reductive amination of epoxy ketone 208 and methylamine under optimized conditions led to 
a mixture of epoxy exo-N-methyllamine 265, epoxy endo-N-methylamine 263 and azetidine 
267 in a 2:1:3 ratio in 74% yield. The three compounds were separated by column 
chromatography. Isolated epoxy endo-amine 265 was subjected to intramolecular cyclization 
using vinylmagnesium bromide and desired azetidine 267 was obtained in 71% (see Scheme 
86). Summarizing, pivaloate substituted azetidine 267 was synthesized over seven steps in 
25% overall yield starting from meso-oxabicycle rac-90. 
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Scheme 86: Synthesis of pivaloate substituted epoxy endo-N-methylamine 266 and oxatricyclic azetidine 267. 
6.5.1.2  Synthesis of Pivaloate Substituted Azetidine 268 
As outlined in Scheme 87, pivaloate substituted epoxy alcohol 160 was prepared 61% yield 
over four steps starting from meso-oxabicycle rac-49. Oxidation of epoxy alcohol 160 
proceeded with PCC affording epoxy ketone 207 in 99% yield. Reductive amination of epoxy 
ketone 207 using pyridine-borane complex or sodium borohydride and titanium (IV) 
isopropoxide afforded stereoselectively epoxy endo-amine 266 in 69 or 70 % yield when the 
reaction was quenched four hours after addition of the reductant. Reductive amination using 
sodium borohydride led also to epoxy endo-amine in similar yield and similar reaction time 
(the reaction was quenched two hours after addition of the hydride reagent). Under the same 
reductive amination conditions, epoxy ketone 207 was converted almost exclusively into 
azetidine 268 in 72% yield together with 6% of epoxy endo-amine 266 when the reaction 
mixture was allowed to stir for a long time. Isolated epoxy endo-N-methylamine 266 was 
subjected to intramolecular cyclization using vinylmagnesium bromide and desired azetidine 
268 was obtained in 83% yield. Starting from meso-oxabicycle rac-49 pivaloate substituted 
azetidine 268 was obtained over six steps in 43% overall yield or over seven steps in 35% 
overall yield. 
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Scheme 87: Synthesis of pivaloate substituted epoxy endo-N-methylamine 266 and oxatricyclic azetidine 268. 
6.5.1.3  Synthesis of Methoxy Substituted Azetidine 270 
As outlined in Scheme 88, methoxy substituted epoxy alcohol 160 was prepared in 61% yield 
over four steps starting from meso-oxabicycle rac-49. Epoxy alcohol 56 was converted 
quantitatively to epoxy ketone 214 using PCC. Starting from epoxy ketone 214, methoxy 
substituted azetidine 270 was prepared by a stereoselective one-pot reductive 
amination/cyclization tandem reaction in 51% yield. The intermediate epoxy endo-amine 
could not be isolated. Starting from meso-oxabicycle rac-49, methoxy substituted azetidine 
270 was synthesized over six steps in 37% yield. 
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Scheme 88: Synthesis of methoxy substituted oxatricyclic azetidine 270. 
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6.5.1.4 Conclusion of the Synthesis of Azetidines 
Comparing the synthesis of azetidines 268 and 270 starting from meso-oxabicycle rac-49, the 
synthesis of methoxy substituted azetidine 270 proceed in lower overall yield than that of the 
corresponding pivaloate 268. The higher hydrophilicity of methoxy substituted azetidine 270 
compared to that of pivaloate 268 raises the risk of losses during the work-up and lowers 
consequently the yield of azetidine 270. An advantage of pivaloate substituted azetidines 267 
and 268 is the possibility of a later deprotection of the endo-hydroxy group at carbon C3 
under milder conditions than the cleavage of the more stable methyl ether. In terms of yield 
and stability, the synthetic route towards pivaloate substituted azetidine 268 is the best choice 
for the synthesis of aza-analogues of subunits of dictyoxetane. 
6.6 Functionalization of the Oxatricyclic Azetidine 
Since the azetidine ring system as substructure has shown a wide range of biological 
activities,141 the synthesis and functionalization of the azatricyclic skeletal structure 
constitutes an access to potential pharmacological active compounds. The free hydroxy group 
at carbon C6 of the azetidine 268 offers the possibility of further transformation of the 
oxazatricyclic skeletal structure.  
As reported in Section 6.5, pivaloate substituted azetidine 268 is the best choice for the 
synthesis of aza-analogues of subunits of dictyoxetane. Therefore, azetidine 268 was chosen 
as starting material for the functionalization of the oxazatricyclic skeletal structure. 
The first step towards derivatives of the oxazatricyclic skeletal structure was the oxidation of 
the hydroxyl group at carbon C6. Swern oxidation of tricyclic azetidine 268 afforded ketone 
301 in 52% yield (see Scheme 89). 
                                                 
141
 See Chapter 1. 
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Scheme 89: Swern oxidation of tricyclic azetidine 268 to afford ketone 301. 
Further functionalization of the oxazatricyclic skeletal structure was not studied in the 
framework of the present work. As outlined in Scheme 90, tricyclic azetidines 268 and 301 
are valuable precursors of a wide variety of new derivatives including aza-glycosides, whose 
synthesis remains open for the future. 
OPiv
O
N
HO Me
OPiv
O
N
O Me
O
O
N
O Me
OH
O
N
HO Me
O
O
N
HO Me
OPiv
O
N
R
MeHO
OH
O
N
HO Me
OPiv
O
N
Me
OH
O
N
O Me
3,6-Diketone
3α,6ß-Diol
3α,6α-Diol6ß-Hydroxy-3-one
3α−Hydroxy-6-one
3α−Pivaloyloxy-6-ene
3α−Pivaloyloxy-6α-ol
301268
303
302
304
305306307
308
 
Scheme 90: Synthetic strategy for further functionalization of the oxazatricyclic skeletal structure. 
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7. Characterization of the Cytostatic and Cytotoxic Activity of Dioxa and 
Oxaza-tricyclononanes 
Natural products containing a strained oxetane ring show a wide spectrum of biological 
activities.142 In dictyoxetane the presence of an oxetane ring in its intricate framework confers 
pharmacological potential to all structurally related segments. Moreover, since the azetidine 
ring system represents an important pharmacophore in several bioactive compounds,143 aza-
analogues of the dioxatricyclic substructure are also interesting substances with potential 
pharmacological activity. 
The pharmacological potential of the dioxatricyclic substructure of dictyoxetane was already 
verified by the anti-tumor activity exhibited by some dioxatricyclic oxetanes. Four 
dioxatricycles, synthesized by J. Wittenberg,144 showed cytostatic activity towards HMO 2 
and HEP G2 cell lines comparable to 5-fluorouracil and a fifth dioxatricyclic oxetane, 
reported by S. Proemmel,145 showed cytostatic activity towards HEP G2 and MCF 7 cell lines. 
The anti-tumor activity showed by the above mentioned oxetanes increased the interest in the 
synthesis and functionalization of new dioxatricyclic oxetanes and aza-analogues of the 
natural product dictyoxetane. Amongst the dioxatricyclic and oxazatricyclic compounds 
reported in the present work, the in vitro anti-tumor activity of seven substances was tested 
against different tumor cells (see Section 7.1). 
7.1 Results of the in vitro Tests in Three Tumor Cell Lines 
The anti-tumor activities of dioxazatricycles 186 and 187, tricyclic amines 265 and 266 and 
tricyclic azetidines 267, 268 and 270 were tested against three tumor cell types (see Scheme 
91). The cytostatic and cytotoxic assays were carried out in vitro, via the HMO 2 (human 
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 See Section 1.1. 
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 See Section 1.2. 
144
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gastric carcinoma), the HEP G2 (human heptocellular carcinoma) and the MCF 7 (mamma 
carcinoma) cell lines,146 according to the NCI guidelines.147 
All tested substances did not show any effect until a concentration of 10 µg/ml towards the 
HMO 2, the HEP G2 and the MCF 7 cell lines. In other words, none of the tricyclic 
compounds exhibited cytotoxic or cytostatic activity against these three tumor cells. 
O
OBn
O
OBn
N
O O
NBr Br
O
NHMe
O
OPiv OMe
O
N
HO Me
OPiv
O
N
HO Me
OPiv
O
N
HO Me
O
NHMe
O
OPiv
186 187 265 267
266 268 270
 
Scheme 91: Tested oxazatricyclic and oxatricyclic substances. 
7.2 Summary and Outlook 
The above mentioned tricyclic compounds exhibited no anti-tumor activity in µmolar range 
towards three studied tumor cell lines. Further anti-tumor assays on other (tumor) cell types 
should be carried out to fully determine the cytostatic and cytotoxic potential of the aza-
analogues of dictyoxetane. On the other hand, the antiviral activity of these aza-analogues 
could also be investigated, e.g. against herpes-simplex virus, hepatitis B virus or 
cytomegalovirus. 
The functionalization of the oxazatricyclic skeletal structure allows the preparation of new 
derivatives with potential biological activity. A promising aza-analogue is azatricyclic ketone 
                                                 
146
 Pharmacological tests were carried out by Prof. W. Beil, Institut für Allgemeine Pharmakologie, Medizinische Hochschule Hannover. 
147
 Grever, M. R.; Schepartz, S. A.; Chabner, B. A. Semin. Oncol. 1992, 19, 622. 
7. Characterization of the Cytostatic and Cytotoxic Activity of Dioxa and Oxaza-
tricyclononaes 
123 
 
301, which contains a carbonyl group instead of the hydroxyl group at carbon C6 as the most 
potent dioxatricyclic oxetane 59 (see Scheme 92). Therefore, azetidine 301 should be tested. 
Another interesting derivative is methoxy substituted azatricyclic ketone 309, which has not 
been prepared in the framework of the present work. 
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Scheme 92: Dioxatricyclic segment 59 reported by J. Wittenberg and aza-analogues 301 and 309. 
Regarding the dioxatricyclic oxetanes, a variation of substituents in the dioxatricyclic 
framework is essential to provide more information to understand the pharmacological 
activity of this class of substances. As summarized in Section 2.1.7, the cytostatic active 
dioxatricyclic oxetanes differ in the protecting group at carbon atom C3 and in the functional 
group at carbon atom C6. Amongst these compounds, the most active 59 has a ketone group 
at carbon atom C6 (see Scheme 92). On the other hand, reported methoxy substituted 
dioxatricyclic oxetane 101 without methyl groups at the carbons C1 and C5 did not show anti-
tumor activity.148 Nevertheless, similar oxatricyclic oxetanes should be investigated to 
establish the influence of the methyl groups in the anti-tumor activity. For example, the 
cytostatic and cytotoxic activity of pivaloate substituted oxetane 132 and of its derivatives 
ketone 150 and diol 151 should still be tested (see Scheme 93). 
Another interesting possibility to deeply study the relation between substituents and 
pharmacological activity of the dioxatricyclic compounds is offered by the series of highly 
functionalized dioxatricyclic segments 217, 218, 220, 222, 224 and 225 (see Scheme 93). 
These dioxatricyclic oxetanes contain an alkyl or aryl group at carbon atom C2 and a 
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 Vidal Pascual, M. PhD Thesis, Universität Hannover, 2003. 
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protected 3-endo-hydroxy group, which appears to be essential to maintain the anti-tumor 
activity.149 
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Scheme 93: Dioxatricyclic oxetanes to be tested. 
A wide spectrum of dioxatricyclic segments and aza-analogues of dictyoxetane with 
biological potential are prepared following an efficient and short route. The advantageous 
availability of this class of substances should be exploited for further SAR (structure-activity 
relationship) studies relating the dioxatricyclic substructure to its biological activity. 
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8. Summary and Outlook 
8.1 Summary 
The comprehensive goal of the present work was the synthesis of new dioxatricyclic oxetanes 
and aza-analogues of dictyoxetane, potential bioactive compounds and also for high-quality 
libraries. 
The first aim was an optimized synthesis of dioxatricyclic oxetanes starting from meso-
oxabicycle rac-90. For this purpose, different esters (pivaloate, benzoate, acetate) were 
chosen as oxygen protecting group at carbon C3 in order to improve the overall yield and 
allow an easier deprotection after oxetane ring closure. 
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Scheme 94: Synthesis of dioxatricyclic segments starting from meso-oxabicycle rac-90. 
Benzoate and acetate showed migration of the acyl group giving mixtures of oxetane 138 and 
tricyclic 137 or TXA2 analogues 144 and 143, respectively (see Scheme 94). In contrast, tert-
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butylester proved to be the best choice for preparing tricyclic oxetanes. In the absence of 
stabilizing methyl groups at the bridgehead carbons, the synthesis of pivaloate substituted 
dioxatricyclic oxetane 131 proved to be clearly more successful than that of the ether 
substituted analogues.150 The first step towards new derivatives of the oxetane skeletal 
structure was then carried out by oxidation of the hydroxyl group at carbon C6 of pivaloate 
131 affording ketone 150, which is moisture sensitive and forms acetal 151 (see Scheme 94). 
On the other hand, attempted synthesis of parent deoxygenated dioxatricyclic oxetane 65 led 
to a mixture of desired oxetane 119 and more stable dioxatricycle 148 (see Scheme 94). 
A broader goal was the shortening of the synthetic route towards dioxatricyclic compounds by 
using Lewis acids to debenzylate and catalyze cyclization to the oxetane ring in one-step 
reaction. Treatment of different oxatricyclic epoxides with BCl3 afforded mixtures of 
oxetanes and unwanted dioxatricycles, resulting of the cleavage of the pivaloate or migration 
of the benzoate group. Nevertheless, the tandem strategy using BCl3 opened a new synthetic 
access to 2,6-dioxatricyclo[3.3.1.03,7]nonanes as TXA2-analogues starting from meso-
oxabicycle rac-49 (see Scheme 95). 
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Scheme 95: Attempts to a shorter and efficient synthetic route towards dioxatricyclic oxetanes. 
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The present work was also concerned with the synthesis of higher functionalized 
dioxatricyclic structures. In the first instance, emphasis was put on the introduction of a 
highly versatile isoxazoline ring in the oxatricyclic skeletal structure. For this purpose, two 
strategic routes were designed starting from oxabicyclic dialkenes 176 and 177 (see Scheme 
96). 
A site selective 1,3-dipolar cycloaddition of bromonitrile oxide to oxabicyclic dialkenes 176 
and 177 occurred on the 1,2-disubstituted double bond affording dioxazatricycles 188, 189, 
190 and 191, which are valuable precursors of a wide variety of open chain compounds. On 
the other hand, attempted site selective epoxidation of the 1,2-disubstituted double bond of 
oxabicyclic dialkenes 176 and 177 provided a mixture of epoxides and diepoxides. The 1,3-
dipolar cycloaddition of bromonitrile oxide to isolated epoxy alkenes 180 and 181 showed 
difficulties under the studied conditions, remaining open for further investigation. 
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Scheme 96: Attempted synthesis of dioxatricyclic oxetanes with an isoxazoline ring at carbon C3. 
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The synthesis of dioxatricyclic oxetanes with an aryl or alkyl group at the oxetane ring system 
was the next goal providing a series of higher functionalized dioxatricyclic structures. 
Following a short and valuable route, arylated and alkylated dioxatricyclic oxetanes were 
prepared starting from meso-oxabicycles rac-49 and rac-90 (Scheme 97). The conversion of 
versatile epoxy alcohols into the corresponding epoxy ketones proceeded quantitatively by 
using PCC oxidation. The introduction of alkyl and aryl groups at carbon C2 proceeded by a 
tandem Grignard reagent-mediated addition-cyclization reaction of epoxy ketones affording 
C2-alkylated and arylated dioxatricyclic oxetanes. Lewis acid-catalyzed cyclization of the 
isolated tertiary epoxy alcohols led also to alkylated dioxatricyclic oxetanes. 
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Scheme 97: Synthesis of arylated and alkylated dioxatricyclic oxetanes starting from meso-
oxabicycles rac-49 and rac-90. 
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Finally, the main aim of the present work was the development of an efficient synthetic route 
towards aza-analogues of the dioxatricyclic subunit of dictyoxetane, which was successfully 
accomplished after many attempts. 
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Scheme 98: Synthesis of tricyclic azetidines starting from meso-oxabicycles rac-49 and rac-90. 
The synthesis of secondary epoxy amines showed difficulties because of the steric hindrance 
and electrophilicity of the epoxy ketones and the use of additives was essential to succeed. 
Pivaloate substituted azetidines 267 and 268 and methoxy substituted azetidine 270 were 
already obtained in six steps starting from meso-oxabicycles rac-49 and rac-90 (Scheme 98). 
Conversion of epoxy ketones 207, 208 and 214 under reductive amination conditions 
proceeded through one-pot reductive amination/cyclization tandem reaction affording directly 
tricyclic azetidines 267, 268 and 270. Moreover, isolated pivaloate epoxy endo-N-
methylamines 265 and 266 underwent smoothly Grignard-mediated intramolecular 
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cyclization to afford tricyclic azetidines 267 and 268. In terms of yield and stability, pivaloate 
substituted azetidine 268 was the best choice for the synthesis of aza-analogues of 
dictyoxetane. A first step towards functionalization of the oxazatricyclic skeletal structure was 
the oxidation of tricyclic azetidine 267 yielding ketone azetidine 301. 
A remarkably short and efficient route to aza-analogues of dictyoxetane has been achieved 
starting from meso-oxabicycles rac-49 and rac-90. This approach provides highly 
functionalized oxazatricyclic azetidines, which are potential pharmacologically active 
compounds but also versatile precursors of a wide variety of derivatives including azasugars. 
The most important dioxatricyclic oxetanes, oxazatricycles and oxazatricyclononanes 
prepared from meso-oxabicycles rac-49 and rac-90 are outlined in Scheme 99. As can be 
seen, the epoxy alcohols represent highly versatile precursors of a wide spectrum of highly 
functionalized dioxatricyclic segments and aza-analogues of dictyoxetane. All compounds 
have pharmacological potential and are easily accessible through an efficient and short route. 
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Scheme 99: Summary of dioxatricyclic oxetanes, oxazatricycles and oxazatricyclononanes 
starting from meso-oxabicycles rac-49 and rac-90. 
8.2 Outlook 
Further synthesis of new dioxatricyclic subunits of dictyoxetane and aza-analogues is of 
interest not only because of the pharmacological potential related to these class of compounds 
but also for understanding the structure-activity relationship of the oxatricyclic segments. 
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In the present work, highly functionalized dioxatricycles were prepared by introduction of an 
aryl or an alkyl group at carbon C2. Further functionalization of these compounds may be 
possible through transformations at carbon C3 and at carbon C6 following an orthogonal 
protection strategy (see Scheme 100). The release of ring strain in ketones 311 and 310 by 
addition of nucleophiles similar functionalization could also be applied for tricyclic 
azetidines. 
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Scheme 100: Strategy for the synthesis of derivatives of C2-arylated and alkylated oxatricyclic oxetanes. 
Regarding the aza-analogues of dictyoxetane, an interesting approach is the synthesis of 
enantiopure tricyclic azetidines. For this purpose, several possibilities remain open such as an 
asymmetric reductive amination reaction to afford chiral epoxy amines of defined 
stereochemistry. 
In last years, the synthetic utility of nitrogen substituted oxyallyl cations as attractive reactive 
intermediates for [4+3] cycloadditions with furan has been already reported.151 Therefore, an 
alternative strategy towards tricyclic azetidines could also be explored starting from 8-
oxabicyclo[3.2.1]oct-6-en-3-ones with a nitrogen substituent at carbon C2. 
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Experimental Part 
9. General remarks 
1H-NMR Spectra were recorded at room temperature on a Bruker AVS 400 or AVS 500 
spectrometer at 400.13 MHz and 500 MHz respectively. All spectra were run in deuterated 
chloroform with tetramethylsilane as internal standard (TMS 0.00 ppm), unless otherwise 
stated. Data are reported in the following order: chemical shift in ppm on the δ-scale, spin 
multiplicities (s = singlet, d = doblet, t = triplet, q = quartet, qu = quintet, m = multiplet, b = 
broad signal), coupling constants J (Hz) and integration rates. 
13C-NMR Spectra were recorded on the above mentioned spectrometers at 100.6 MHz and 
125 MHz under proton broadband decoupling. CDCl3 was used as solvent and as internal 
standard (77.0 ppm). Chemical shifts are given in ppm on the δ-scale. 13C multiplicities were 
determined with DEPT 90 and DEPT 135 experiments and indicated by CH3 (primary), CH2 
(secondary), CH (tertiary) and Cq (quaternary). 
H,H-COSY, HBMC, HMQC and NOE spectra were recorded on the above mentioned 
spectrometers. 
Infrared Spectra (IR) were recorded on a Perkin-Elmer 1710 infrared spectrometer using a 
“Golden Gate” single-reflection ATR system. Characteristic IR bands are specified in cm-1 
and band intensities are given as follows: vs = very strong, s = strong, m = medium, w = 
weak, b = broad. 
Mass Spectra (EI-MS) were carried out on a Finnigan MAT 312 mass spectrometer 
(ionization potential 70 eV) at room temperature, unless otherwise stated. Characteristic EI-
MS peaks are given in m/z (mass to charge ratio) and percent relative intensity to the base 
peak. 
High Resolution Mass Spectra (HR-MR) were recorded on a VG Autospec spectrometer 
with the peak matching method (PKF) and the NBA-Matrix was used. 
Elemental Analysis was performed on a Heräus CHN-Rapid elemental analyzer. 
9. General remarks 134 
 
Melting Points (m.p.) were measured on a Büchi apparatus according to Dr. Tottoli and are 
uncorrected. 
Kugelrohr Distillation was carried out using a Büchi GKR 50 apparatus at reduced. 
Gas Chromatography (GC) was performed out on a HP 6890 capillary gas chromatograph 
with a SE-54 capillary column combined with a flame ionization detector and nitrogen as 
carrier gas. The integration of the signals was performed on a HP 3896 integrator. 
Column Chromatography was performed on 230-400 mesh silica gel from Macherey Nagel. 
Thin Layer Chromatography (TLC) was carried out on aluminium backed TLC plates 
coated with 0.2 mm silica gel 60 F254 from Merck. TLC plates were visualized under 
ultraviolet (λ = 254 nm) and using cerium sulphate or bromocresol green as stains. 
Reactions were monitored by TLC or GC. Air and moisture sensitive reactions were 
performed in oven-dried glassware under nitrogen or argon using standard syringe techniques 
and magnetic stirring unless otherwise noted. 
Solvents were distilled and dried using standard methods. THF was dried, distilled from KOH 
pellets and then distilled from sodium and benzophenone under argon immediately prior to 
use. DCM was freshly distilled from CaH2 before used. Diisopropylamine, triethylamine and 
pyridine were dried, distilled and stored over KOH. DMF was dried over powdered BaO for 2 
weeks, followed by decanting and then distilling under reduced pressure. Ethanol and 
methanol were dried and distilled from CaH2. 
Reagents were commercially obtained at highest commercial quality and used without further 
purification except where noted. 
Yields refer to chromatographically and spectroscopically homogeneous materials, unless 
otherwise stated. 
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10. General Experimental Procedures 
GP1 Low Temperature [4+3] Cycloaddition 
Silyl enol ether (1.0 eq) was dissolved in dichloromethane (1M) and stirred at −78°C. Furan 
(1 eq) was added and the mixture was allowed to cool down. After 15 min TMSOTf (0.1 eq) 
was added carefully. The mixture was stirred for 30 min at –78°C and then poured into a 
separating funnel containing saturated solution of sodium bicarbonate. The solution was 
shaken thoroughly until it reached room temperature. The aqueous layer was extracted three 
times with dichloromethane and the combined organic phase was dried (Na2SO4). After 
removal of the solvent the crude product was purified by silica gel column chromatography. 
GP2 Diastereoselective Reduction of Ketones with DIBAH 
DIBAH (1.2 M in toluene, 2.2 eq) was added dropwise to a solution of bicyclic ketone (1 eq) 
in THF (1 M) at –78°C. The solution was stirred at this temperature until completion of the 
reaction (TLC control) and then allowed to reach room temperature. The reaction mixture was 
quenched at 0°C with 2 N aqueous HCl and extracted with MTBE. The combined organic 
layer was dried (Na2SO4), concentrated and purified by column chromatography on silica gel. 
GP3 Epoxidation of Double Bonds with m-CPBA 
Bicyclic alkene (1 eq) was dissolved in DCM (0.2-0.4 M) and m-CPBA (70-75%, 2.0-2.4 eq) 
was added portionwise at 0°C. The reaction mixture was stirred at 0°C until the epoxidation 
was completed (TLC control) and then washed three times with 5% aqueous Na2CO3 and 
extracted with DCM. The combined organic phase was washed with saturated aqueous NaCl, 
dried (Na2SO4) and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel. 
GP4 Debenzylation with H2/Pd-C 
To a solution of bicyclic benzyl ether (1 eq) in EA (0.15 M) and AcOH (EA/AcOH 49:1) was 
added a catalytic amount of Pd/C (10% Pd) and the mixture was rapidly stirred at room 
temperature under hydrogen atmosphere (1 atm) until the reaction was shown to be completed 
by TLC. Filtration through silica gel (EA/MTBE 1:1) and removal of solvents gave a residue 
which was diluted in MTBE and then washed three times with saturated aqueous NaHCO3 
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and once with saturated aqueous NaCl. The aqueous layer was extracted several times with 
DCM and the combined organic phase was dried (Na2SO4), concentrated and purified by 
column chromatography on silica gel. 
GP5 Intramolecular Lewis Acid-Catalyzed Cyclization to Oxetane 
To a solution of epoxy alcohol (1 eq) in DCM (0.15 M) was added BF3·OEt2 (2.1 eq) 
dropwise at 0°C. The reaction mixture was stirred at room temperature until completion of the 
reaction (TLC control) and then quenched with saturated NaHCO3 solution and DCM. The 
aqueous phase was extracted several times with DCM and the combined organic layer was 
dried (Na2SO4), concentrated and purified by silica gel column chromatography. 
GP6 1,3-Dipolar Cycloaddition of Bromonitrile Oxide with [3.2.1] Oxabicycles 
using DBU  
A solution of alkene (1 eq) in acetonitrile (0.5 M) was added to a stirred solution of 
dibromoformaldoxime (2.5 eq) in acetonitrile (1 M). At 0°C DBU (3.0 eq) was injected 
dropwise. The mixture was stirred at rt until the reaction was completed and then quenched by 
careful addition of water. The aqueous layer was extracted with EA and the combined organic 
layer was dried (MgSO4), concentrated and purified by column chromatography on silica gel. 
GP7 1,3-Dipolar Cycloaddition of Bromonitrile Oxide with [3.2.1] Oxabicycles 
using KOH 
A solution of alkene (1 eq) in THF (0.5 M) was added to a stirred solution of 
dibromoformaldoxime (2.0 eq) in THF (1 M). At 0°C potassium hydroxide (2.2 eq) was 
added. The mixture was stirred at rt until the reaction was completed and then quenched by 
careful addition of water. The aqueous layer was extracted with EA and the combined organic 
layer was dried (MgSO4), concentrated and purified by column chromatography on silica gel. 
GP8 Oxidation of Alcohols to Ketones with PCC 
PCC (4 eq), anhydrous sodium acetate (4 eq), 4 Å molecular sieves (previously activated) 
(1g/1 mmol alcohol) and anhydrous DCM (4/5 of the calculated amount) were placed in a 
light-protected flask and stirred under argon atmosphere for 10 min. A solution of the alcohol 
(1 eq) in anhydrous DCM (1/5 of the calculated amount) was added to the suspension, so that 
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a 0.1 M reaction mixture was obtained. The stirring was maintained at room temperature until 
the reaction was completed (TLC control). The remaining solution was then diluted with 
MTBE, filtered through silica gel, and evaporated to dryness obtaining the product. 
GP9 Acetylation of Alcohols 
To a solution of alcohol (1 eq) in pyridine (3.5 M) were added DMAP (0.06 eq) and acetic 
anhydride (5.2 eq) at 0°C. The mixture was stirred at room temperature until completion of 
the reaction (TLC control) and quenched with water and MTBE. The aqueous phase was 
extracted with MTBE and the combined organic layers washed with 2N HCl and sat. aq. 
NaHCO3 solution and dried (Na2SO4). After removal of the solvents the crude product was 
purified by column chromatography on silica gel. 
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11. Attempts to Chapter 4 
11.1 Attempts to Section 4.1 
1,1-Bis-benzyloxy-propan-2-one 46 
O
OMe
OMe
O
OBn
OBn
46
 
Pyruvic aldehyde dimethyl acetal (12.1 ml, 100 mmol, 1 eq) was dissolved in cyclohexane (50 
ml). Benzyl alcohol (22.8 ml, 220 mmol, 2.2 eq) and p-toluenesulfonic acid monohydrate 
(0.95 g, 5 mmol, 0.05 eq) were added and the resulting mixture was heated at reflux for 2 h 
using a Dean–Stark separator for the removal of MeOH. When the reaction was completed 
(approx. 2 h), 8.1 ml (200 mmol) of MeOH were obtained. The reaction mixture was cooled 
to room temperature and washed with 25 ml of saturated potassium carbonate solution and 20 
ml of water. The aqueous layer was extracted twice with cyclohexane (2 x 50 ml). The 
combined organic phase was dried (Na2SO4), evaporated and purified by column 
chromatography on silica gel (MTBE/CH 1:20) to afford keto acetal 46. 
Yield:  22.0 g (81.4 mmol), 80 % yellowish oil 
 C17H18O3 [270.32 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.26 (m, 10 H, Ar-H), 4.72 (s, 1 H, H-1), 4.67 (d, J = 11.8 Hz, 2 H, 
OCH2Ph), 4.58 (d, J = 11.8 Hz, 2 H, OCH2Ph), 2.23 (s, 3 H, H-3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
203.7 (Cq, C-2), 136.9 (Cq, Ar-C), 128.5/128.0 (CH, Ar-C), 101.0 (CH, C-1), 
69.3 (2 x CH2, OCH2Ph), 24.9 (CH3, C-3). 
IR (neat): 3008 s, 2928 s, 1728 s, 1496 m, 1452 m, 1356 m, 1232 m, 1108 s, 1052 s, 1024 
s, 908 w, 828 w. 
EI-MS (rt): no M+, 228 (10), 227 (29, M+-CH3CO), 182 (28), 181 (43), 164 (14), 135 (10), 
108 (19), 93 (12), 92 (47), 91 (100). 
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HR-MS: calcd for C15H15O2 (M+- C2H3O) 227.107205, observed 227.107208. 
[1,1-(Bis-benzyloxy-methyl)-vinyloxy]-trimethylsilane 48 
O
OBn
OBn
OSiMe3
OBn
OBn
46 48
 
Method 1: A LDA solution was prepared with diisopropylamine (5.1 ml, 36 mmol, 1.2 eq) in 
THF (36 ml) and n-BuLi (1.6 M solution in hexane, 22.5 ml, 36 mmol, 1.2 eq) at −78°C. The 
resulting mixture was stirred for a further 15 min at room temperature. Separately dibenzyl 
acetal 46 (8.1 g, 30 mmol, 1 eq) and chlorotrimethylsilane (5.7 ml, 45 mmol, 1.5 eq) were 
dissolved in THF (30 ml) and stirred at -78°C. To this mixture was added the LDA solution 
and triethylamine (18.8 ml, 135 mmol, 4.5 eq). The resulting reaction mixture was stirred for 
one more hour at −78°C and then washed with 25 ml of water and stirred until room 
temperature was reached. The aqueous phase was extracted twice with cyclohexane. After 
being dried (Na2SO4), the organic solution was concentrated under vacuum giving a light 
yellowish liquid, which was used directly in the [4+3] cycloaddition reaction. 
Method 2: Dibenzyl acetal 46 (27 g, 100 mmol, 1 eq) was dissolved in anhydrous DMF (36 
ml, 3M solution) and chlorotrimethylsilane (28.8 ml, 230 mmol, 2.25 eq) and heated at 75°C. 
Triethylamine (38.9 ml, 280 mmol, 2.8 eq) was added via perfusion (30 ml/h). The reaction 
mixture was refluxed for 16 h at 75°C turning thicker and dark brown. The reaction mixture 
was cooled to 0°C, washed with 30 ml of a cold saturated solution of ammonium chloride and 
with ca. 20 ml of water. The aqueous phase was re-extracted with cyclohexane (4 x 50 ml). 
The organic phase was dried (Na2SO4) and the solvent removed with a rotatory evaporator. 
The resulting brown viscous oil was used directly in the [4+3] cycloaddition reaction.152 
                                                 
152
 Method 1 is convenient for up to 30 mmols of dibenzyl acetal 46 and method 2 is recommended up to 130 mmols. 
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[1,1-(Bis-benzyloxy-methyl)-vinyloxy]-triethylsilane 47 
O
OBn
OBn
OSiEt3
OBn
OBn
46 47
 
A LDA solution was prepared by syringing n-BuLi (1.6 M solution in hexane, 22.5 ml, 36 
mmol, 1.2 eq) into a solution containing diisopropylamine (5.1 ml, 36 mmol, 1.2 eq) in THF 
(36 ml) at −78°C. The resulting mixture was stirred for a further 15 min at room temperature. 
Separately dibenzyl acetal 46 (8.1 g, 30 mmol, 1 eq) and chlorotriethylsilane (7.5 ml, 45 
mmol, 1.5 eq) were dissolved in THF (30 ml) and stirred at -78°C. To this mixture was added 
carefully the LDA solution and then triethylamine (18.8 ml, 135 mmol, 4.5 eq). The resulting 
reaction mixture was stirred for 16 h at −78°C and then 25 ml of water were poured in and the 
mixture was stirred until room temperature is reached. The aqueous phase was extracted twice 
with cyclohexane. After being dried (Na2SO4) the organic solution was concentrated under 
vacuum and purified by column chromatography on silica gel (MTBE/CH 1:100/Et3N) to 
afford the silyl enol ether 47. 
Yield:  9.2 g (23.9 mmol), 80 % yellowish oil 
 C23H32O3Si [384.58 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.23 (m, 10 H, Ar-H), 4.94 (s, 1 H, H-1), 4.75 (br s, 1 H, H-3trans), 4.68 
(d, J = 12.0 Hz, 2 H, OCH2Ph), 4.60 (d, J = 12.0 Hz, 2 H, OCH2Ph), 4.43 (d, J 
= 1.0 Hz, 1 H, H-3cis), 1.00 (tr, J = 8.0 Hz, 9 H, Si(CH2CH3)3), 0.74 (q, J = 8.0 
Hz, 6H, Si(CH2CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
153.7 (Cq, C-2), 138.1 (Cq, Ar-C), 128.3 (CH, m-Ar-C), 127.8 (CH, o-Ar-C), 
127.5 (CH, p-Ar-C), 99.1 (CH2, C-3), 92.2 (CH, C-1), 67.9 (CH2, 2 x 
OCH2Ph), 6.6 (CH3, Si(CH2CH3)3), 4.8 (CH2, Si(CH2CH3)3). 
MS (rt): no M+, 279 (9), 249 (4), 248 (3), 193 (4), 187 (6), 181 (7), 159 (14), 157 (13), 
115 (17), 91 (100). 
IR (neat): 2956 s, 2912 m, 2857 s, 1640 m, 1456 m, 1256 s, 1112 s, 1056 s, 1024 s. 
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2α-Benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-90 
OSiMe3
OBn
OBn
O O
O
OBn
48 rac-90
 
According to GP1, silyl enol ether 48 (max. 30 mmol, 1 eq) was dissolved in DCM (30 ml) 
and furan (2.2 ml, 30 mmol, 1 eq) was added. TMSOTf (0.5 ml, 3.0 mmol, 0.1 eq) was added 
carefully at –78°C. After completion of the reaction, the mixture was poured into a separating 
funnel containing 30 ml of a saturated NaHCO3 solution. The crude product was purified by 
column chromatography on silica gel (MTBE/cyclohexane, 1:2) to afford cycloadduct 4 as a 
light yellow oil which solidifies to a yellowish solid. The oil was essentially pure cycloadduct 
rac-90 which can be separated from remaining BnOH by Kugelrohr distillation at 100°C 
during 2 h. On being kept in the icebox of a refrigerator it crystallized from tert-butyl methyl 
ether or pentane, giving white crystals. 
Yield:  2.83 g (12.3 mmol), 41 % (over two steps) white crystals (m. p. 64-65°C) 
 C14H14O3 [230.26 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.27 (m, 5 H, Ar-H), 6.34 (dd, J = 6.1, 1.6 Hz, 1 H, H-7), 6.30 (dd, J = 
6.1, 1.6 Hz, 1 H, H-6), 4.99 (ddd, J = 4.9, 1.6, 0.75 Hz, 1 H, H-5), 4.98 (d, J = 
12.2 Hz, 1 H, OCH2Ph), 4.91 (dd, J = 5.0, 1.6 Hz, 1 H, H-1), 4.64 (d, J = 12.2 
Hz, 1 H, OCH2Ph), 4.13 (d, J = 5.0 Hz, 1H, H-2), 2.76 (dd, J = 15.4, 4.9 Hz, 1 
H, Hax, H-4), 2.38 (d, J = 15.4 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
204.8 (Cq, C-3), 137.6 (Cq, Ar-C), 134.6 (CH, C-6), 131.7 (CH, C-7), 128.5-
127.9 (CH, Ar-C), 84.1 (CH, C-2), 79.8 (CH, C-5), 78.3 (CH, C-1), 73.5 (CH2, 
OCH2Ph), 45.9 (CH2, C-4). 
IR (CHCl3): 3063 w, 2977 m, 2862 m, 1724 vs, 1112 vs, 731 s, 697 s. 
EI-MS (rt): 230 (6, M+), 201 (4), 158 (38), 139 (31, M+-Bn), 121 (10), 108 (25), 91 (100), 
81 (30), 77 (14), 69 (23). 
EA: Anal. Calcd for C14H14O3 : C, 72.89; H, 6.05. Found: C, 73.03; H, 6.13. 
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2α-Benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-49 
OSiMe3
OBn
OBn
O O
O
OBn
rac-4948
 
According to GP1, silyl enol ether 48 (max. 30 mmol, 1 eq) was dissolved in DCM (30 ml) 
and 2,5-dimethylfuran (2.2 ml, 30 mmol, 1 eq) was added. TMSOTf (0.5 ml, 3.0 mmol, 0.1 
eq) was added carefully at –78°C. When the reaction was completed, it was poured into a 
separating funnel containing 30 ml of a saturated solution of sodium bicarbonate. The residue 
was purified by column chromatography on silica gel (MTBE/cyclohexane, 1:4) to afford 
cycloadduct rac-49 as white crystals. 
Yield:  4.11 g (15.9 mmol), 53 % (over two steps) white crystals (m.p. 79-80° C) 
 C16H18O3 [258.31 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.27 (m, 5 H, Ar-H), 6.05 (d, J = 5.8 Hz, 1 H, H-7), 6.00 (d, J = 5.8 Hz, 1 
H, H-6), 5.03 (d, J = 11.7 Hz, 1 H, OCH2Ph), 4.59 (d, J = 11.7 Hz, 1 H, 
OCH2Ph), 3.80 (s, 1H, H-2), 2.62 (d, J = 15.2 Hz, 1 H, Hax, H-4), 2.43 (d, J = 
15.2 Hz, 1H, Heq, H-4), 1.47 (s, 6 H, 2 × CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
206.3 (Cq, C-3), 137.6 (Cq, Ar-C), 137.1 (CH, C-6), 134.8 (CH, C-7), 128.4-
127.9 (CH, Ar-C), 87.4 (CH, C-2), 86.8 (CH, C-5), 84.8 (CH, C-1), 74.4 (CH2, 
OCH2Ph), 51.7 (CH2, C-4), 23.1/20.5 (CH3, 2× CH3). 
IR (CHCl3): 3034 w, 2976 m, 2929 m, 2874 m, 1718 vs, 1498 w, 1454 m, 1401 m, 1378 m, 
1340 m, 1319 m, 1269 w, 1243 w, 1220 w, 1177 m, 1109 vs, 758 s, 705 s. 
EI-MS (rt): 258 (3, M+), 191 (5), 167 (84, M+-Bn), 152 (86), 139 (17), 109 (56), 97 (41), 
91 (100), 79 (21), 65 (33). 
EA: Anal. Calcd for C16H18O3: C, 74.26; H, 6.91. Found: C, 74.39; H, 7.02. 
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2α-Benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-ol 125 
O
O
OBn
OH
O
OBn
rac-90 125
 
Following GP2, DIBAH (1.2 M in toluene, 27.5 ml, 33 mmol, 2.2 eq) was added  at –78°C to 
a solution of 8-oxabicyclo[3.2.1]oct-6-en-3-one 2 (1.86 g, 15.0 mmol, 1 eq) in THF (15 ml). 
The solution was stirred at -78°C until completion of the reaction (TLC control). Column 
chromatography (MTBE/CH 1:2) afforded alcohol 125. 
Yield:  2.79 g (12.0 mmol), 80 % yellowish oil 
 C14H16O3 [232.28 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.39-7.30 (m, 5 H, Ar-H), 6.37 (dd, J = 6.1, 1.6 Hz, 1 H, H-7), 6.30 (ddd, J = 
6.1, 1.6, 0.4 Hz, 1 H, H-6), 4.70 (m, 1 H, H-5), 4.69 (d, J = 11.8 Hz, 1 H, 
OCH2Ph), 4.64 (m, 1 H, H-1), 4.58 (d, J = 11.8 Hz, 1 H, OCH2Ph), 4.22 (dt, J 
= 5.0, 1.0 Hz, 1H, H-3), 3.77 (dd, J = 5.3, 4.1 Hz, 1 H, H-2), 2.56 (bd, 1 H, 
OH), 2.08 (ddd, J = 14.7, 5.3, 4.1 Hz, 1H, Hax, H-4), 2.38 (d, J = 14.7 Hz, 1H, 
Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.6 (Cq, Ar-C), 136.6 (CH, C-6), 131.7 (CH, C-7), 128.5/128.1/127.8 (CH, 
Ar-C), 78.35 (CH, C-2), 78.27 (CH, C-1), 74.3 (CH, C-5), 71.2 (CH2, 
OCH2Ph), 65.3 (CH, C-3), 32.9 (CH2, C-4). 
IR (CHCl3): 2942 m, 2920 m, 1454 m, 1350 m, 1190 m, 1092 s, 1028 s, 944 m. 
EI-MS (rt): 232 (2, M+), 214 (2), 141 (47), 126 (45), 108 (14), 91 (79), 81 (100). 
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2α-Benzyloxy-3α-pivaloyloxy-8-oxabicyclo[3.2.1]oct-6-ene 129 
OH
O
OBn
OPiv
O
OBn
125 129
 
To a solution of the alcohol 125 (5.6 g, 24 mmol, 1 eq) in pyridine (20 ml) were added DMAP 
(60 mg, 0.48 mmol, 0.02 eq) and pivaloyl chloride (5.9 ml, 48 mmol, 2 eq) at 0°C. The 
mixture was stirred for 1 h at 0°C and overnight at rt, then water and MTBE were added. The 
aqueous layer was extracted with MTBE (3x) and the combined organic phase washed with 
2N HCl, with sat. aq. NaHCO3 solution and dried (Na2SO4). After removal of the solvent the 
crude product was purified by column chromatography (CH/MTBE 3:1) to afford pivaloate 
129 as a clear liquid. 
Yield:  7.44 g (23.5 mmol), 98 % colourless oil 
 C19H24O4 [316.39 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.34-7.27 (m, 5 H, Ar-H), 6.36 (ddd, J = 6.1, 1.8, 0.5 Hz, 1 H, H-7), 6.27 (dd, J 
= 6.1, 1.7 Hz, 1 H, H-6), 5.50 (trm, J = 5.2, 1.2 Hz, 1 H, H-3), 4.70 (m, 1 H, H-
1), 4.64 (m. 1 H, H-5), 4.56 (d, J = 11.9 Hz, 1 H, OCH2Ph), 4.40 (d, J = 11.9 
Hz, 1 H, OCH2Ph), 3.82 (dd, J = 5.3, 3.9 Hz, 1 H, H-2), 2.22 (ddd, J = 15.1, 
5.3, 4.0 Hz, 1 H, Hax, H-4), 1.61 (dtr, J = 15.1, 1.3 Hz, 1H, Heq, H-4), 1.15 (s, 9 
H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.8 (Cq, OCOC(CH3)3), 138.0 (Cq, Ar-C), 134.5 (CH, C-6), 132.2 (CH, C-7), 
128.3/127.6/127.6 (CH, Ar-C), 79.0 (CH, C-5), 77.9 (CH, C-1), 74.1 (CH, C-
2), 71.3 (CH2, OCH2Ph), 65.8 (CH, C-3), 38.7 (Cq, OCOC(CH3)3), 32.1 (CH2, 
C-4), 27.1 (CH3, OCOC(CH3)3). 
IR (neat): 2977 m, 2954 w, 2870 w, 1720 vs, 1479 m, 1286 m, 1159 vs, 1096 s, 1031 s, 
1005 m, 879 m, 732 s, 698 s, 683 s. 
EI MS (rt): 316 (5, M+), 272 (3), 225 (20), 191 (12), 185 (6), 167 (4), 141 (5), 123 (97), 
108 (85), 95 (23), 91 (100), 85 (82), 81 (27). 
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6α-Benzyloxy-7α-pivaloyloxy-3,9-dioxatricyclo-[3.3.1.02,4]-nonane 130 
OPiv
O
OBn
OPiv
O
OBn
O
129 130
 
Following GP3, m-CPBA (70-75%, 15.6 g, 68 mmol, 2 eq) was added slowly to a solution of 
the pivaloate 129 (10.8 g, 34 mmol, 1 eq) in DCM (85 ml) at 0°C. The mixture was stirred for 
4 h at 0°C and then quenched. The crude product was purified by column chromatography 
(CH/MTBE 1:1) obtaining epoxide 130. 
Yield:  9.27 g (27.9 mmol), 82 % yellowish oil 
 C19H24O5 [332.39 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.38-7.24 (m, 5 H, Ar-H), 5.51 (trm, J = 4.6, 0.8 Hz, 1 H, H-3), 4.58 (d, J = 
11.7 Hz, 1 H, OCH2Ph), 4.43 (d, J = 11.7 Hz, 1 H, OCH2Ph), 4.23/4.21 (bs, 2 
H, H-1/H-5), 3.87 (d, J = 3.1 Hz, 1 H, H-7), 3.75 (tr, J = 4.5 Hz, 1 H, H-2), 
3.60 (d, J = 3.1 Hz, 1 H, H-6), 2.22 (dtr, J = 15.6, 4.6 Hz, 1 H, Hax, H-4), 1.76 
(d, J = 15.8 Hz, 1H, Heq, H-4), 1.18 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.3 (Cq, OCOC(CH3)3), 137.5 (Cq, Ar-C), 128.4/127.9/127.7 (CH, Ar-C), 
73.3 (CH, C-2), 72.7 (CH, C-1), 71.5 (CH, OCH2Ph), 71.0 (CH, C-3), 53.8 
(CH, C-6), 52.9 (CH, C-7), 38.7 (Cq, OCOC(CH3)3), 32.2 (CH2, C-4), 27.1 
(CH3, OCOC(CH3)3). 
IR (neat): 2948 w, 2869 w, 1719 vs, 1455 m, 1397 m, 1367 m, 1284 m, 1163 ws, 1109 m, 
1044 s, 1030 w, 865 s, 741 s, 694 s. 
EI MS (rt): 332 (26, M+), 241 72), 177 (2), 157 (15), 139 (63), 132 (13), 111 (14), 95 (15), 
91 (100), 85 (62), 81 (12), 69 (27). 
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7α-Pivaloyloxy-3,9-dioxatricyclo-[3.3.1.02,4]-nonan-6α-ol 131 
OPiv
O
OH
O
OPiv
O
OBn
O
130 131
 
According to GP4, a solution of epoxide 130 (2.33 g, 7 mmol, 1 eq), AcOH (1 ml) and a 
catalytic amount of Pd/C (10% Pd) in EA (49 ml) were hydrogenated for 16 h at rt. Column 
chromatography (CH/MTBE 1:1) afforded epoxy alcohol 131. 
Yield:  1.51 g (6.23 mmol), 89 % white crystals 
 C12H18O5 [242.27 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.26 (dm, J = 4.8, 0.75 Hz, 1 H, H-3), 4.24 (bd, J = 4.3 Hz, 1 H, H-5), 4.22 (bd, 
J = 3.7 Hz, 1 H, H-1), 4.10 (tr, J = 4.6 Hz, 1 H, H-2), 3.83 (d, J = 3.0 Hz, 1 H, 
H-7), 3.60 (d, J = 3.0 Hz, 1 H, H-6), 2.28 (dtr, J = 15.7, 4.8 Hz, 1 H, Hax, H-4), 
1.81 (d, J = 15.7 Hz, 1H, Heq, H-4), 1.23 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
179.0 (Cq, OCOC(CH3)3), 73.3 (CH, C-1), 70.7 (CH, C-5), 68.0 (CH, C-3), 
67.7 (CH, C-2), 53.6 (CH, C-6), 52.5 (CH, C-7), 38.8 (Cq, OCOC(CH3)3), 31.6 
(CH2, C-4), 27.1 (CH3, OCOC(CH3)3). 
IR (neat): 3448 w, 2953 w, 2870 w, 1717 vs, 1477 m, 1393 m, 1279 ws, 1164 ws, 1034 
vs, 856 vs, 719 s. 
EI MS (rt): 242 (4, M+), 228 (4), 171 (4), 157 (14), 140 (35), 122 (12), 111 (16), 103 (13), 
99 (27), 91 (4), 87 (4), 85 (92), 81 (38), 71 (21), 68 (100). 
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4α-Pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 132 
OPiv
O
OH
O
OPiv
O
O
HO
131 132
 
Following GP5, BF3·OEt2 (1.3 ml, 10.5 mmol, 2.1 eq) was added dropwise to a solution of 
epoxy alcohol 131 (1.21 g, 5.0 mmol, 1 eq) in DCM (34 ml) at 0°C. The mixture was allowed 
to warm slowly to rt and stirring was continued for 8 h. Purification of the crude product by 
column chromatography (CH/MTBE 1:1) yielded oxetane 132 as a white solid. 
Yield:  681 mg (2.81 mmol), 56% white solid 
 C12H18O5 [242.27 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.32 (dd, J = 5.9, 4.3 Hz, 1 H, H-1), 4.95 (m, 1 H, H-2), 4.93 (m, 1H, H-3), 
4.89 (dm, J = 5.2 Hz, 1 H, H-5), 4.56(bd, J = 9.7 Hz, H-7), 4.24 (d, J = 7.4 Hz, 
1 H, H-6), 2.70 (dddd, J = 13.5, 9.7, 8.8, 0.9 Hz, 1 H, Heq, H-4), 2.00 (d, J = 
7.4 Hz, 1 H, OH), 1.78 (ddd, J = 13.9, 8.5, 1 Hz, 1H, Hax, H-4), 1.18 (s, 9 H, 
OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.8 (Cq, OCOC(CH3)3), 89.8 (CH, C-2), 82.1 (CH, C-5), 80.3 (CH, C-7), 
78.5 (CH, C-6), 74.7 (CH, C-1), 68.0 (CH, C-3), 38.7 (Cq, OCOC(CH3)3), 27.4 
(CH2, C-4), 27.0 (CH3, OCOC(CH3)3). 
IR (neat): 3233 w, 2958 wm, 1726 vs, 1479 m, 1282 m, 1159 vs, 1075 s, 1042 vs, 988 vs, 
938 m, 852 m. 
EI MS (rt): 243 (3, M+), 197 (2), 181 (9), 157 (22), 140 (77), 122 (53), 113(41), 97 (67), 84 
(100), 68 (48). 
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2α-Benzyloxy-3α-benzoyloxy-8-oxabicyclo[3.2.1]oct-6-ene 134 
OH
O
OBn
OBz
O
OBn
125 134
 
To a solution of the alcohol 125 (2.32 g, 10.0 mmol, 1 eq) in pyridine (2.6 ml) and THF (3.5 
ml) were added DMAP (37 mg, 0.3 mmol, 0.03 eq) and benzoyl chloride (2.6 ml, 22.5 mmol, 
2.25 eq) at 0°C. The mixture was stirred for 1 h at that temperature and then overnight at rt. 
The reaction was quenched with water and MTBE and the aqueous layer was extracted with 
MTBE (3x). The combined organic phase was washed with 2N HCl, with sat. aq. NaHCO3 
solution and dried (Na2SO4). After removal of the solvents the crude product was purified by 
column chromatography (MTBE/CH 1:6) to afford benzoate 134. 
Yield:  3.16 g (9.4 mmol), 94 % yellowish solid 
 C21H20O4 [336.38 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.08 (m, 2 H, o-Ar’-H), 7.60 (m, 1 H, p-Ar’-H 7), 7.48 (m, 2 H, m-Ar’-H), 7.41-
7.31 (m, 5 H, Ar-H), 6.56 (ddd, J = 6.1, 1.8, 0.6 Hz, 1 H, H-7), 6.39 (dd, J = 
6.1, 1.7 Hz, 1 H, H-6), 5.75 (trm, J = 5.3, 1.2 Hz, 1 H, H-3), 4.75 (m, 1 H, H-
1), 4.68 (m. 1 H, H-5), 4.60 (d, J = 11.9 Hz, 1 H, OCH2Ph), 4.45 (d, J = 11.9 
Hz, 1 H, OCH2Ph), 3.92 (dd, J = 5.2, 3.9 Hz, 1 H, H-2), 2.32 (ddd, J = 15.1, 
5.3, 4.0 Hz, 1 H, Hax, H-4), 1.8 (dtr, J = 15.2, 1.3 Hz, 1H, Heq, H-4) 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.8 (Cq, OCOPh), 137.9 (Cq, Ar-C), 134.8 (CH, p-Ar’-C), 134.5 (CH, C-6), 
132.2 (CH, C-7), 130.6 (Cq, Ar’-C), 129.7/128.9 (CH, Ar’-C), 
128.3/127.7/127.6 (CH, Ar-C), 79.0 (CH, C-5), 77.9 (CH, C-1), 73.9 (CH, C-
2), 71.4 (CH2, OCH2Ph), 66.9 (CH, C-3), 32.1 (CH2, C-4). 
IR (neat): 2947 w, 2873 m; 1705 vs, 1453 m, 1280 wvs, 1096 m, 1028 m, 1006 m, 941 
m, 885 m, 751 s, 713 s, 700 vs. 
EI MS (rt): no M+, 244 (29), 214 (37), 161 (34), 123 (55), 105 (100), 91 (65), 77 (36). 
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6α-Benzyloxy-7α-benzoyloxy-3,9-dioxatricyclo[3.3.1.02,4]-nonane 135 
OBz
O
OBn
OBz
O
OBn
O
134 135
 
Following GP3, m-CPBA (70-75%, 4.53 g, 19.7 mmol, 2.1 eq) was added portionwise to a 
solution of the benzoate 134 (3.16 g, 9.4 mmol, 1 eq) in DCM (50 ml) at 0°C. The mixture 
was stirred for 1.5 h at 0°C and then overnight at rt. Extractive workup followed by column 
chromatography (MTBE/CH 1:4) afforded the epoxide 135 as a pale syrup which foams 
turning into a white solid. 
Yield:  9.27 g (27.9 mmol), 99% white solid 
 C21H20O5 [352.38 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.02 (m, 2 H, o-Ar’-H), 7.57 (m, 1 H, p-Ar’-H 7), 7.45 (m, 2 H, m-Ar’-H), 7.32-
7.21 (m, 5 H, Ar-H), 5.74 (btr, J = 4.4 Hz, 1 H, H-3), 4.64 (d, J = 11.9 Hz, 1 H, 
OCH2Ph), 4.47 (d, J = 11.9 Hz, 1 H, OCH2Ph), 4.28/4.27 (bs, J = 4.5 Hz, 2 H, 
H-1/H-5), 4.04 (d, J = 3.1 Hz, 1 H, H-7), 3.84 (tr, J = 4.5 Hz, 1 H, H-2), 3.74 
(d, J = 3.1 Hz, 1 H, H-6), 2.31 (dtr, J = 15.7, 4.6 Hz, 1 H, Hax, H-4), 1.96 (d, J 
= 15.8 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
165.6 (Cq, OCOPh), 137.4 (Cq, Ar-C), 133.2 (CH, p-Ar’-C), 130.0 (Cq, Ar’-C), 
129.5/128.5 (CH, Ar’-C), 128.3/127.7/127.6 (CH, Ar-C), 73.2 (CH, C-2), 72.7 
(CH, C-1), 71.5 (CH2, OCH2Ph), 71.1 (CH, C-5), 65.8 (CH, C-3), 53.9 (CH, C-
6), 52.9 (CH; C-7), 32.2 (CH2, C-4). 
IR (neat): 3031 m, 2955 w, 1714 s, 1452 m, 1367 m, 1313 m, 1269 vs, 1113 s, 1096 s, 
1025 m, 967 m, 856 vs, 708 vs. 
EI MS (rt): 352 (2, M+), 261 (17), 191 (3), 139 (19), 111 (4), 105 (100), 91 (56), 77 (12). 
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7α-Benzoyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonan-6α-ol 136 
OBz
O
OH
O
OBz
O
OBn
O
135 136
 
Following GP4, a solution of epoxide 135 (1.16 g, 3.3 mmol, 1 eq), AcOH (0.4 ml) and a 
catalytic amount of Pd/C (10% Pd) in MeOH (25 ml) was hydrogenated overnight at rt. 
Column chromatography (CH/MTBE 1:2) afforded epoxy alcohol 136. 
Yield:  779 mg (2.97 mmol), 90 % white crystals 
 C14H14O5 [262.26 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.99 (m, 2 H, o-Ar’-H), 7.60 (m, 1 H, p-Ar’-H 7), 7.46 (m, 2 H, m-Ar’-H), 5.54 
(btr, J = 4.8, 0.8 Hz, 1 H, H-3), 4.29 (d, J = 4.3 Hz, 1 H, H-5), 4.26 (d, J = 4.3 
Hz, 1 H, H-1), 4.18 (dd, J = 9.3, 4.8 Hz, 1 H, H-2), 3.96 (d, J = 3.0 Hz, 1 H, H-
7), 3.74 (tr, J = 3.0 Hz, 1 H, H-6), 2.53 (bs, 1 H, OH), 2.35 (dtr, J = 15.7, 4.7 
Hz, 1 H, Hax, H-4), 1.97 (d, J = 15.7 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
166.8 (Cq, OCOPh), 133.5 (CH, p-Ar’-C), 129.6 (Cq, Ar’-C), 129.5-128.6 (CH, 
Ar’-C), 73.5 (CH, C-5), 70.8 (CH, C-1), 68.9 (CH, C-3), 67.7 (CH, C-2), 53.7 
(CH, C-6), 52.6 (CH, C-7), 31.8 (CH2, C-4). 
IR (neat): 3461 m, 3401 w, 2970 m, 2930 m, 1711 s, 1365 m, 1271 s, 1118 m, 1024 s, 
973 m, 858 s, 710 s. 
EI MS (rt): no M+, 190 (1), 148 (2), 122 (5), 111 (6), 105 (100), 97 (5), 94 (7), 84 (15), 81 
(10), 77 (49), 68 (23). 
EA: Anal. Calcd for C14H14O5 : C, 64.12; H, 5.38. Found: C, 64.06; H, 5.29. 
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 4α-Benzoyloxy--2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 138 and 8α-Benzoyloxy-2,6-
dioxatricyclo[3.3.1.03,7]nonan-4ß-ol 137 
OBz
O
OH
O
O
O
HO
OBz
O
OBz
HO
O
2 : 1
136 138 137
 
Following GP5, BF3·OEt2 (1.3 ml, 10.5 mmol, 2.1 eq) was added dropwise to a solution of 
epoxy alcohol 136 (1.21 g, 5.0 mmol, 1 eq) in DCM (34 ml) at 0°C. The mixture was allowed 
to warm slowly to rt and stirring was continued for 8 h. Purification of the crude product by 
column chromatography (CH/MTBE 1:2) yielded a mixture of oxetane 138 and dioxatricycle 
137 in a 2:1 ratio as a white solid. Compounds 137 and 138 were not separable by column 
chromatography. 
Yield:  729 mg (3.01 mmol), 60% white solid 
 C12H18O5 [242.27 g/mol] 
Data for the main product 138: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.03 (m, 2 H, o-Ar’-H), 7.55 (m, 1 H, p-Ar’-H 7), 7.43 (m, 2 H, m-Ar’-H), 5.26 
(dd, J = 6.2, 4.2 Hz, 1 H, H-1), 5.21 (dd, J = 8.8, 1.9 Hz, 1 H, H-3), 5.05 (dd, J 
= 6.0, 2.0 Hz, 1H, H-5), 5.01 (dd, J = 4.2, 1.5 Hz, 1 H, H-2), 4.62 (bd, J = 9.7 
Hz, H-7), 4.29 (s, 1 H, H-6), 2.84 (dddd, J = 13.5, 9.3, 9.1, 0.6 Hz, 1 H, Heq, H-
4), 1.96 (ddd, J = 13.6, 8.6, 0.8 Hz, 1H, Hax, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
165.7 (Cq, Ar-C), 133.3 (CH, p-Ar’-C), 129.8 (Cq, Ar’-C), 129.5-128.3 (CH, 
Ar’-C), 89.9 (CH, C-2), 82.8 (CH, C-5), 80.4 (CH, C-7), 78.6 (CH, C-6), 74.8 
(CH, C-1), 68.8 (CH, C-3), 27.6 (CH2, C-4). 
IR (neat): 3434 wm, 2970 wm, 1710 s, 1452 m, 1317 m, 1270 ws, 1068 s, 999 m, 923 m, 
815 m, 771 m, 705 s. 
EI MS (rt): 262 (4, M+), 233 (2), 201 (2), 140 (10), 122 (13), 111 (10), 105 (100), 97 (8), 
91 (3), 84 (33), 81 (19), 77 (33), 67 (5). 
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3α-Acetyloxy-2α-benzyloxy-8-oxabicyclo[3.2.1]oct-6-en 139 
OH
O
OBn
OAc
O
OBn
125 139
 
According to GP9, to a solution of the alcohol 125 (6.97 g, 30 mmol, 1 eq) in pyridine (8 ml) 
were added DMAP (0.22 g, 1.8 mmol, 0.06 eq) and acetic anhydride (14.7 ml, 156 mmol, 5.2 
eq) at 0°C. The mixture was stirred for 1 h at 0°C and overnight at rt, then water and MTBE 
were added. Purification by column chromatography (CH/MTBE 5:1) afforded the acetate 
139. 
Yield:  7.24 g (26.4 mmol), 88 % pale yellowish oil 
 C16H18O4 [274.31 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.38-7.27 (m, 5 H, Ar-H), 6.34 (ddd, J = 6.1, 1.8, 0.5 Hz, 1 H, H-7), 6.26 (dd, J 
= 6.2, 1.7 Hz, 1 H, H-6), 5.49 (trm, J = 5.4, 1.1 Hz, 1 H, H-3), 4.68 (m, 1 H, H-
1), 4.60 (m. 1 H, H-5), 4.58 (d, J = 11.9 Hz, 1 H, OCH2Ph), 4.45 (d, J = 11.9 
Hz, 1 H, OCH2Ph), 3.80 (dd, J = 5.4, 3.9 Hz, 1 H, H-2), 2.21 (ddd, J = 15.2, 
5.5, 4.0 Hz, 1 H, Hax, H-4), 2.02 (s, 3 H, OCOCH3), 1.66 (dtr, J = 15.2, 1.3 Hz, 
1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
170.5 (Cq, OCOCH3), 138.0 (Cq, Ar-C), 134.6 (CH, C-6), 132.1 (CH, C-7), 
128.4/127.7/127.6 (CH, Ar-C), 79.0 (CH, C-5), 77.8 (CH, C-1), 73.8 (CH, C-
2), 71.5 (CH2, OCH2Ph), 66.4 (CH, C-3), 32.0 (CH2, C-4), 21.3 (CH3, 
OCOCH3). 
IR (neat): 2950 mw, 1729 vs 1375 m, 1241 vs, 1204 s, 1098 s, 1029 vs, 883 s, 733 s, 698 
s. 
EI-MS (rt): no M+, 231 (2), 214 (3), 183 (14), 168 (4), 141 (3), 123 (70), 108 (55), 95 (18), 
91 (100), 81 (35), 67 (29). 
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7α-Acetyloxy-6α-benzyloxy-3,9-oxatricyclo-[3.3.1.02,4]-nonane 140 
OAc
O
OBn
OAc
O
OBn
O
139 140
 
Following GP3, m-CPBA (70-75%, 10.95 g, 47.6 mmol, 2 eq) was added to a solution of the 
acetate 139 (6.53 g, 23.8 mmol, 1 eq) in DCM (60 ml) at 0°C. The mixture was stirred for 2 h 
at 0°C and then quenched. The crude product was purified by column chromatography 
(CH/MTBE 2:1) obtaining the epoxide 140. 
Yield:  5.54 g (19.1 mmol), 80 % pale yellow oil 
 C16H18O5 [290.31 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.39-7.27 (m, 5 H, Ar-H), 5.48 (trm, J = 4.7, 0.8 Hz, 1 H, H-3), 4.61 (d, J = 
11.8 Hz, 1 H, OCH2Ph), 4.45 (d, J = 11.8 Hz, 1 H, OCH2Ph), 4.21 (m, 1 H, H-
1), 4.19 (m. 1 H, H-5), 3.84 (d, J = 3.1 Hz, 1 H, H-7), 3.72 (tr, J = 4.5 Hz, 1 H, 
H-2), 3.59 (d, J = 3.1 Hz, 1 H, H-6), 2.20 (dtr, J = 15.6, 4.7 Hz, 1 H, Hax, H-4), 
2.07 (s, 3 H, OCOCH3), 1.80 (dtr, J = 15.6, 0.8 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
169.9 (Cq, OCOCH3), 137.5 (Cq, Ar-C), 128.5/127.9/127.6 (CH, Ar-C), 73.2 
(CH, C-2), 72.7 (CH, C-1), 71.6 (CH2, OCH2Ph), 71.1 (CH, C-5), 65.2 (CH, C-
3), 53.7 (CH, C-6), 52.7 (CH, C-7), 32.1 (CH2, C-4), 21.2 (CH3, OCOCH3). 
IR (neat): 2954 mw, 1731 vs, 1374 m, 1240 vs, 1197 s, 1099 m, 1040 s, 1028 s, 883 m, 
856 vs, 739 m, 699 s. 
EI-MS (rt): 291 (2, M+), 248 (1), 218 (1), 199 (37), 183 (3), 157 (12), 150 (7), 139 (23), 
123 (8), 111 (24), 105 (8), 97 810), 91 (100), 83 (22), 69 (26). 
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7α-Acetyloxy-3,9-oxatricyclo-[3.3.1.02,4]-nonan-6α-ol 142 and 6α-acetyloxy-3,9-
dioxatricyclo[3.3.1.02,4]nonan-7α-ol 141 
OAc
O
OH
O
OAc
O
OBn
O
OH
O
OAc
O3  :  1
140 142 141
 
Following GP4, a solution of epoxide 140 (1.68 g, 5.8 mmol, 1 eq), AcOH (0.6 ml) and a 
catalytic amount of Pd/C (10% Pd) in MeOH (28 ml) was hydrogenated overnight at rt. 
Column chromatography (CH/MTBE 1:3) afforded a mixture of epoxy alcohol 136 and epoxy 
alcohol 141, which were not separable by column chromatography. 
Yield:  1.103 g (5.51 mmol), 95 % white solid 
 C9H12O5 [200.18 g/mol] 
Data for epoxy alcohol 142: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.26 (btr, J = 4.8 Hz, 1 H, H-3), 4.23 (m, 1 H, H-1), 4.22 (m. 1 H, H-5), 4.08 
(tr, J = 4.6 Hz, 1 H, H-2), 3.81 (d, J = 3.1 Hz, 1 H, H-7), 3.59 (d, J = 3.1 Hz, 1 
H, H-6), 2.28 (dtr, J = 15.7, 4.7 Hz, 1 H, Hax, H-4), 2.12 (s, 3 H, OCOCH3), 
1.85 (d, J = 15.6 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
171.3 (Cq, OCOCH3), 73.4 (CH, C-1), 70.8 (CH, C-5), 68.4 (CH, C-3), 67.6 
(CH, C-2), 53.5 (CH, C-6), 52.4 (CH, C-7), 33.5 (CH2, C-4), 21.2 (CH3, 
OCOCH3). 
IR (neat): 3435 w, 2956 w, 1731 s, 1375 m, 1236 vs, 1196 m, 1052 s, 1029 vs, 977 m, 
880 m, 856 s. 
EI-MS (rt): 200 (4, M+), 171 (2), 157 (14), 140 (21), 122 (14), 111 (44), 99 (48), 97 (54), 
83 (78), 73 (76), 69 (100). 
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8α-Acetyloxy-2,6-dioxatricyclo[3.3.1.03,7]nonan-4ß-ol 144 and 9α-acetyloxy-2,6-
dioxatricyclo[3.3.1.03,7]nonan-4ß-ol 143 
O
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O
HO
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5  :  2
OAc
O
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O
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O
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O3  :  1
142 141 144 143
 
Following GP5, BF3·OEt2 (0.26 ml, 2.1 mmol, 2.1 eq) was added dropwise to a solution of 
epoxy alcohol 136 (200 mg, 1.0 mmol, 1 eq) in DCM (7 ml) at 0°C. The mixture was allowed 
to warm slowly to rt and stirring was continued for 8 h. Purification of the crude product by 
column chromatography (CH/MTBE 1:3) yielded a mixture of dioxatricycle 144 and 
dioxatricycle 143 in a 5:2 ratio as a white solid. Compounds 144 and 143 were not separable 
by column chromatography. 
Yield:  150 mg (0.75 mmol), 75% white solid 
 C9H12O5 [200.18 g/mol] 
Data for product 144: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.02 (s, 1 H, H-2), 4.69 (m, 1 H, H-5), 4.64 (m, 1 H, H-1), 4.36 (dtr, J = 4.8, 
1.5 Hz, 1 H, H-3), 4.36 (dtr, J = 4.6, 1.4 Hz, 1 H, H-7), 4.09 (d, J = 9.99 Hz, 1 
H, H-6), 2.08 (s, 1 H, OCOCH3), 2.04 (d, 1 H, OH), 1.93 (ddd, J = 13.9, 10.2, 
1.1 Hz, 1 H, Hax, H-4), 1.84 (d, J = 13.9, 4.8, 1.1Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
170.1 (Cq, OCOCH3), 82.7 (CH, C-1), 80.4 (CH, C-5), 78.0 (CH, C-7), 77.7 
(CH, C-2), 76.2 (CH, C-3), 75.9 (CH, C-6), 33.4 (CH2, C-4), 20.9 (CH3, 
OCOCH3). 
IR (neat): 3408 mw, 2971 m, 2940 m, 1734 vs, 1376 s, 1237 vs, 1218 vs, 1203 s, 1102 s, 
1038 s, 994 s, 978 s, 886 vs, 754 m, 701 s. 
EI-MS (rt): 200 (10, M+), 171 (4), 158 (25), 140 (28), 122 (61), 111 (100), 97 (73), 94 (29), 
84 (78), 81 (90), 69 (42). 
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11.2 Attempts to Section 4.2 
Dithiocarbonic acid O-(2α−Benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3 α-yl)-S-methylester 144 
OH
O
OBn
OCS2Me
O
OBn
125 144
 
A solution of alcohol 125 (950 mg, 4.09 mmol, 1 eq) in THF (8 ml) was dropped slowly into 
a suspension of sodium hydride (60% dispersion in mineral oil, 262 mg, 6.54 mmol, 1.6 eq) in 
THF (8 ml) at 0°C. The reaction mixture was stirred for 1 h at rt and then carbon disulfide 
(0.74 ml, 12.27 mmol, 3 eq) was added. After 4 h, iodomethane (0.46 ml, 7.36 mmol, 1.8 eq) 
was added and the mixture was stirred overnight. The reaction was quenched with water and 
MTBE. The aqueous phase was extracted with MTBE (x5) and the combined organic layers 
were dried (Na2SO4) and evaporated. The residue was purified by column chromatography 
(MTBE/CH 1:10). 
Yield:  1.293 g (4.01 mmol), 98 % yellow solid 
 C16H18O3S2 [322.44 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.38-7.26 (m, 5 H, Ar-H), 6.41 (ddd, J = 6.1, 1.8, 0.5 Hz, 1 H, H-7), 6.29 (dd, J 
= 6.1, 1.6 Hz, 1 H, H-6), 6.24 (trm, J = 5.2, 1.1 Hz, 1 H, H-3), 4.72 (m, 1 H, H-
5), 4.69 (m. 1 H, H-1), 4.55 (d, J = 11.7 Hz, 1 H, OCH2Ph), 4.40 (d, J = 11.7 
Hz, 1 H, OCH2Ph), 3.93 (dd, J = 5.3, 3.9 Hz, 1 H, H-2), 2.52 (s, 1 H, 
OCS2CH3), 2.52 (ddd, J = 15.6, 5.3, 4.0 Hz, 1 H, Hax, H-4), 1.91 (dd, J = 15.6, 
1.1 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
214.9 (Cq, OCS2CH3), 137.6 (Cq, Ar-C), 134.2 (CH, C-6), 132.4 (CH, C-7), 
128.4/127.9/127.8 (CH, Ar-C), 78.8 (CH, C-5), 77.7 (CH, C-1), 76.1 (CH, C-
2), 73.8 (CH, C-3), 71.3 (CH2, OCH2Ph), 31.5 (CH2, C-4), 18.4 (CH3, 
OCS2CH3). 
IR (neat): 2951 m, 2860 m, 1739 wm, 1350 m, 1316 m, 1227 s, 1210 s, 1189 s, 1063 s, 
1053 s, 1042 s, 1018 s, 898 s, 883 s, 769 vs, 704 vs. 
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EI MS (rt): 322 (2, M+), 275 (3), 246 (2), 215 (8), 159 (2), 147 (21), 123 (6), 91 (100), 77 
(4), 67 (8). 
2α−Benzyloxy-8-oxabicyclo[3.2.1]oct-6-ene 145 
OCS2Me
O
OBn
O
OBn
144 145
 
To a solution of dithiocarbonate 144 (6.23 g, 19.3 mmol, 1 eq) in anhydrous toluene (190 ml) 
under argon were added tributylstannanne (10.9 ml, 40.5 mmol, 2.1 eq) and AIBN (38 mg, 
0.23 mmol, 0.012 eq). The mixture was refluxed 4 h under argon and the solvent was 
evaporated. The pure product 145 was obtained by column chromatography (MTBE/CH 
1:20). 
Yield:  3.67 g (16.9 mmol), 88 % clear oil 
 C14H16O2 [216.28 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.26 (m, 5 H, Ar-H), 6.22 (dd, J = 6.1, 1.8 Hz, 1 H, H-7), 6.16 (dd, J = 
6.1, 1.8 Hz, 1 H, H-6), 4.74 (m, 1 H, H-5), 4.68 (m. 1 H, H-1), 4.58 (d, J = 12.1 
Hz, 1 H, OCH2Ph), 4.53 (d, J = 12.1 Hz, 1 H, OCH2Ph), 3.58 (ddd, J = 9.6, 5.6, 
3.9 Hz, 1 H, H-2), 1.88 (m, 1 H, H-3), 1.76-1.56 (m, 3 H, H-3/H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
138.6 (Cq, Ar-C), 131.6 (CH, C-6), 129.3 (CH, C-7), 128.4/127.6/127.5 (CH, 
Ar-C), 79.4 (CH, C-5), 79.0 (CH, C-1), 72.0 (CH, C-2), 70.7 (CH2, OCH2Ph), 
23.3 (CH2, C-3/C-4). 
IR (neat): 3436 w, 3030 w, 2948 wm, 2868 w, 1738 m, 1721 m, 1453 m, 1347 m, 1204 
m, 1090 s, 1074 s, 1049 vs, 888 vs, 738 m, 714 vs, 697 vs. 
ESI MS: Calcd for C14H16O2: 216.1150. Found: 216.0650. 
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6α−Benzyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonane 146 
O
OBn
O
OBn
O
145 146
 
Following GP3, m-CPBA (70-75%, 6.35 g, 27.6 mmol, 2 eq) was added to a solution of 
alkene 145 (2.98 g, 13.8 mmol, 1 eq) in DCM (46 ml) at 0°C. The mixture was stirred for 4 h 
at 0 °C and then overnight at rt. The crude product was purified by column chromatography 
(MTBE/CH 1:4) obtaining the epoxide 146. 
Yield:  2.69 g (11.6 mmol), 84 % orange oil 
 C14H16O3 [232.28 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.39-7.27 (m, 5 H, Ar-H), 4.60 (d, J = 11.8 Hz, 1 H, OCH2Ph), 4.56 (d, J = 
11.8 Hz, 1 H, OCH2Ph), 4.23 (bd, J = 4.1 Hz, 1 H, H-5), 4.14 (bd, J = 3.6 Hz, 1 
H, H-1), 3.79 (d, J = 3.1 Hz, 1 H, H-7), 3.70 (ddd, J = 10.2, 6.0, 4.2 Hz, 1 H, 
H-2), 3.52 (d, J = 3.1 Hz, 1 H, H-6), 1.94/1.62 (m, 2 H, H-3), 1.85/1.71 (m, 1 
H, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
138.1 (Cq, Ar-C), 128.4/127.8/127.5 (CH, Ar-C), 73.1 (CH, C-2), 72.3 (CH, C-
5), 71.6 (CH, C-1), 71.0 (CH2, OCH2Ph), 52.6 (CH, C-6), 51.4 (CH, C-7), 25.4 
(CH2, C-4), 24.4 (CH2, C-3). 
ESI MS: Calcd for C14H16O3: 232.1099. Found: 232.0506. 
3,9-Dioxatricyclo[3.3.1.02,4]nonan-6α-ol 147 
O
OH
O
O
OBn
O
146 147
 
According to GP4, a solution of epoxide 146 (100 mg, 0.43 mmol, 1 eq), AcOH (60 µL) and a 
catalytic amount of Pd/C (10% Pd) in EA (3 ml) was hydrogenated for 3 d at rt. The high 
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hydrophilicity of the compound demanded an intensive extractive workup followed by 
column chromatography (MTBE/CH 6:1) to obtain alcohol 147. 
Yield:  53 mg (0.37 mmol), 86 % white solid 
 C7H10O3 [142.25 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
4.15 (bd, J = 4.4 Hz, 1 H, H-5), 4.11 (bd, J = 4.3 Hz, 1 H, H-1), 3.96 (b, 1 H, 
H-2), 3.81 (d, J = 3.1 Hz, 1 H, H-7), 3.54 (d, J = 3.1 Hz, 1 H, H-6), 2.28 (br, 1 
H, OH), 1.96-1.85 (m, 2 H, H-3/H-4), 1.72 (m, 1 H, H-3), 1.61 (m, 1 H, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
74.2 (CH, C-1), 71.4 (CH, C-5), 66.4 (CH, C-2), 52.5 (CH, C-6), 51.1 (CH, C-
7), 26.4 (CH2, C-4), 25.4 (CH2, C-3). 
IR (neat): 3371 s, 2958 m, 2931 m, 2869 m, 1738 wm, 1197 m, 1069 s, 1052 s, 1016 s, 
959 s, 901 s, 838 vs, 788 s, 750 s. 
ESI MS: Calcd for C7H10O3: 142.0630. Found: 142.0190. 
2,7-dioxatricyclo[4.2.1.03,8]nonan-9ß-ol 119 and hexahydro-1,4-dioxa-2,5-cycloinden-3ß-ol 
148 
O
OH
O
O
O
HO
O
O
OH
2 : 5
147 119 148
 
Following GP5, BF3·OEt2 (0.49 ml, 3.93 mmol, 2.1 eq) was added dropwise to a solution of 
epoxy alcohol 147 (266 mg, 1.87 mmol, 1 eq) in DCM (12 ml) at 0°C. The mixture was 
allowed to warm slowly to rt and stirring was continued for 16 h. Purification of the crude 
product by column chromatography (MTBE/CH 4:1) yielded a mixture of oxetane 119 and 
dioxacycle 148 as a white solid. Oxetane 119 and dioxacycle 148 were not separable by 
column chromatography. 
Yield:  45 mg (0.32 mmol), 17% white solid 
 C7H10O3 [142.15 g/mol] 
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Data for the main product 138: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.07 (dd, J = 5.9, 4.3 Hz, 1 H, H-1), 4.92 (dd, J = 4.3, 1.7 Hz, 1 H, H-5), 4.88 
(trm, J = 4.71 Hz, 1H, H-2), 4.46 (dd, J = 9.53, 1.6 Hz, 1 H, H-7), 4.16 (s, 1 H, 
H-6), 1.93-1.63 (m, 4 H, H-3/H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
89.5 (CH, C-2), 82.9 (CH, C-5), 81.2 (CH, C-7), 79.1 (CH, C-6), 74.8 (CH, C-
1), 22.2 (CH2, C-4), 20.9 (CH2, C-3). 
IR (neat): 3390 w, 2969 wm, 2854 m, 1738 wm, 1203 m, 1085 s, 1041 s, 988 vs, 976 vs, 
898 s, 843 s, 829 s, 751 s. 
EI MS (rt): 142 (26, M+), 124 (35), 97 (29), 83 (100), 70 (61), 67 (40), 57 (55), 55 (76). 
11.3 Attempts to Section 4.3 
4α-Pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9-one 150 
OPiv
O
O
O
OPiv
O
O
HO
132 150
 
To a solution of Py.SO3 complex (526 mgr, 3.30 mmol, 4 eq) in DCM (2.3 ml) was added 
triethylamine (0.6 ml, 4.13 mmol, 5 eq) and DMSO (0.6 ml) at 0°C. A solution of oxetane 
132 (200 mg, 0.83 mmol, 1 eq) in DCM (0.8 ml) was dropped into and the resulting reaction 
mixture was stirred at 0°C for 24 h. Then saturated NH4Cl solution was added and the 
aqueous phase was extracted with MTBE. The combined organic layer was dried (NasSO4), 
evaporated and purified by column chromatography (MTBE/CH 2:1) to afford the ketone 150. 
Yield:  165 mg (0.69 mmol), 83 % white solid 
 C12H16O5 [240.25 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.32 (ddd, J = 6.1, 4.3, 0.7 Hz, 1 H, H-1), 5.26 dd, J = 5.2, 2.3 Hz, 1 H, H-5), 
5.14 (ddd, J = 10.1, 9.1, 2.3 Hz, 1H, H-3), 4.68 (ddd, J = 4.3, 1.4, 0.5 Hz, 1 H, 
H-2), 4.37 (dm, J = 9.7 Hz, 1 H, H-7), 2.87 (ddd, J = 14.1, 9.5, 0.5 Hz, 1 H, 
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Heq, H-4), 1.93 (ddd, J = 14.1, 8.0, 1 Hz, 1H, Hax, H-4), 1.19 (s, 9 H, 
OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
206.2 (Cq, C-6), 177.6 (Cq, OCOC(CH3)3), 83.5 (CH, C-2), 80.2 (CH, C-5), 
74.3 (CH, C-1), 73.6 (CH, C-7), 66.4 (CH, C-3), 38.8 (Cq, OCOC(CH3)3), 27.4 
(CH2, C-4), 27.0 (CH3, OCOC(CH3)3). 
IR (neat): 3411 w, 3306 w, 2970 wm, 2873 m, 1730 s, 1281 m, 1142 vs, 1070 vs, 1040 
vs, 984 s, 940 s, 905 s, 866 s. 
EI MS (rt): 240 (28, M+), 223 (2), 212 (21), 199 (5), 183 (3), 168 (65), 156 (64), 139 (47), 
127 (78), 111 (63), 99 (31), 85 (100), 69 (65). 
11.4 Attempts to Section 4.4 
 4α-Benzoyloxy-6,8-dimethyl-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 71, 8α-Benzyloxy-
5,7-dimethyl-2,6-dioxatricyclo[3.3.1.03,7]nonan-4β-ol 156 and 9α-benzyloxy-5,7-dimethyl-
2,6-dioxatricyclo[3.3.1. 03,7]nonan-4β-ol 157 
OBz
O
OBn
O
OBz
O
O
HO
O
OBz
O
HO
O
O
OH
OBz
1  :  7  :  3.5
156 15771155
 
BCl3 (1M solution in hexanes, 1.5 ml, 1.50 mmol, 2.2 eq) was dropped into a solution of 
epoxide 155 (259 mg, 0.68 mmol, 1 eq) in DCM (3.4 ml) at –78°C. After 2 h, water was 
added and the mixture was allowed to warm slowly to rt. The aqueous layer was extracted 
with DCM and the combined organic phase was dried and evaporated. The crude product was 
purified by column chromatography (MTBE/CH 1:1) and oxetane 71, dioxatricycle 156 and 
dioxatricycle 157 were separated in high purity. 
Yield:  174 mg (0.60 mmol), 88 % total yield 
 C16H18O5 [290.31 g/mol] 
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Data for product 71: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.03 (m, 2 H, o-Ar-H), 7.54 (m, 1 H, p-Ar-H 7), 7.43 (m, 2 H, m-Ar’-H), 5.21 
(dtr, J = 8.8, 1.9 Hz, 1 H, H-3), 4.78 (d, J = 1.6 Hz, 1 H, H-2), 4.66 (s, 1 H, H-
7), 4.0.2 (s, 1 H, H-6), 2.49 (dd, J = 13.4, 8.8 Hz, 1 H, Heq, H-4), 2.17 (bs, 1 H, 
OH), 2.05 (dd, J = 13.5, 9.2 Hz, 1H, Hax, H-4), 1.67 (s, 3 H, CH3), 1.50 (s, 3 H, 
CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
165.9 (Cq, Ar-C), 133.2 (CH, p-Ar-C), 129.8 (Cq, Ar-C), 129.7/128.4 (CH, o- 
and m-Ar-C), 94.4 (CH, C-2), 86.1 (CH, C-7), 83.8/81.6 (Cq, C-1/C-5), 80.6 
(CH, C-6), 70.1 (CH, C-3), 34.3 (CH2, C-4), 21.6/19.2 (CH3, 2 x CH3). 
IR (CHCl3): 3403 m, 2981 w, 2939 m, 1715 vs, 1450 m, 1377 m, 1263 s, 1199 m, 1110 s, 
1070 s, 981 m, 920 m, 826 m. 
EI MS (rt): 290 (4, M+), 229 (5), 185 (5), 168 (6), 150 (4), 125 (6), 112 (38), 105 (100), 95 
(8), 77 (16). 
 
Data for dioxatricycle 157: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.06 (m, 2 H, o-Ar-H), 7.59 (m, 1 H, p-Ar-H 7), 7.46 (m, 2 H, m-Ar’-H), 4.97 
(s, 1 H, H-2), 4.46 (d, J = 5.4 Hz, 1 H, H-3), 4.24 (bs, 1 H, H-7), 4.19 (s, 1 H, 
H-6), 2.19 (d, J = 11.8 Hz, 1 H, Hax, H-4), 1.88 (dd, J = 11.8, 5.5 Hz, 1H, Heq, 
H-4), 1.61 (s, 3 H, CH3), 1.36 (s, 3 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
165.6 (Cq, Ar-C), 133.4 (CH, p-Ar-C), 129.6 (Cq, Ar-C), 129.7/128.5 (CH, o- 
and m-Ar-C), 87.0 (CH, C-6), 86.7 (Cq, C-5), 85.4 (Cq, C-1), 77.7 (CH, C-3), 
77.0 (CH, C-7), 74.9 (CH, C-2), 43.8 (CH2, C-4), 21.3/15.3 (CH3, 2 x CH3). 
IR (neat): 3436 w, 2973 mw, 2936 m, 1718 s, 1451 m, 1378 m, 1319 m, 1260 s, 1094 s, 
1070 s, 1038 m, 1026 s, 958 m, 937 m, 802 m, 709 vs. 
EI MS (rt): 290 (14, M+), 168 (16), 150 (7), 139 (12), 125 (11), 111 (9), 105 (100), 84 (41), 
77 (34), 51 (10), 43 (37), 29 (6). 
11. Attempts to Chapter 4 163 
 
6,8-Dimethyl-4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 70 and 9α-
benzyloxy-5,7-dimethyl-2,6-dioxatricyclo[3.3.1.03,7]nonan-4β-ol 161 
OPiv
O
OBn
O
OPiv
O
O
HO
O
OBn
HO
O
1.2  :  1
70 161160
 
BCl3 (1M solution in hexanes, 1.8 ml, 1.76 mmol, 2.2 eq) was dropped into a solution of 
epoxide 160 (289 mg, 0.80 mmol, 1 eq) in DCM (15 ml) at –78°C. After 16 h water was 
added and the mixture was allowed to warm slowly to rt. The aqueous layer was extracted 
with DCM and the combined organic phase was dried and evaporated. The crude product was 
purified by column chromatography (MTBE/CH 1:2) and oxetane 70 and dioxatricycle 161 
were separated in a 1.2:1 ratio. 
Total yield:  86 % 
Yield of product 70:  102 mg (0.38 mmol), 47 % white solid 
 C14H22O5 [270.32 g/mol] 
Yield of product 161:  86 mg (0.31 mmol), 39 % white solid 
 C16H20O4 [276.32 g/mol] 
Data for oxetane 70: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
4.92 (dtr, J = 8.8, 1.8 Hz, 1 H, H-3), 4.61 (d, J = 1.75 Hz, 1 H, H-2), 4.59 (s, 1 
H, H-7), 3.95 (s, 1 H, H-6), 2.34 (ddd, J = 13.3, 8.7, 0.75 Hz, 1 H, Heq, H-4), 
1.87 (dd, J = 13.3, 9.2 Hz, 1H, Hax, H-4), 1.61 (s, 3 H, CH3), 1.46 (s, 3 H, 
CH3), 1.18 (s, 9 H, OCOC(CH3)3)). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.9 (Cq, OCOC(CH3)3) ), 94.3 (CH, C-2), 86.1 (CH, C-7), 83.8/81.6 (Cq, C-
1/C-5), 80.6 (CH, C-6), 69.2 (CH, C-3), 38.8 (Cq, OCOC(CH3)3) ), 34.1 (CH2, 
C-4), 27.1 (CH3, OCOC(CH3)3)), 21.6/19.1 (CH3, 2 x CH3). 
IR (CHCl3): 3403 m, 2981 w, 2939 m, 1715 vs, 1450 m, 1377 m, 1263 s, 1199 m, 1110 s, 
1070 s, 981 m, 920 m, 826 m. 
EI MS (rt): 270 (11, M+), 209 (7), 186 (17), 168 (19), 139 (28), 125 (27), 112 (100), 95 
(50), 85 (46). 
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8α-Benzyloxy-5,7-dimethyl-2,6-dioxatricyclo[3.3.1.03,7]nonan-4β-ol 161 and 9α-benzyloxy-
5,7-dimethyl-2,6-dioxatricyclo[3.3.1.03,7]nonan-4β-ol 165 
OMe
O
OBn
O
O
OBn
O
HO
O
O
OH
OBn
2  :  1
161 16556
 
BCl3 (1M solution in hexanes, 1.5 ml, 1.52 mmol, 2.2 eq) was dropped into a solution of 
epoxide 56 (200 mg, 0.69 mmol, 1 eq) in DCM (3.5 ml) at –78°C. After 5 min, water was 
added and the mixture was allowed to warm slowly to rt. The aqueous layer was extracted 
with DCM and the combined organic phase was dried and evaporated. The crude product was 
purified by column chromatography (MTBE/CH 1:2) and dioxatricycle 161 and dioxatricycle 
165 were separated. 
Yield:  187 mg (0.68 mmol), 98 % white solid 
 C16H20O4 [276.32 g/mol] 
Data for product 161: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.38-7.28 (m, 5 H, Ar-H), 4.65 (d, J = 12.3 Hz, 1 H, OCH2Ph), 4.55 (d, J = 
12.3 Hz, 1 H, OCH2Ph), 4.32 (d, J = 4.1 Hz, 1 H, H-3), 4.16 (d, J = 0.5 Hz, 1 
H, H-7), 3.79 (bs, 1 H, H-6), 3.65 (s, 1 H, H-2), 1.87 (dd, J = 13.8, 4.6 Hz, 1 H, 
Hax, H-4), 1.69 (d, J = 13.7 Hz, 1H, Heq, H-4), 1.56 (s, 3 H, CH3), 1.27 (s, 3 H, 
CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.9 (Cq, Ar-C), 128.4/127.8/127.7 (CH, Ar-C), 89.0 (Cq, C-1), 86.9 (CH, C-
7), 85.2 (CH, C-2), 83.3 (Cq, C-5), 78.9 (CH, C-6), 77.1 (CH, C-3), 71.3 (CH, 
OCH2Ph ), 40.0 (CH2, C-4), 17.7 (CH3, 2 x CH3). 
IR (neat): 3393 mw, 2961 m, 2934 m, 1738 mw, 1453 m, 1378 s, 1355 m, 1233 m, 1217 
m, 1205 m, 1076 vs, 1026 s, 885 s, 802 s, 735 s. 
ESI MS: Calcd for C16H20O4: 276.1362. Found: 276.1295. 
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Data for product 165: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.27 (m, 5 H, Ar-H), 4.69 (d, J = 11.9 Hz, 1 H, OCH2Ph), 4.48 (d, J = 
11.9 Hz, 1 H, OCH2Ph), 4.39 (d, J = 5.5 Hz, 1 H, H-3), 4.10 (s, 1 H, H-7), 4.09 
(s, 1 H, H-6), 3.29 (d, J = 1.1 Hz, 1 H, H-2), 1.95 (d, J = 11.7 Hz, 1 H, Hax, H-
4), 1.81 (d, J = 11.6 Hz, 1H, Heq, H-4), 1.52 (s, 3 H, CH3), 1.32 (s, 3 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.8 (Cq, Ar-C), 128.3/127.8/127.7 (CH, Ar-C), 87.0.0 (CH, C-6), 86.4 (Cq, 
C-1), 86.3 (Cq, C-5), 80.0 (CH, C-2), 76.7 (CH, C-7), 76.0 (CH, C-3), 71.5 
(CH, OCH2Ph ), 43.5 (CH2, C-4), 21.3/15.5 (CH3, 2 x CH3). 
IR (neat): 3435 w, 2972 m, 2937 m, 2884 m, 1722 mw, 1453 m, 1374 m, 1242 s, 1200 s, 
1079 vs, 1030 vs, 937 s, 806 s, 737 s, 697 s. 
ESI MS: Calcd for C16H20O4: 276.1362. Found: 276.1846. 
11.5 Attempts to Section 4.5 
2α-Benzyloxy-3-methylene-8-oxabicyclo[3.2.1]oct-6-ene 176 
O
O
OBn
O
OBn
rac-90 176
 
A suspension of methyltriphenylphosphonium bromide (3.829 g, 10.72 mmol, 2.7 eq) and 
potassium tert-butoxide (1.114 g, 9.93 mmol, 2.5 eq) in anhydrous THF (38 ml) was heated at 
reflux for 30 min. The dark yellow mixture was allowed to cool to room temperature before a 
solution of ketone rac-90 (914 mg, 3.97 mmol, 1 eq) in dry THF (20 ml) was injected. The 
reaction mixture was heated for 4 h, then cooled to room temperature and quenched with 
water and MTBE. The organic layer was separated and the aqueous was extracted with 
MTBE. The combined extracts were washed with brine, dried (Na2SO4) and concentrated 
under reduced pressure. Purification by silica-gel column chromatography (MTBE/CH 1:10) 
furnished alkene 176. 
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Yield:  726 mg (3.18 mmol), 80% pale yellowish oil 
 C15H16O2 [228.29 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.41-7.26 (m, 5 H, Ar-H), 6.20 (dd, J = 6.1, 1.8 Hz, 1 H, H-7), 6.16 (dd, J = 
6.1, 1.6 Hz, 1 H, H-6), 5.28 (m, 1 H, H-3’), 4.89 (m, 1 H, H-3’), 4.75/4.74 (bd, 
2 x 1 H, H-1/H-5), 4.73 (d, J = 12.1 Hz, 1 H, OCH2Ph), 4.69 (d, J = 12.1 Hz, 1 
H, OCH2Ph), 4.01 (bd, 1H, H-2), 2.55 (dm, J = 14.4 Hz, 1 H, Hax, H-4), 2.10 
(d, J = 14.4 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
142 (Cq, C-3), 138.4 (Cq, Ar-C), 132.9 (CH, C-6), 130.0 (CH, C-7), 
128.4/127.7/127.5 (CH, Ar-C), 112.3 (CH2, C-3’), 79.2/79.0 (CH, C-1/C-5), 
78.7 (CH, C-2), 72.4 (CH2, OCH2Ph), 35.8 (CH2, C-4). 
IR (neat): 3435 w, 3030 m, 2952 mw, 2861 m, 1721 vsw, 1454 m, 1343 m, 1268 m, 1229 
m, 1216 m, 1096 vsw, 1048 s, 1027 s, 903 m, 881 m, 735 s, 713 s, 698 vs. 
ESI MS: Calcd for C15H16O2: 228.1150. Found: 228.1150. 
2α-Benzyloxy-1,5-dimethyl-3-methylene-8-oxabicyclo[3.2.1]oct-6-ene 177 
O
O
OBn
O
OBn
rac-49 177
 
A suspension of methyltriphenylphosphonium bromide (3.733 g, 10.45 mmol, 2.7 eq) and 
potassium tert-butoxide (1.085 g, 9.68 mmol, 2.5 eq) in anhydrous THF (37 ml) was heated at 
reflux for 30 min. The orange mixture was allowed to cool to room temperature and a solution 
of ketone rac-49 (1.00 g, 3.87 mmol,1 eq) in anhydrous THF (19 ml) was added dropwise. 
The reaction mixture was heated for 3h, cooled to rt and quenched with water and MTBE. 
The organic phase was separated and the aqueous layer was extracted with MTBE. The 
combined extracts were washed with brine, dried (Na2SO4) and evaporated. The crude 
product was purified by column chromatography (MTBE/CH 1:15). 
Yield:  982 mg (3.83 mmol), 99% pale yellowish oil 
 C17H20O2 [256.34 g/mol] 
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1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.43-7.28 (m, 5 H, Ar-H), 5.94 (d, J = 5.8 Hz, 1 H, H-7), 5.88 (d, J = 5.8 Hz, 1 
H, H-6), 5.15 (m, 1 H, H-3’), 4.83 (m, 1 H, H-3’), 4.76 (d, J = 11.4 Hz, 1 H, 
OCH2Ph), 4.64 (d, J = 11.4 Hz, 1 H, OCH2Ph), 3.86 (b, 1H, H-2), 2.43 (bd, J = 
14.1 Hz, 1 H, Hax, H-4), 2.20 (d, J = 14.1 Hz, 1H, Heq, H-4), 1.43 (s, 1 H, CH3), 
1.40 (s, 1 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
144.0 (Cq, C-3), 138.1 (Cq, Ar-C), 135.8 (CH, C-6), 133.3 (CH, C-7), 
128.3/128.1/127.7 (CH, Ar-C), 110.5 (CH2, C-3’), 86.9 (Cq, C-1), 85.3 (Cq, C-
5), 84.0 (CH, C-2), 74.8 (CH2, OCH2Ph), 42.9 (CH2, C-4), 23.1/20.5 (CH3, 2 x 
CH3). 
IR (neat): 3435 w, 3030 m, 2971 m, 2930 mw, 2870 m, 1722 s, 1452 m, 1375 m, 1270 m, 
1217 m, 1205 m, 1175 m, 1094 vsw, 929 m, 748 m, 699 s. 
ESI MS: Calcd for C17H20O2: 256.1463. Found: 256.1430. 
10α-Benzyloxy-5-bromo-9-methylene-3,11-dioxa-4-aza-tricyclo[5.3.1.02,6]undec-4-ene 188 
and 8α-benzyloxy-5-bromo-9-methylene-3,11-dioxa-4-aza-tricyclo[5.3.1.02,6]undec-4-ene 
189 
O
OBn
O
OBn
N
OBr
O
OBn
O
N Br176
188 189
4  :  5
 
According to GP7, a solution of alkene 176 (92 mg, 0.403 mmol, 1 eq) in THF (0.8 ml) was 
added to a stirred solution of dibromoformaldoxime (163 mg, 0.806 mmol, 2 eq) in THF (0.8 
ml). At 0°C KOH (50 mg, 0.887 mmol, 2.2 eq) was added. After standard extractive workup 
azatricyclo 188 and azatricyclo 189 were separated by column chromatography on silica gel 
(MTBE/CH 1:10) in a 4:5 ratio. 
Yield:  54 mg (0.385 mmol), 77% white solid 
 C16H16BrNO3  [350.21 g/mol] 
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Data for product 188: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.43-7.29 (m, 5 H, Ar-H), 5.32 (dd, J = 3.9, 1.9 Hz,1 H, H-3’), 5.00 (dd, J = 
4.0, 2.0 Hz, 1 H, H-3’), 4.85 (d, J = 8.7 Hz, 1 H, H-7), 4.72 (d, J = 12.9 Hz, 1 
H, OCH2Ph), 4.69 (d, J = 12.9 Hz, 1 H, OCH2Ph), 4.59 (bdd, J = 4.3, 1.7 Hz, 1 
H, H-5), 4.53 (bd, J = 4.3 Hz, 1 H, H-1), 4.03 (dm, J = 5.26 Hz, 1 H, H-2), 3.83 
(d, J = 8.7 Hz, 1 H, H-6), 2.57 (dm, J = 14.4 Hz, 1 H, Hax, H-4), 2.29 (dd, J = 
14.4, 1.6 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
140.0 (Cq, C-3), 137.4 (Cq, CBr=N), 137.7 (Cq, Ar-C), 128.5/128.0/127.7 (CH, 
Ar-C), 111.9 (CH2, C-3’), 88.1 (CH, C-7), 83.3 (CH, C-5), 80.1 (CH, C-1), 
76.6 (CH, C-2), 72.2 (CH2, OCH2Ph), 59.0 (CH, C-6), 37.0 (CH2, C-4). 
IR (neat): 2968 m, 2927 mw, 2874 m, 1738 m, 1373 m, 1281 m, 1268 m, 1215 s, 1109 s, 
1077 vs, 1047 s, 1007 m, 946 m, 882 vs, 854 s, 756 s, 705 s, 682 vs. 
EI-MS (rt): 351 (3, M++1), 350 (1, M+), 349 (3, M+-1), 91 (100), 65 (7). 
 
Data for product 189: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.41-7.28 (m, 5 H, Ar-H), 5.34 (dd, J = 3.8, 1.9 Hz,1 H, H-3’), 5.10 (d, J = 8.8 
Hz, 1 H, H-6), 4.97 (dd, J = 4.0, 2.0 Hz, 1 H, H-3’), 4.71 (d, J = 12.1 Hz, 1 H, 
OCH2Ph), 4.68 (d, J = 12.1 Hz, 1 H, OCH2Ph), 4.60 (bdd, J = 3.9, 1.25 Hz, 1 
H, H-5), 4.58 (bd, J = 4.5 Hz, 1 H, H-1), 3.96 (dm, J = 4.41 Hz, 1 H, H-2), 3.55 
(d, J = 8.8 Hz, 1 H, H-7), 2.57 (dm, J = 14.1 Hz, 1 H, Hax, H-4), 2.24 (dd, J = 
14.2, 0.9 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
140.0 (Cq, C-3), 137.8 (Cq, CBr=N), 137.7 (Cq, Ar-C), 128.5/127.9/127.5 (CH, 
Ar-C), 111.6 (CH2, C-3’), 85.4 (CH, C-6), 84.2 (CH, C-5), 79.1 (CH, C-1), 
76.4 (CH, C-2), 72.2 (CH2, OCH2Ph), 62.4 (CH, C-7), 39.1 (CH2, C-4). 
IR (neat): 3030 m, 2958 mw, 2863 m, 1726 m, 1356 mw, 1208 s, 1100 vs, 1052 vs, 889 
vs, 864 s, 739 s, 696 vs, 683 vs. 
EI-MS (rt): 351 (9, M++1), 350 (9, M+), 349 (7, M+-1), 91 (100), 77 (5), 65 (15). 
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10α-Benzyloxy-5-bromo-1,7-dimethyl-9-methylene-3,11-dioxa-4-aza-
tricyclo[5.3.1.02,6]undec-4-ene 190 and 8α-benzyloxy-5-bromo-1,7-dimethyl-9-methylene-
3,11-dioxa-4-aza-tricyclo[5.3.1.02,6]undec-4-ene 191 
O
OBn
O
OBn
N
OBr
O
OBn
O
N Br177
190 191
1  :  1
 
Following GP7, a solution of alkene (102 mg, 0.398 mmol, 1 eq) in THF (0.8 ml) was added 
to a stirred solution of dibromoformaldoxime (161 mg, 0.796 mmol, 2eq) in THF (0.8 ml). At 
0°C KOH (49 mg, 0.876 mmol, 2.2 eq) was added. Standard extractive workup followed by 
column chromatography on silica gel (MTBE/CH 1:9) provided a mixture of azatricycle 190 
and azatricycle 191 in a 1:1 ratio. 
Yield:  87 mg (0.231 mmol), 58% white solid 
 C18H20BrNO3  [378.26 g/mol] 
Data for azatricycle 191: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.41-7.27 (m, 5 H, Ar-H), 5.24 (dd, J = 3.6, 1.9 Hz,1 H, H-3’), 4.95 (dd, J = 
3.6, 1.7 Hz, 1 H, H-3’), 4.91 (d, J = 9.2 Hz, 1 H, H-6), 4.75 (d, J = 11.4 Hz, 1 
H, OCH2Ph), 4.59 (d, J = 11.4 Hz, 1 H, OCH2Ph), 3.68 (bs, 1 H, H-2), 3.43 (d, 
J = 9.2 Hz, 1 H, H-7), 2.38 (dm, J = 13.6 Hz, 1 H, Hax, H-4), 2.30 (dm, J = 
13.6 Hz, 1H, Heq, H-4), 1.50 (s, 3 H, CH3), 1.40 (s, 3 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
140.9 (Cq, C-3), 137.5 (Cq, CBr=N), 137.3 (Cq, Ar-C), 128.4-127.9 (CH, Ar-
C), 110.8 (CH2, C-3’), 89.0 (CH, C-6), 87.3/84.8 (Cq, C-1/C-5), 82.0 (CH, C-
2), 74.1 (CH2, OCH2Ph), 64.3 (CH, C-7), 47.3 (CH2, C-4), 22.5/17.2 (CH3, 2 x 
CH3). 
IR (neat): 2971 m, 2935 mw, 2859 m, 1738 m, 1454 m, 1377 m, 1237 m, 1210 m, 1094 
vs, 961 s, 894 vs, 858 s, 736 s, 698 vs. 
EI-MS (rt): 379 (5, M++1), 378 (2, M+), 377 (5, M+-1), 350 (2), 244 (8), 125 (8), 91 (100), 
65 (6). 
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6α-Benzyloxy-7-methylene-3,9-dioxa-tricyclo[3.3.1.02,4]nonane 180 
O
OBn
O
OBn
O
O
OBn
O
O
O
OBn
O
O
OBn
O
O
176 180 194 196 198
2  :  7  :  9  :  9
 
Following GP3, m-CPBA (70-75%, 410 mg, 1.70 mmol, 1.25 eq) was added to a solution of 
the alkene 176 (310 g, 1.36 mmol, 1 eq) in DCM (7 ml) at 0°C. The mixture was stirred for 16 
h at 0°C and then quenched. The crude product was purified by column chromatography 
(CH/MTBE 4:1→2:1) and epoxide 180, epoxide 194, diepoxide 196 and diepoxide 198 were 
separated. 
Total yield:    93 % 
Yield of epoxides 180:  23 mg (0.095 mmol), 7 % oily solid 
C14H16O3 [244.11 g/mol] 
Yield of epoxides 194:  80 mg (0.33 mmol), 24 % white solid 
C14H16O3 [244.11 g/mol] 
Yield of diepoxide 196:  110 mg (0.42 mmol), 31 % oily white solid 
 C15H16O4 [260.29 g/mol] 
Yield of diepoxide 198:  110 mg (0.42 mmol), 31 % white solid 
 C15H16O4 [260.29 g/mol] 
Data for product 196: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.39-7.28 (m, 5 H, Ar-H), 4.65 (d, J = 11.8 Hz, 1 H, OCH2Ph), 4.52 (d, J = 
11.8 Hz, 1 H, OCH2Ph), 4.34 (dd, J = 4.1, 1.3 Hz, 1H, H-5), 4.30 (d, J = 4.4 
Hz, 1H, H-1), 3.83 (d, J = 4.3 Hz, 1H, H-2), 3.76 (d, J = 3.0 Hz, 1H, H-7), 3.52 
(d, J = 3.0 Hz, 1H, H-6), 3.24 (dd, J = 5.9, 1,5 Hz, 1H, H-3’), 2.53 (d, J = 5.6 
Hz, 1H, H-3’), 2.39 (ddd, J = 14.2, 4.3, 1.6 Hz, 1 H, Hax, H-4), 1.53 (dd, J = 
14.2, 1.0 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.7 (Cq, Ar-C), 128.5/127.9/127.6 (CH, Ar-C), 74.6 (CH, C-1), 74.0 (CH2, 
OCH2Ph), 73.3 (CH, C-2), 72.4 (CH, C-5), 57.6 (Cq, C-3), 53.0 (CH, C-6), 
52.0 (CH2, C-3’), 51.9 (CH, C-7), 35.3 (CH2, C-4). 
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EI-MS (rt): no M+, 158 (38), 156 (100), 139 (96), 123 (17), 111 (55), 107 (20), 91 (92), 81 
(29), 75 (24), 65 (18), 50 (17), 30 (15). 
 
Data for product 198: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.41-7.28 (m, 5 H, Ar-H), 4.65 (d, J = 12.2 Hz, 1 H, OCH2Ph), 4.59 (d, J = 
12.2 Hz, 1 H, OCH2Ph), 4.29 (d, J = 3.9 Hz, 1H, H-5), 4.25 (d, J = 3.9 Hz, 1H, 
H-1), 3.94 (d, J = 3.1 Hz, 1H, H-7), 3.87 (d, J = 4.0 Hz, 1H, H-2), 3.75 (d, J = 
3.1 Hz, 1H, H-6), 2.87 (d, J = 4.9 Hz, 1H, H-3’), 2.45 (dd, J = 14.8, 4.4 Hz, 1 
H, Hax, H-4), 2.44 (d, J = 4.9 Hz, 1H, H-3’), 1.39 (d, J = 14.9 Hz, 1H, Heq, H-
4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.2 (Cq, Ar-C), 128.7/128.3/128.2 (CH, Ar-C), 72.9 (CH2, OCH2Ph), 72.7 
(CH, C-1), 72.4 (CH, C-2), 72.1 (CH; C5), 55.2 (Cq, C-3), 53.6 (CH, C-6), 52.6 
(CH, C-7), 47.0 (CH2, C-3’), 35.8 (CH2, C-4). 
IR (neat): 3285 m, 3031 m, 2954 mw, 1723 mw, 1454 m, 1342 m, 1217 m, 1096 s, 1049 
s, 902 m, 856 m, 802 s, 734 s, 698 vs. 
EI-MS (rt): no M+, 199 (7), 169 (8), 158 (14), 156 (42), 139 (43), 111 (22), 105 (10), 91 
(100), 77 (11), 69 (14), 55 (10), 41 (14). 
6α-Benzyloxy-1,5-dimethyl-7-methylene-3,9-dioxa-tricyclo[3.3.1.02,4]nonane 181 
O
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2  :  1  :  5  :  3
 
Following GP3, m-CPBA (70-75%, 600 mg, 2.44 mmol, 1.25 eq) was added to a solution of 
the alkene 177 (500 g, 1.95 mmol, 1 eq) in DCM (10 ml) at 0°C. The mixture was stirred for 
16 h at 0°C and then quenched. The crude product was purified by column chromatography 
(CH/MTBE 8:1→4:1) and diepoxide 197, diepoxide 199 and a mixture of epoxide 181 and 
epoxide 195 were separated. 
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Total yield:     96 % 
Yield of epoxides 181 and 195:  143 mg (0.53 mmol), 27 % clear oil 
 C17H20O3 [272.34 g/mol] 
Yield of diepoxide 197:   234 mg (0.86 mmol), 44 % oily white solid 
  C16H17O4 [273.30 g/mol] 
Yield of diepoxide 199:   133 mg (0.49 mmol), 25 % white solid 
  C16H17O4 [273.30 g/mol] 
Data for product 181: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.43-7.28 (m, 5 H, Ar-H), 5.09 (dd, J = 4.3, 2.1 Hz, 1 H, H-3’), 4.88 (dd, J = 
4.3, 2.1 Hz, 1 H, H-3’), 4.71 (d, J = 11.5 Hz, 1 H, OCH2Ph), 4.61 (d, J = 11.5 
Hz, 1 H, OCH2Ph), 3.80 (s, 1H, H-2), 3.39 (d, J = 3.1 Hz, 1 H, H-7), 3.38 (d, J 
= 3.1 Hz, 1 H, H-6), 2.49 (bd, J = 14.4 Hz, 1 H, Hax, H-4), 2.35 (bd, J = 14.4 
Hz, 1H, Heq, H-4), 1.24 (s, 1 H, CH3), 1.19 (s, 1 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
142.6 (Cq, C-3), 138.2 (Cq, Ar-C), 128.3-127.5 (CH, Ar-C), 109.6 (CH2, C-3’), 
82.1 (CH, C-2), 79.1/77.3 (Cq, C-1/C-5), 74.1 (CH2, OCH2Ph), 56.9 (CH, C-6), 
55.5 (CH, C-7), 42.6 (CH2, C-4), 19.4/17.2 (CH3, 2 x CH3). 
IR (neat): 3307 w, 2971 m, 2932 m, 1725 sw, 1453 m, 1375 s, 1228 m, 1217 m, 1095 vs, 
986 m, 955 m, 890 m, 864 m, 699 s. 
EI-MS (rt): 272 (2, M+), 229 (6), 181 (9), 158 (33), 156 (92), 141 (31), 139 (87), 111 (49), 
91 (100), 77 (14), 75 (23), 65 (14), 43 (39). 
ESI MS: Calcd for C17H20O3: 272.1414. Found: 272.0439. 
 
Data for product 197: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.39-7.26 (m, 5 H, Ar-H), 4.65 (d, J = 11.2 Hz, 1 H, OCH2Ph), 4.48 (d, J = 
11.2 Hz, 1 H, OCH2Ph), 3.56 (s, 1H, H-2), 3.54 (d, J = 3.0 Hz, 1H, H-7), 3.35 
(d, J = 3.0 Hz, 1H, H-6), 3.23 (dd, J = 5.7, 1,5 Hz, 1H, H-3’), 2.54 (d, J = 5.7 
Hz, 1H, H-3’), 2.28 (dd, J = 13.8, 1.5 Hz, 1 H, Hax, H-4), 1.56 (dd, J = 13.8 Hz, 
1H, Heq, H-4), 1.40 (s, 3 H, CH3), 1.37 (s, 3 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.7 (Cq, Ar-C), 128.4/128.1/127.9 (CH, Ar-C), 80.1/78.1 (Cq, C-1/C-5), 79.4 
(CH, C-2), 75.6 (CH2, OCH2Ph), 58.5 (Cq, C-3), 57.3 (CH, C-6), 56.0 (CH, C-
7), 52.2 (CH2, C-3’), 42.0 (CH2, C-4), 19.6/17.1 (CH3, 2 x CH3). 
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IR (neat): 3030m, 2972 m, 2933 m, 2875 m, 1726 mw, 1454 m, 1374 m, 1218 m, 1099 
vs, 1077 s, 990 s, 959 m, 889 m, 868 m, 840 m, 807 m, 769 s, 695 s. 
EI-MS (rt): no M+, 219 (6), 160 (7), 158 (22), 156 (66), 141 (23), 139 (64), 111 (32), 91 
(100), 75 (14), 65 (9), 50 (9), 43 (28). 
 
Data for product 199: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.40-7.29 (m, 5 H, Ar-H), 4.71 (d, J = 11.5 Hz, 1 H, OCH2Ph), 4.53 (d, J = 
11.5 Hz, 1 H, OCH2Ph), 3.73 (d, J = 3.0 Hz, 1H, H-7), 3.67 (s, 1H, H-2), 3.55 
(d, J = 3.0 Hz, 1H, H-6), 2.70 (d, J = 4.6 Hz, 1H, H-3’), 2.40 (d, J = 4.6 Hz, 
1H, H-3’), 2.31 (d, J = 14.6 Hz, 1 H, Hax, H-4), 1.45 (dd, J = 14.6 Hz, 1H, Heq, 
H-4), 1.43 (s, 3 H, CH3), 1.34 (s, 3 H, CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
137.0 (Cq, Ar-C), 128.6/128.3/128.2 (CH, Ar-C), 80.5/78.2 (Cq, C-1/C-5), 78.4 
(CH, C-2), 75.9 (CH2, OCH2Ph), 57.8 (CH, C-6), 56.6 (CH, C-7), 55.8 (Cq, C-
3), 47.0 (CH2, C-3’), 42.7 (CH2, C-4), 19.6/17.3 (CH3, 2 x CH3). 
IR (neat): 3467 w, 2971 m, 2932 mw, 1723 vs, 1454 m, 1375 m, 1253 s, 1217 s, 1095 vs, 
1075 vs, 989 m, 953 m, 893 s, 747 s, 698 s. 
EI-MS (rt): no M+, 219 (7), 160 (14), 158 (27), 156 (77), 141 (25), 139 (72), 111 (39), 91 
(100), 77 (14), 75 (18), 65 (14), 50 (13), 43 (41). 
11.6 Attempts to Section 4.6 
1,5-dimethyl-7α-Pivaloyloxy-3,9-dioxatricyclo-[3.3.1.02,4]-nonan-6-one 207 
OPiv
O
O
O
OPiv
O
OH
O
160 207
 
According to GP8, PCC (23.28 g, 108.0 mmol, 4 eq), anhydrous sodium acetate (8.86 g, 
108.0 mmol, 4 eq), 4 Å molecular sieves (previously activated) (27 g) and DCM (140 ml) 
were placed in a light-protected flask and stirred for 10 min at rt. A solution of the alcohol 
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160 (7.30 g, 27.0 mmol, 1 eq) in DCM (35 ml) was added to the suspension and stirred for 
further 30 min. Filtration of the reaction mixture through silica gel and evaporation of the 
solvents provided ketone 207. 
Yield:  7.17 g (26.7 mmol), 99 % white crystals 
 C14H20O5 [268.31 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.46 (dd, J = 10.35, 8.6 Hz, 1 H, H-3), 3.49 (d, J = 2.8 Hz, 1 H, H-7), 3.41 (d, J 
= 2.9 Hz, 1 H, H-6), 2.59 (dd, J = 13.7, 10.4 Hz, 1 H, Hax, H-4), 1.91 (dd, J = 
13.7, 8.5 Hz, 1H, Heq, H-4), 1.53/1.47 (s, 3 H, 2 x CH3), 1.24 (s, 9 H, 
OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
205.4 (Cq, C-2), 177.2 (Cq, OCOC(CH3)3), 85.1 (Cq, C-1), 76.5 (Cq, C-5), 70.0 
(CH, C-3), 58.1 (CH, C-6), 56.2 (CH, C-7), 38.7 (Cq, OCOC(CH3)3), 36.0 
(CH2, C-4), 27.1 (CH3, OCOC(CH3)3), 21.1/13.9 (CH3, 2 x CH3) 
IR (neat): 2971 mw, 2939 mw, 1740 vs, 1719 vs, 1370 m, 1230 m, 1217 m, 1158 s, 995 
m, 955 m, 843 m. 
EI-MS (rt): 268 (6, M+), 253 (2), 240 (4), 182 (57), 156 (59), 138 (69), 125 (33), 112 (66), 
109 (36), 95 (59), 85 (100), 69 (51). 
EA: Anal. Calcd for C14H20O5 : C, 62.67; H, 7.51. Found: C, 62.70; H, 7.29. 
7α-Pivaloyloxy-3,9-dioxatricyclo-[3.3.1.02,4]-nonan-6-one 208 
OPiv
O
O
O
OPiv
O
OH
O
131 208
 
According to GP8, PCC (11.3 g, 52.4 mmol, 4 eq), anhydrous sodium acetate (4.3 g, 52.4 
mmol, 4 eq), 4 Å molecular sieves (previously activated) (13 g) and DCM (68 ml) were 
placed in a light-protected flask and stirred for 10 min at rt. A solution of the alcohol 131 
(3.18 g, 13.1 mmol, 1 eq) in DCM (17 ml) was added to the suspension and stirred for further 
30 min. Filtration of the reaction mixture through silica gel and evaporation of the solvents 
provided ketone 208. 
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Yield:  2.99 g (12.4 mmol), 95% white crystals 
 C12H16O5 [240.25 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.40 (dd, J = 10.5, 8.7 Hz, 1 H, H-3), 4.59 (dd, J = 8.6, 1.6 Hz, 1 H, H-5), 4.49 
(s, 1 H, H-1), 3.74 (d, J = 2.9 Hz, 1 H, H-7), 3.59 (d, J = 2.9 Hz, 1 H, H-6), 
2.88 (ddd, J = 13.6, 10.4, 8.7 Hz, 1 H, Hax, H-4), 1.66 (ddd, J = 13.6, 8.7, 1.5 
Hz, 1H, Heq, H-4), 1.24 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
202 (Cq, C-2), 177.1 (Cq, OCOC(CH3)3), 79.0 (CH, C-1), 70.1 (CH, C-5), 69.8 
(CH, C-3), 53.9 (CH, C-6), 52.1 (CH, C-7), 38.7 (Cq, OCOC(CH3)3), 28.3 
(CH2, C-4), 27.0 (CH3, OCOC(CH3)3). 
IR (neat): 2970 w, 2932 m, 1745 vs, 1726 vs, 1280 m, 1158 vs, 1145 vs, 1060 s, 1044 m, 
857 s, 850 s, 798 s. 
EI-MS (rt): 240 (6, M+), 212 (3), 197 (7), 183 (6), 168 (18), 156 (7), 138 (19), 127 (48), 
110 (24), 99 (33), 91 (100), 85 (100), 69 (28). 
EA: Anal. Calcd for C12H16O5 : C, 59.99; H, 6.71. Found: C, 60.01; H, 6.47. 
7α-Benzoyloxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonan-6-one 210 
OBz
O
O
O
OBz
O
OH
O
155 210
 
Following GP8, PCC (1207 mg, 5.6 mmol, 4 eq), anhydrous sodium acetate (460 mg, 5.6 
mmol, 4 eq), 4 Å molecular sieves (previously activated) (1.4 g) and DCM (7.6 ml) were 
placed in a light-protected flask and stirred for 10 min at rt. A solution of the alcohol 155 (406 
mg, 1.4 mmol, 1 eq) in DCM (1.8 ml) was added to the suspension and stirred for further 30 
min. Filtration of the reaction mixture through silica gel and evaporation of the solvents 
provided ketone 210. 
Yield:  494 mg (1.9 mmol), 96 % white solid 
 C16H16O5 [288.30 g/mol] 
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1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.04 (m, 2 H, o-Ar’-H), 7.58 (m, 1 H, p-Ar’-H 7), 7.45 (m, 2 H, m-Ar’-H), 5.75 
(dd, J = 10.4, 8.5 Hz, 1 H, H-3), 3.54 (d, J = 2.8 Hz, 1 H, H-7), 3.45 (d, J = 2.8 
Hz, 1 H, H-6), 2.73 (dd, J = 13.6, 10.4 Hz, 1 H, Hax, H-4), 2.05 (dd, J = 13.8, 
8.5 Hz, 1H, Heq, H-4), 1.55/1.51 (s, 3 H, 2 x CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
205.2 (Cq, C-2), 165.2 (Cq, OCOPh), 133.4 (CH, p-Ar-C), 129.8 (CH, Ar-C), 
129.2 (Cq, Ar-C), 128.4 (CH, Ar-C), 85.2 (Cq, C-1), 70.8 (Cq, C-5), 70.8 (CH, 
C-3), 58.1 (CH, C-6), 56.2 (CH, C-7), 36.3 (CH2, C-4), 21.1/14.0 (CH3, 2 x 
CH3). 
IR (neat): 2923 mw, 1740 s, 1721 vs, 1450 m, 1376 m, 1291 m, 1271 s, 1228 m, 1119 s, 
1062 m, 865 m, 842 m, 823 m, 699 s. 
EI MS (rt) : 290 (4, M+ + 1), 229 (5), 185 (5), 168 (6), 150 (4), 125 (6), 112 (38), 105 (100), 
95 (8), 77 (16). 
7α-Benzoyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonan-6-one 212 
OBz
O
O
O
OBz
O
OH
O
136 212
 
Following GP8, PCC (1724 mg, 8.0 mmol, 4 eq), anhydrous sodium acetate (656 mg, 8.0 
mmol, 4 eq), 4 Å molecular sieves (previously activated) (2 g) and DCM (10 ml) were placed 
in a light-protected flask and stirred for 10 min at rt. A solution of the alcohol 136 (525 mg, 
2.0 mmol, 1 eq) in DCM (2.6 ml) was added to the suspension and stirred for further 30 min. 
Filtration of the reaction mixture through silica gel and evaporation of the solvents provided 
ketone 212. 
Yield:  489 mg (1.88 mmol), 94 % white solid 
 C14H12O5 [260.24 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
8.06 (m, 2 H, o-Ar’-H), 7.59 (m, 1 H, p-Ar’-H 7), 7.46 (m, 2 H, m-Ar’-H), 5.71 
(ddd, J = 10.5, 8.7, 0.5 Hz, 1 H, H-3), 4.65 (dd, J = 8.7, 1.6 Hz, 1 H, H-5), 4.56 
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(s, 1 H, H-1), 3.79 (d, J = 2.9 Hz, 1 H, H-7), 3.64 (tr, J = 2.9 Hz, 1 H, H-6), 
3.03 (dd, J = 13.6, 8.7 Hz, 1 H, Hax, H-4), 1.81 (dd, J = 13.6, 8.7, 1.5 Hz, 1H, 
Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
202.7 (Cq, C-2), 165.1 (Cq, OCOPh), 133.5 (CH, p-Ar’-C), 129.8 (CH, o-Ar’-
C), 129.0 (Cq, Ar’-C), 128.4 (CH, m-Ar’-C), 79.1 (CH, C-1), 70.6 (CH, C-3), 
70.1 (CH, C-5), 53.9 (CH, C-6), 52.7 (CH, C-7), 28.5 (CH2, C-4). 
IR (neat): 2970 m, 2919 mw, 1742 vs, 1720 vs, 1366 m, 1353 m, 1264 s, 1116 s, 1058 s, 
842 s, 799 m, 705 s. 
EI-MS (rt): no M+, 204 (1), 188 (5), 176 (3), 162 (2), 127 (5), 105 (100), 77 (23), 69 (3). 
7α-Methoxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonan-6-one 214 
OMe
O
O
O
OMe
O
OH
O
56 214
 
Following GP8, PCC (6661 mg, 30.4 mmol, 4 eq), anhydrous sodium acetate (2536 mg, 30.4 
mmol, 4 eq), 4 Å molecular sieves (previously activated) (7.7 g) and DCM (40 ml) were 
placed in a light-protected flask and stirred for 10 min at rt. A solution of the alcohol 56 (1520 
mg, 7.6 mmol, 1 eq) in DCM (10 ml) was added to the suspension and stirred for further 30 
min. Filtration of the reaction mixture through silica gel and evaporation of the solvents 
provided ketone 214. 
Yield:  1491 mg (7.52 mmol), 99 % white solid 
 C10H14O4 [198.23 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
3.58 (dd, J = 8.5, 5.8 Hz, 1 H, H-3), 3.47 (d, J = 3.0 Hz, 1 H, H-7), 3.42 (d, J = 
3.0 Hz, 1 H, H-6), 3.40 (s, 3 H, OCH3), 2.48 (dd, J = 14.3, 8.5 Hz, 1 H, Hax, H-
4), 1.88 (dd, J = 14.3, 5.9 Hz, 1H, Heq, H-4), 1.46 (s, 3 H, CH3), 1.43 (s, 3 H, 
CH3). 
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13C-NMR:  (100 MHz, CDCl3 with TMS) 
205.8 (Cq, C-2), 84.4 (Cq, C-1), 78.0 (CH, C-3), 77.0 (Cq, C-5), 58.5 (CH, 
OCH3), 58.2 (CH, C-6), 56.4 (CH, C-7), 39.1 (CH2, C-4), 20.6/20.5 (CH3, 2 x 
CH3) 
IR (neat): 3467 w, 2971 mw, 2938 mw, 1736 vs, 1230 m, 1208 m, 1117 m, 1096 m, 1077 
m, 863 m. 
EI MS (rt):  198 (14, M+), 170 (9), 141 (22), 127 (100), 112 (25), 109 (25), 98 (48), 95 (93), 
85 (38), 71 (15) 
7α-Methoxy-3,9-dioxatricyclo[3.3.1.02,4]nonan-6-one 215 
OMe
O
O
O
OMe
O
OH
O
94 215
 
According to GP8, PCC (2138 mg, 9.9 mmol, 4 eq), anhydrous sodium acetate (812 mg, 9.9 
mmol, 4 eq), 4 Å molecular sieves (previously activated) (2.5 g) and DCM (13 ml) were 
placed in a light-protected flask and stirred for 10 min at rt. A solution of the alcohol 94 (427 
mg, 2.5 mmol, 1 eq) in DCM (3 ml) was added to the suspension and stirred for further 30 
min. Filtration of the reaction mixture through silica gel and evaporation of the solvents 
provided ketone 215. 
Yield:  236 mg (1.39 mmol), 56 % yellowish oil 
 C8H10O4 [170.16 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
4.50 (dd, J = 7.5, 1.5 Hz, 1 H, H-5), 4.40 (s, 1 H, H-1), 3.94 (ddd, J = 8.8, 6.5, 
0.7 Hz, 1 H, H-3), 3.71 (d, J = 3.0 Hz, 1 H, H-7), 3.59 (d, J = 3.0 Hz, 1 H, H-
6), 3.43 (s, 3 H, OCH3), 2.80 (ddd, J = 14.0, 8.9, 7.6 Hz, 1 H, Hax, H-4), 1.67 
(ddd, J = 14.0, 6.5, 1.5 Hz, 1H, Heq, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
204.3 (Cq, C-2), 79.1 (CH, C-1), 77.6 (CH, C-3), 70.6 (CH, C-5), 58.65 (CH3, 
OCH3 ), 53.9 (CH, C-6), 52.1 (CH, C-7), 31.0 (CH2, C-4). 
11. Attempts to Chapter 4 179 
 
IR (neat): 3435 w, 2970 w, 2835 m, 1732 vs, 1268 m, 1216 m, 1198 m, 1115 s, 1057 s, 
1043 s, 980 s, 851 s, 794 m. 
ESI MS: Calcd for C8H10O4: 170.0579. Found: 170.0281. 
3,9-Dioxatricyclo[3.3.1.02,4]nonan-6-one 216 
O
O
O
O
OH
O
147 216
 
A solution of the alcohol 147 (71 mg, 0.5 mmol,1 eq) in DCM (2.5 ml) was added to a stirred 
solution of Dess-Martin reagent (381 mg, 0.9 mmol, 1.8 eq) in DCM (5 ml). The mixture was 
stirred overnight at rt and then quenched with DCM (6 ml), NaHCO3 (5 ml) and Na2S2O3 (1 
ml). After 5 min, the aqueous phase was separated and extracted with DCM (8x) and the 
combined organic layer was dried (Na2SO4) and concentrated. Purification by column 
chromatography (MTBE/CH 6:1) afforded ketone 216. 
Yield:  54 mg (0.385 mmol), 77% white solid 
 C7H8O3 [140.14 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
4.46 (d, J = 6.0 Hz, 1 H, H-5), 4.27 (s, 1 H, H-1), 3.72 (d, J = 2.9 Hz, 1 H, H-
7), 3.66 (d, J = 2.9 Hz, 1 H, H-6), 2.54-2.45 (m, 1 H, H-3), 2.45-2.32 (2 H, H-
3/H-4), 1.97-1.88 (m, 1 H, H-4). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
205.1 (Cq, C-2), 79.6 (CH, C-1), 70.9 (CH, C-5), 52.9 (CH, C-6), 52.4 (CH, C-
7), 33.1 (CH2, C-3), 24.4 (CH2, C-4). 
ESI MS: Calcd for C7H8O3: 140.0473. Found: 140.8300. 
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3β-Phenyl−4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 217 
OPiv
O
O
O
OPiv
O
O
HO
Ph
208 217
 
To a solution of ketone 208 (96 mg, 0.4 mmol, 1 eq) in THF (2 ml) was added dropwise 
phenylmagnesiumbromide solution (3 M in Et2O, 0.27 ml, 0.8 mmol, 2 eq) at –30°C. The 
mixture was allowed to warm slowly to rt and stirring was continued for 4 h. The reaction was 
quenched with sat. aq. NH4Cl solution and sat. aq. Na,K tartrate solution and extracted with 
MTBE. The combined organic phase was dried (Na2SO4), evaporated and the resulting crude 
product was purified by column chromatography (MTBE/CH 1:1). 
Yield:  83 mg (0.26 mmol), 65 % white solid 
 C18H22O5 [318.36 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.58-7.31 (m, 5 H, Ar-H), 5.31 (tr, J = 8.5 Hz, 1 H, H-3), 5.03 (d, J = 4.3 Hz , 1 
H, H-5), 4.96 (ddd, J = 4.3, 1.7, 0.7 Hz, 1 H, H-1), 4.68 (d, J = 9.9 Hz, 1 H, H-
7), 4.35 (s, 1H, H-6), 2.82 (ddd, J = 13.4, 9.7, 8.7 Hz, 1 H, Heq, H-4), 1.77 (dd, 
J = 13.4, 8.5, 0.9 Hz, 1H, Hax, H-4), 0.86 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.3 (Cq, OCOC(CH3)3), 139.9 (Cq, Ar-C), 128.2-124.4 (CH, Ar-C), 90.3 (Cq, 
C-2), 86.2 (CH, C-1), 81.3 (CH, C-5), 80.8 (CH, C-7), 78.3 (CH, C-6), 70.3 
(CH, C-3), 38.5 (Cq, OCOC(CH3)3), 28.4 (CH2, C-4), 26.9-27.7 (CH3, 
OCOC(CH3)3). 
IR (neat): 3436 w, 2971 m, 2956 m, 2873 m, 1723 vs, 1479 m, 1449 m, 1366 m, 1283 m, 
1150 vs, 1096 s, 1054 vs, 990 s, 970 vs, 897 m, 754 s, 698 vs. 
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6,8-Dimethyl-3β-phenyl-4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 218 
OPiv
O
O
O
OPiv
O
O
HO
Ph
207 218
 
Ketone 207 (107 mg, 0.40 mmol, 1 eq) was dissolved in THF (2 ml) and cooled to –30°C. 
Phenylmagnesiumbromide solution (3 M in Et2O, 0.27 ml, 0.8 mmol, 2 eq) was slowly added 
and the mixture was stirred at rt overnight. The reaction was quenched with sat. aq. NH4Cl 
solution and sat. aq. Na,K tartrate solution and extracted with MTBE. The combined organic 
layer was dried (Na2SO4), evaporated and purified by column chromatography (MTBE/CH 
1:2). 
Yield:  98 mg (0.27 mmol), 68 % white solid 
 C20H26O5 [346.42 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.65 (m, 1 H, o-Ar’-H), 7.39 (m, 1 H, p-Ar’-H), 7.27 (m, 2 H, m-Ar’-H), 6.98 
(m, 1 H, o-Ar’-H), 5.52 (tr, J = 8.8 Hz, 1 H, H-3), 4.63 (s, 1 H, H-7), 4.10 (s, 
1H, H-6), 2.53 (dd, J = 13.4, 8.5 Hz, 1 H, Heq, H-4), 1.99 (dd, J = 13.3, 9.0 Hz, 
1H, Hax, H-4), 1.53/1.16 (CH3, 2 x CH3), 0.78 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.5 (Cq, OCOC(CH3)3), 138.1 (Cq, Ar-C), 128.4-123.8 (CH, Ar-C), 92.5 (Cq, 
C-2), 91.6 (CH, C-7), 85.7 (Cq, C-1), 83.7 (Cq, C-5), 80.5 (CH, C-6), 70.5 (CH, 
C-3), 38.5 (Cq, OCOC(CH3)3), 35.6 (CH2, C-4), 27.0 (CH3, OCOC(CH3)3), 
21.6 (CH3, C5-CH3), 18.1 (CH3, C1-CH3). 
IR (neat): 3487 w, 2971 m, 2950 m, 2870 m, 1727 vs, 1480 m, 1448 m, 1369 m, 1284 m, 
1147 vs, 1078 s, 1034 vs, 981 s, 958 vs, 826 m, 758 s, 698 vs. 
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6ß-Ethynyl-7α-pivaloyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonan-6ß-ol 221 and 3β−ethynyl-4α-
pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 222 
OPiv
O
O
O
OPiv
O
O
HO
208 222
OPiv
O
O
OH
221
3  :  1
 
To a solution of ketone 208 (96 mg, 0.4 mmol, 1 eq) in THF (2 ml) was added slowly 
ethynylmagnesiumchloride solution (0.5 M in THF, 1.6 ml, 0.8 mmol, 2 eq) at –30°C. The 
mixture was allowed to warm slowly to rt and stirred overnight. The reaction was quenched 
with sat. aq. NH4Cl solution and sat. aq. Na,K tartrate solution and the aqueous phase was 
extracted with MTBE. The combined organic layer was dried (Na2SO4), evaporated and the 
resulting crude product was purified by column chromatography (MTBE/CH 1:4→1:2). 
Epoxy alcohol 221 and oxetane 222 were separated in a 5:1 ratio. 
Yield: 69 mg (0.26 mmol), 65 % total yield 
 C14H18O5 [266.29 g/mol] 
Data for alcohol 221: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.24 (d, J = 5.0 Hz, 1 H, H-3), 4.31 (bd, J = 4.4 Hz , 1 H, H-1), 4.19 (bs, 1 H, 
H-5), 3.82 (d, J = 3.0 Hz, 1 H, H-7), 3.62 (d, J = 3.1 Hz, 1 H, H-6), 2.78 (s, 1 
H, C≡CH), 2.65 (s, 1 H, ), 2.50 (dtr, J = 15.6, 4.7 Hz, 1 H, Hax, H-4), 1.76 (dtr, 
J = 15.6, 1.8 Hz, 1H, Heq, H-4), 1.22 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
179.0 (Cq, OCOC(CH3)3), 83.7 (Cq, C-2), 76.0 (CH, C5/C≡CH), 74.6 (CH, 
C≡CH), 71.1 (CH, C-1/C-3), 53.3 (CH, C-6), 51.9 (CH, C-7), 38.8 (Cq, 
OCOC(CH3)3), 30.5 (CH2, C-4), 27.1 (CH3, OCOC(CH3)3). 
 
Data for oxetane 222: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.16 (d, J = 4.3 Hz, 1 H, H-5), 5.07 (dr, J = 8.7 Hz, 1 H, H-3), 4.97 (ddd, J = 
4.3, 1.7, 0.6 Hz, 1 H, H-1), 4.60 (d, J = 9.9 Hz, 1 H, H-7), 4.23 (s, 1H, H-6), 
11. Attempts to Chapter 4 183 
 
2.84 (s, 1 H, C≡CH), 2.74 (ddd, J = 13.6, 9.7, 9.8, 8.8 Hz, 1 H, Heq, H-4), 1.65 
(ddd, J = 13.6, 8.6, 0.9 Hz, 1H, Hax, H-4), 1.21 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.4 (Cq, OCOC(CH3)3), 87.3 (CH, C-1), 81.9 (Cq, C-2), 80.6 (CH, C-7), 79.9 
(CH, C-5), 79.8 (Cq, C≡CH), 79.0 (CH, C≡CH), 77.9 (CH, C-6), 69.5 (CH, C-
3), 38.8 (Cq, OCOC(CH3)3), 37.7 (CH2, C-4), 27.8/27.1/26.9 (CH3, 
OCOC(CH3)3). 
3β−ethynyl-4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 222 
OPiv
O
O
O
OPiv
O
O
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To a solution of ketone 208 (96 mg, 0.4 mmol, 1 eq) in THF (2 ml) was added slowly 
ethynylmagnesiumbromide solution (0.5 M in THF, 1.6 ml, 0.8 mmol, 2 eq) at –30°C. The 
mixture was allowed to warm slowly to rt and stirred overnight. The reaction was quenched 
with sat. aq. NH4Cl solution and sat. aq. Na,K tartrate solution and the aqueous phase was 
extracted with MTBE. The combined organic layer was dried (Na2SO4), evaporated and the 
resulting crude product was purified by column chromatography (MTBE/CH 1:2) affording 
oxetane 222. 
Yield:  27 mg (0.10 mmol), 25% oily white solid 
 C14H18O5 [266.29 g/mol] 
Data for product 222: See preceding reaction. 
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3β−Ethynyl-4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 222 
OPiv
O
O
HO
222
OPiv
O
O
OH
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Following GP5, BF3·OEt2 (37 µl, 0.29 mmol, 2.1 eq) was added dropwise to a solution of 
epoxy alcohol 221 (38 mg, 0.14 mmol, 1 eq) in DCM (1.4 ml) at 0°C. The mixture was 
allowed to warm slowly to rt and stirring was continued for 8 h. Purification of the crude 
product by column chromatography (CH/MTBE 1:2) yielded oxetane 222. 
Yield:  21 mg (0.08 mmol), 56% oily white solid 
 C14H18O5 [266.29 g/mol] 
Data for product 222: See preceding reaction- 
6ß-Ethynyl-6,8-dimethyl-7α-pivaloyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonan-6ß-ol 223 and 3β-
ethynyl-6,8-dimethyl-4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 224 
OPiv
O
O
O
OPiv
O
O
HO
207 224
OPiv
O
O
OH
223
1  :  4
 
Ketone (107 mg, 0.40 mmol, 1 eq) was dissolved in THF (2 ml) and cooled to –30°C. 
Ethynylmagnesiumbromide solution (0.5 M in THF, 1.6 ml, 0.8 mmol, 2 eq) was slowly 
added and the mixture was stirred at rt overnight. After addition of aq. NH4Cl solution and 
sat. aq. Na,K tartrate solution, the aqueous phase was extracted with MTBE. The combined 
organic layer was dried (Na2SO4), evaporated and purified by column chromatography 
(MTBE/CH 1:2). Alcohol 223 and oxetane 224 were separated in a 1.4 ratio. 
Yield:  43 mg (0.148 mmol), 55 % total yield 
 C16H22O5 [294.34 g/mol] 
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Data for oxetane 224: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.08 (tr, J = 8.8 Hz, 1 H, H-3), 4.61 (s, 1 H, H-7), 3.97 (s, 1H, H-6), 2.83 (s, 1 
H, C≡CH), 2.43 (dd, J = 13.4, 8.5 Hz, 1 H, Heq, H-4), 1.84 (dd, J = 13.3, 9.2 
Hz, 1H, Hax, H-4), 1.68/1.46 (CH3, 2 x CH3), 1.21 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.5 (Cq, OCOC(CH3)3), 93.0 (CH, C-7), 85.0 (Cq, C-2), 84.5 (Cq, C-1), 83.8 
(Cq, C-5), 80.1 (CH, C-6), 80.0 (Cq, C≡CH), 78.5 (CH, C≡CH), 70.5 (CH, C-
3), 38.8 (Cq, OCOC(CH3)3), 34.9 (CH2, C-4), 27.1/27.0/26.9 (CH3, 
OCOC(CH3)3), 21.4/17.8 (CH3, 2 x CH3). 
IR (neat): 3463 w, 3289 mw, 2960 mw, 2932 m, 1726 s, 1713 vs, 1479 m, 1394 m, 1366 
m, 1283 s, 1160 vs, 1064 m, 1037 vs, 1022 s, 987 s, 858 vs, 757 m. 
3β-Ethynyl-6,8-dimethyl-4α-pivaloyloxy-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 224 
OPiv
O
O
HO
224
OPiv
O
O
OH
223
 
Following GP5, BF3·OEt2 (72 µl, 0.50 mmol, 2.1 eq) was added dropwise to a solution of 
epoxy alcohol 223 (71 mg, 0.24 mmol, 1 eq) in DCM (2.5 ml) at 0°C. The mixture was 
allowed to warm slowly to rt and stirring was continued for 8 h. Purification of the crude 
product by column chromatography (CH/MTBE 1:2) yielded oxetane 224. 
Yield:  43 mg (0.15 mmol), 61% yellowish oil 
 C16H22O5 [294.34 g/mol] 
Data for oxetane 224: See preceding reaction. 
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6,8-Dimethyl-4α-pivaloyloxy-3-vinyl-2,7-dioxatricyclo[4.2.1.03,8]nonan-9ß-ol 225 
OPiv
O
O
O
OPiv
O
O
HO
207 225
 
Ketone 207 (80 mg, 0.30 mmol, 1 eq) was dissolved in THF (1.5 ml) and cooled to –30°C. 
Vinylmagnesiumbromide solution (1 M in THF, 0.3 ml, 0.30 mmol, 2 eq) was slowly added 
and the mixture was stirred at rt overnight. The reaction was quenched with sat. aq. NH4Cl 
solution and sat. aq. Na,K tartrate solution and extracted with MTBE. The combined organic 
layer was dried (Na2SO4), evaporated and purified by column chromatography (MTBE/CH 
2:1). 
Yield:  37 mg (0.13 mmol), 42 % white solid 
 C16H24O5 [296.36 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.72 (dd, Jtrans = 17.2 Hz, Jcis = 10.9 Hz, CH=CH2), 5.47 (dd, Jtrans = 17.2 Hz, 
Jgem = 1.8 Hz, CH=CH2), 5.33 (3d, Jcis = 10.9 Hz, Jgem = 1.8 Hz, CH=CH2), 
5.12 (tr, J = 8.9 Hz, 1 H, H-3), 4.50 (s, 1 H, H-7), 4.00 (s, 1H, H-6), 2.38 (dd, J 
= 13.4, 8.6 Hz, 1 H, Heq, H-4), 1.90 (dd, J = 13.4, 9.0 Hz, 1H, Hax, H-4), 
1.42/1.20 (CH3, 2 x CH3), 1.12 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.7 (Cq, OCOC(CH3)3), 134.4 (CH, CH=CH2), 117.1 (CH2, CH=CH2), 91.5 
(CH, C-7), 85.3 (Cq, C-2), 83.8 (Cq, C-1), 83.4 (Cq, C-5), 80.6 (CH, C-6), 69.4 
(CH, C-3), 38.7 (Cq, OCOC(CH3)3), 35.2 (CH2, C-4), 27.1 (CH3, 
OCOC(CH3)3), 21.5/17.2 (CH3, 2 x CH3). 
IR (neat): 3463 w, 3289 mw, 2960 mw, 2932 m, 1726 s, 1713 vs, 1479 m, 1394 m, 1366 
m, 1283 s, 1160 vs, 1064 m, 1037 vs, 1022 s, 987 s, 858 vs, 757 m. 
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7α-Methoxy-6,8-dimethyl-6ß-phenyl-3,9-dioxatricyclo[3.3.1.02,4]nonan-6ß-ol 219 4α-
methoxy-6,8-dimethyl-3β-phenyl-2,7-dioxatricyclo-[4.2.1.03,8]-nonan-9β-ol 220 
OMe
O
O
O
OMe
O
O
HO
Ph
214 220
OMe
O
O
Ph
OH
219
5  :  2
 
To a solution of ketone 214 (99 mg, 0.50 mmol, 1 eq) in THF (2.5 ml) was added dropwise 
phenylmagnesiumbromide solution (3 M in Et2O, 0.3 ml, 1.0 mmol, 2 eq) at -30°C. The 
mixture was allowed to warm slowly to rt and stirring was continued overnight. The reaction 
was quenched with sat. aq. NH4Cl solution and sat. aq. Na,K tartrate solution and extracted 
with MTBE. The combined organic phase was dried (Na2SO4), evaporated and the resulting 
crude product was purified by column chromatography (MTBE/CH 1:8→1:2). Alcohol 219 
and oxetane 220 were separated in a 5:2 ratio. 
Yield:  91 mg (0.33 mmol), 66% total yield 
 C16H20O4 [276.33 g/mol] 
Data for alcohol 219: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.68 (m, 2 H, o-Ar-H), 7.35 (m, 2 H, m-Ar-H), 7.29 (m, 1 H, p-Ar-H), 3.97 (d, 
J = 3.1 Hz, 1 H, H-7), 3.52 (d, J = 3.1 Hz, 1H, H-6), 3.24 (dd, J = 4.4, 1.4 Hz, 
1 H, H-3), 2.92 (s, 3 H, OCH3), 2.16 (dd, J = 15.1, 4.4 Hz, 1 H, Hax, H-4), 1.89 
(dd, J = 15.1, 1.4 Hz, 1H, Heq, H-4), 1.39/1.13 (CH3, 2 x CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
139.8 (Cq, Ar-C), 127.8/127.3/127.2 (CH, Ar-C), 83.9 (Cq, C-1), 83.7 (CH, C-
3), 78.1 (Cq, C5), 74.9 (Cq, C2), 58.6 (CH, OCH3), 58.4 (CH: C-6), 57.2 (CH, 
C-7), 35.5 (CH2, C-4), 20.2/14.7 (CH3, 2 x CH3). 
IR (neat): 3530 m, 2990 m, 2927 mw, 1715 mw, 1490 m, 1446 s, 1373 m, 1357 m, 1247 
s, 1138 m, 1086 vs, 997 s, 931 vs, 856 s, 847 s, 763 s, 698 vs. 
Data for oxetane 220: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
7.68 (b, 1 H, Ar-H), 7.39 (b, 2 H, Ar-H), 7.28 (m, 1 H, Ar-H), 7.20 (b, 1 H, Ar-
H), 4.56 (s, 1 H, H-7), 4.07 (s, 1H, H-6), 3.95 (tr, J = 8.5 Hz, 1 H, H-3), 3.05 
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(s, 3 H, OCH3), 2.52 (dd, J = 13.5, 8.5 Hz, 1 H, Heq, H-4), 2.01 (dd, J = 13.5, 
8.7 Hz, 1H, Hax, H-4), 1.52/1.10 (CH3, 2 x CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
139.4 (Cq, Ar-C), 127.1 (CH, Ar-C), 92.8 (Cq, C-2), 91.5 (CH, C-7), 85.4 (Cq, 
C1), 83.6 (Cq, C5), 80.7 (CH, C-6), 77.6 (CH, C-3), 57.4 (CH3, OCH3), 35.9 
(CH2, C-4), 21.8/18.3 (CH3, 2 x CH3). 
IR (neat): 3434 w, 2971 m, 2933 mw, 2826 m, 1738 mw, 1446 m, 1375 m, 1201 s, 1096 
vs, 993 vs, 962 vs, 945 s, 828 m, 764 m, 700 s. 
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12. Attempts to Chapter 5 
6α-Acetyloxy-7α-pivaloyloxy-3,9-dioxatricyclo-[3.3.1.02,4]-nonane 243 
OPiv
O
OH
O
OPiv
O
OAc
O
131 243
 
Following GP9, DMAP (7 mg, 0.06 mmol, 0.06 eq) and acetic anhydride (0.49 ml, 5.2 mmol, 
5.2 eq) were added to a solution of the alcohol 131 (243 mg, 1.0 mmol, 1 eq) in pyridine (270 
µL) at 0°C. The mixture was stirred for 1.5 h at 0°C and then water and MTBE were added. 
Purification by column chromatography (MTBE/CH 1:1) afforded the acetate 243. 
Yield:  282 mg (0.99 mmol), 99 % yellowish oil 
 C14H20O6 [284.31 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.41 (tr, J = 4.6 Hz, 1 H, H-3), 5.13 (tr, J = 4.6 Hz, 1 H, H-2), 4.28 (bd, J = 4.4 
Hz, 1 H, H-5), 4.22 (bd, J = 4.3 Hz, 1 H, H-1), 3.84 (d, J = 3.1 Hz, 1 H, H-7), 
3.65 (d, J = 3.0 Hz, 1 H, H-6), 2.33 (dtr, J = 15.7, 4.7 Hz, 1 H, Hax, H-4), 2.03 
(s, 3 H, OCOCH3), 1.80 (d, J = 15.7 Hz, 1H, Heq, H-4), 1.23 (s, 9 H, 
OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
176.9 (Cq, OCOC(CH3)3), 169.1 (Cq, OCOCH3), 71.7 (CH, C-1), 71.0 (CH, C-
5), 67.4 (CH, C-3), 65.1 (CH, C-2), 53.6 (CH, C-6), 52.5 (CH, C-7), 38.7 (Cq, 
OCOC(CH3)3), 32.1 (CH2, C-4), 27.1 (CH3, OCOC(CH3)3), 20.5 (CH3, 
OCCH3). 
IR (neat): 2969 w, 2877 m, 1742 s, 1718 s, 1372 m, 1285 m, 1231 s, 1154 vs, 1061 s, 
1039 s, 876 s, 860 s, 845 m, 724 m. 
EI MS (rt): no M+, 241 (11), 199 (9), 140 (17), 122 (8), 111 (20), 97 (8), 85 (72), 81 (27), 
68 (45), 57 (100), 43 (76), 29 (27). 
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6α-Acetyloxy-7α-pivaloyloxy-1,5-dimethyl-3,9-dioxatricyclo-[3.3.1.02,4]-nonane 245 
OPiv
O
OH
O
OPiv
O
OAc
O
38 245
 
According to GP9, to a solution of the alcohol 38 (270 mg, 1.0 mmol, 1 eq) in pyridine (270 
µL) were added DMAP (7 mg, 0.06 mmol, 0.06 eq) and acetic anhydride (0.49 ml, 5.2 mmol, 
5.2 eq) at 0°C. The mixture was stirred for 1.5 h at 0°C and then water and MTBE were 
added. Purification by column chromatography (MTBE/CH 1:4) afforded the acetate 245. 
Yield:  307 mg (0.98 mmol), 98 % transparent oil 
 C16H24O6 [312.36 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.39 (tr, J = 4.9, 1.5 Hz, 1 H, H-3), 4.91 (d, J = 4.6 Hz, 1 H, H-2), 3.63 (d, J = 
3.0 Hz, 1 H, H-7), 3.44 (d, J = 3.0 Hz, 1 H, H-6), 2.13 (dd, J = 15.5, 5.0 Hz, 1 
H, Hax, H-4), 2.03 (s, 3 H, OCOCH3), 1.83 (dd, J = 15.5, 1.5 Hz, 1H, Heq, H-4), 
1.35 (s, 3 H, CH3), 1.31 (s, 3 H, CH3), 1.21 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.0 (Cq, OCOC(CH3)3), 169.4 (Cq, OCOCH3), 78.1/77.1 (Cq, C-1/C-5), 71.82 
(CH, C-3), 66.0 (CH, C-2), 57.8 (CH, C-6), 56.5 (CH, C-7), 38.8 (Cq, 
OCOC(CH3)3), 38.8 (CH2, C-4), 27.1 (CH3, OCOC(CH3)3), 20.6 (CH3, 
OCCH3), 19.7/16.8 (CH3, 2 x CH3). 
IR (neat): 2971 w, 2934 m, 2874 m, 1727 vs, 1368 m, 1274 m, 1234 vs, 1220 s, 1144 vs, 
1044 s, 911 m, 879 m, 859 m, 803 m, 760 m. 
EI MS (rt): no M+, 213 (22), 168 (17), 150 (17), 129 (37), 125 (37), 108 (11), 95 (70), 85 
(72), 82 (22), 69 (8), 57 (100), 43 (90), 29 (22). 
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9β-Acetyloxy-4α-pivaloyloxy-2,7-oxatricyclo-[4.2.1.03,8]-nonane rac-247 
OPiv
O
O
HO
OPiv
O
O
AcO
132 247
 
Following GP9, DMAP (4 mg, 0.03 mmol, 0.06 eq) and acetic anhydride (246 µL, 2.6 mmol, 
5.2 eq) were added to a solution of the alcohol 132(121 mg, 0.5 mmol, 1 eq) in pyridine (134 
µL) at 0°C. The mixture was stirred for 1.5 h at 0°C and then water and MTBE were added. 
Purification by column chromatography (MTBE/CH 1:4) afforded the acetate 247. 
Yield:  141 mg (0.495 mmol), 99 % white solid 
 C14H20O6 [284.31 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.23 (btr, J = 4.9 Hz, 1 H, H-3), 5.15 (s, 1 H, H-6), 5.06 (bd, J = 3.0 Hz, 1H, H-
1), 4.94 (s, 1 H, H-2), 4.92 (b, 1 H, H-5), 4.66 (d, J = 9.7 Hz, 1 H, H-7), 2.75 
(bdd, J = 13.8, 9.8 Hz, 1 H, Heq, H-4), 2.96 (s, 1 H, OCOCH3), 1.85 (dd, J = 
13.8, 8.6 Hz, 1 H, Hax, H-4), 1.18 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.7 (Cq, OCOC(CH3)3), 169.9 (Cq, OCOCH3), 88.3 (CH, C-2), 83.0 (CH, C-
5), 79.8 (CH, C-7), 78.1 (CH, C-6), 75.0 (CH, C-1), 67.7 (CH, C-3), 38.7 (Cq, 
OCOC(CH3)3), 27.6 (CH2, C-4), 27.0 (CH3, OCOC(CH3)3), 20.8 (177.7 (CH3, 
OCOCH3). 
IR (neat): 2969 w, 2873 m, 1724 vs, 1377 m, 1236 s, 1160 s, 1047 s, 988 s, 900 s, 771 m. 
EI MS (rt): no M+, 225 (6), 183 (6), 157 (8), 140 (45), 122 (55), 111 (32), 97 (12), 85 (53), 
81 (56), 69 (12), 57 (100), 43 (79), 41 (33), 29 (30). 
13. Attempts to Chapter 6 192 
 
13. Attempts to Chapter 6 
13.1 Attempts to Section 6.3 
 (7α-Pivaloyloxy-3,9-dioxatricyclo[3.3.1.02,4]non-6-yl)-methyl-amine 265 and 2-Methyl-4α-
pivaloyloxy-7-oxa-2-azatricyclo[4.2.1.03,8]nonan-9β-ol 267 
OPiv
O
NHMe
O
OPiv
O
O
O
OPiv
O
N
HO
Me
208 265 267
1  :  3
 
A mixture of oxabicyclic ketone 208 (961 mg, 4.0 mmol, 1 eq), methylamine hydrochloride 
(1.35 g, 20.0 mmol, 5 eq) triethylamine (1.2 ml, 8.8 mmol, 2.2 eq) and titanium (IV) 
isopropoxide (2.4 ml, 8.0 mmol, 2 eq) in abs MeOH (16 ml) was stirred at rt for 16 h. BH3⋅py 
(0.6 ml, 6.0 mmol, 1.5 eq) was carefully added and the resulting mixture was stirred for 4 h. 
The reaction was quenched with 1 N NaOH and the resulting inorganic precipitate was 
filtered and washed with MeOH. The filtrate was concentrated in vacuo and dissolved in 
CHCl3. The aqueous phase was extracted thoroughly with CHCl3 and the combined organic 
layer was dried (Na2SO4), evaporated and purified by column chromatography (MTBE/CH 
10:1). 
Yield:  756 mg (2.96 mmol), 74 % total yield 
 C13H21NO4 [255.31 g/mol] 
Data for product 265: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.29 (btr, J = 4.5 Hz, 1 H, H-3), 4.26 (bd, J = 3.9 Hz, 1H, H-1), 4.24 (bd, J = 
4.4 Hz, 1H, H-5), 3.72 (d, J = 3.1 Hz, 1H, H-7), 3.53 (d, J = 3.0 Hz, 1H, H-6), 
3.00 (tr, J = 4.3 Hz, 1H, H-2), 2.41 (s, 3 H, NHCH3), 2.18 (dtr, J = 15.7, 4.6 
Hz, 1 H, Hax, H-4), 1.76 (d, J = 15.7 Hz, 1H, Heq, H-4), 1.23 (s, 9 H, 
OCOC(CH3)3). 
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13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.3 (Cq, OCOC(CH3)3), 73.0 (CH, C-1), 70.8 (CH, C-5), 65.9 (CH, C-3), 
58.6 (CH, C-2), 53.8 (CH, C-6), 52.4 (CH, C-7), 38.8 (Cq, OCOC(CH3)3), 34.0 
(CH3, NHCH3), 31.9 (CH2, C-4), 27.0 (CH3, OCOC(CH3)3). 
IR (neat): 3345 w, 2957 mw, 2798 m, 1721 vs, 1480 m, 1366 m, 1282 s, 1151 vs, 1054 s, 
1034 m, 876 m, 855 s. 
EI MS (rt): 255 (6, M+), 170 (15), 157 (80), 98 (12), 85 (31), 81 (26), 73 (94), 70 (47), 57 
(100), 44 (25), 41 (39), 29 (29). 
Data for product 266: See Section 13.2. 
(1,5-Dimethyl-7α-pivaloyloxy-3,9-dioxatricyclo[3.3.1.02,4]non-6-yl)-methyl-amine 266 
OPiv
O
NHMe
O
OPiv
O
O
O
207 266
 
Method 1: A mixture of oxabicyclic ketone 207 (1.07 g, 4.0 mmol, 1 eq), methylamine 
hydrochloride (1.35 g, 20.0 mmol, 5 eq) triethylamine (1.2 ml, 8.8 mmol, 2.2 eq) and titanium 
(IV) isopropoxide (2.4 ml, 8.0 mmol, 2 eq) in abs MeOH (16 ml) was stirred at rt for 16 h. 
BH3⋅py (0.6 ml, 6.0 mmol, 1.5 eq) was carefully added and the resulting mixture was stirred 
for 4 h. The reaction was quenched with 1 N NaOH and the resulting inorganic precipitate 
was filtered and washed with MeOH. The filtrate was concentrated in vacuo and dissolved in 
CHCl3. The aqueous phase was extracted thoroughly with CHCl3 and the combined organic 
layer was dried (Na2SO4), evaporated and purified by column chromatography (CH/MTBE 
1:1) affording methylamine 266. 
Yield:  140 mg (0.495 mmol), 69 % white solid 
 C15H25NO4 [283.36 g/mol] 
Method 2: A mixture of oxabicyclic ketone 207 (107 mg, 0.4 mmol, 1 eq), methylamine 
hydrochloride (54 mg, 0.8 mmol, 2 eq) triethylamine (111 µl, 0.8 mmol, 2.0 eq) and titanium 
(IV) isopropoxide (240 µl, 0.8 mmol, 2 eq) in abs MeOH (1.6 ml) was stirred at rt for 16 h. 
NaBH4 (23 mg, 0.6 mmol, 1.5 eq) was carefully added and the resulting mixture was stirred 
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for 4 h. The reaction was quenched with 1 N NaOH and the resulting inorganic precipitate 
was filtered and washed with MeOH. The filtrate was concentrated in vacuo and dissolved in 
CHCl3. The aqueous phase was extracted thoroughly with CHCl3 and the combined organic 
layer was dried (Na2SO4), evaporated and purified by column chromatography (MTBE/CH 
1:1) affording methylamine 266. 
Yield:  79 mg (0.28 mmol), 70 % white solid 
 C15H25NO4 [283.36 g/mol] 
Data for product 266: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.30 (dtr, J = 4.8, 1.5 Hz, 1 H, H-3), 3.49 (d, J = 3.0 Hz, 1H, H-7), 3.31 (d, J = 
3.0 Hz, 1H, H-6), 2.63 (d, J = 4.6 Hz, 1H, H-2), 2.36 (s, 3 H, NHCH3), 2.02 
(dd, J = 15.6, 4.8 Hz, 1 H, Hax, H-4), 1.84 (dd, J = 15.6, 1.4 Hz, 1H, Heq, H-4), 
1.43 (CH3, C1-CH3), 1.31 (CH3, C5-CH3), 1.22 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.3 (Cq, OCOC(CH3)3), 80.1 (Cq, C-1), 76.4 (Cq, C-5), 66.1 (CH, C-3), 63.6 
(CH, C-2), 58.1 (CH, C-6), 56.6 (CH, C-7), 39.0 (Cq, OCOC(CH3)3), 38.9 
(CH2, C-4), 34.9 (CH3, NHCH3), 27.1-26.9 (CH3, OCOC(CH3)3), 19.9 (CH3, 
C5-CH3), 17.8 (CH3, C1-CH3). 
IR (neat): 3352 w, 2972 m, 2933 m, 1723 s, 1480 m, 1455 m, 1370 m, 1283 m, 1144 vs, 
991 m, 954 m, 909 m, 866 m, 806 m. 
EI MS (rt): 240 (4, M+), 182 (7), 170 (10), 157 (100), 138 (14), 127 (7), 112 (39), 96 (23), 
85 (45), 73 (96), 57 (87), 43 (33), 29 (20). 
2,6,8-Trimethyl-4α-pivaloyloxy-7-oxa-2-azatricyclo[4.2.1.03,8]nonan-9β-ol 268 
OPiv
O
O
O
OPiv
O
N
HO
Me
207 268
 
A mixture of oxabicyclic ketone 207 (537 mg, 2.0 mmol, 1 eq), methylamine hydrochloride 
(270 mg, 4.0 mmol, 2 eq) triethylamine (0.5 ml, 4.0 mmol, 2.0 eq) and titanium (IV) 
isopropoxide (1.2 ml, 4.0 mmol, 2 eq) in abs MeOH (8 ml) was stirred at rt for 16 h. NaBH4 
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(113 mg, 3 mmol, 1.5 eq) was carefully added and the resulting mixture was stirred for 36-48 
h. The reaction was quenched with 1 N NaOH and the resulting inorganic precipitate was 
filtered and washed with MeOH. The filtrate was concentrated in vacuo and dissolved in 
CHCl3. The aqueous phase was extracted thoroughly with CHCl3 and the combined organic 
layer was dried (Na2SO4), evaporated and purified by column chromatography (MTBE/CH 
1:1) affording azetidine 268. 
Yield:  408 mg (1.44 mmol), 72 % white solid 
 C15H25NO4 [283.36 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
4.89 (dd, J = 8.9, 2.9 Hz, 1 H, H-3), 3.91 (s, 1 H, H-6), 3.27 (b, 1H, H-7), 3.25 
(bd, 1 H, H-2), 2.56 (s, 3 H, NHCH3), 2.28 (ddd, J = 13.3, 8.6, 0.8 Hz, 1 H, 
Heq, H-4), 1.92 (dd, J = 13.3, 9.2 Hz, 1H, Hax, H-4), 1.60 (CH3, C1-CH3), 1.42 
(CH3, C5-CH3), 1.18 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.9 (Cq, OCOC(CH3)3), 83.9 (Cq, C-5), 80.6 (CH, C-6), 80.0 (CH, C-7), 79.8 
(Cq, C-1), 69.9 (CH, C-2), 69.5 (CH, C-3), 42.5 (CH3, NHCH3), 38.7 (Cq, 
OCOC(CH3)3), 35.1 (CH2, C-4), 27.1 (CH3, OCOC(CH3)3), 22.5 (CH3, C1-
CH3), 22.0 (CH3, C5-CH3). 
IR (neat): 3435 w, 2970 m, 2930 mw, 2784 m, 1726 vs, 1454 m, 1372 m, 1281 m, 1157 
vs, 1140 vs, 1057 m, 989 m. 
EI MS (rt): 284 (15, M+), 268 (6), 240 (10), 198 (9), 182 (34), 164 (17), 152 (14), 138 (36), 
127 (33), 112 (69), 109 (86), 96 (59), 85 (30), 84 (34), 73 (48), 70 (100), 57 
(90), 42 (70), 29 (46). 
EA: Anal. Calcd for C15H25NO4 : C, 63.58; H, 8.89; N, 4.94. Found: C, 62.90; H, 
8.61; N, 5.41. 
4α-Methoxy-2,6,8-trimethyl-7-oxa-2-azatricyclo[4.2.1.03,8]nonan-9β-ol 270 
OMe
O
O
O
OMe
O
N
HO
Me
214 270
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A mixture of oxabicyclic ketone 214 (793 mg, 4 mmol, 1 eq), methylamine hydrochloride 
(540 mg, 8 mmol, 2 eq) triethylamine (1.2 ml, 8.8 mmol, 2.2 eq) and titanium (IV) 
isopropoxide (2.4 ml, 8.0 mmol, 2 eq) in abs MeOH (16 ml) was stirred at rt for 16 h. BH3⋅py 
(0.6 ml, 6 mmol, 1.5 eq) was carefully added and the resulting mixture was stirred for an 
additional 4 h. The reaction was quenched with 1 N NaOH and the resulting inorganic 
precipitate was filtered and washed with EtOH. The filtrate was concentrated in vacuo and 
dissolved in CHCl3. The aqueous phase was extracted thoroughly with CHCl3 and the 
combined organic layer was dried (Na2SO4), evaporated and purified by column 
chromatography (MTBE/MeOH 10:1) obtaining azetidine 270. 
Yield:  141 mg (0.495 mmol), 51 % white solid 
 C11H19NO3 [213.27 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
3.90 (s, 1 H, H-6), 3.44 (dtr, J = 8.7, 3.1 Hz, 1 H, H-3), 3.32 (s, 3 H, OCH3), 
3.27 (bd, 1H, H-2), 3.22 (b, H-7), 2.60 (s, 3 H, NHCH3), 2.25 (ddd, J = 13.5, 
8.5, 1.0 Hz, 1 H, Heq, H-4), 1.84 (dd, J = 13.5, 9.0 Hz, 1H, Hax, H-4), 1.60 
(CH3, C1-CH3), 1.41 (CH3, C5-CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
83.8 (Cq, C-5), 81.0 (CH, C-6), 80.2 (CH, C-7), 79.6 (Cq, C-1), 75.3 (CH, C-3), 
69.4 (CH, C-2), 56.0 (CH3, OCH3), 43.6 (CH3, NHCH3), 35.8 (CH2, C-4), 22.9 
(CH3, C1-CH3), 22.1 (CH3, C5-CH3). 
IR (neat): 3412 w, 2970 m, 2930 mw, 1738 m, 1454 m, 1371 s, 1206 s, 1093 vs, 1060 s, 
952 s. 
EI MS (rt): 213 (11, M+), 141 (45), 109 (71), 101 (42), 96 (51), 87 (77), 70 (100), 56 ( 16), 
43 (71), 29 (16). 
EA: Anal. Calcd for C11H19NO3 : C, 61.95; H, 8.98; N, 6.57. Found: C, 58.89; H, 
9.08; N, 6.39. 
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(7α-Pivaloyloxy-3,9-dioxatricyclo[3.3.1.02,4]non-6-yl)-ethyl-amine 271 
OPiv
O
NHEt
O
OPiv
O
O
O
208 271
 
To a suspension of powdered and activated 4 Å molecular sieves (150 mg) in abs. MeOH (2.4 
ml) were added sequentially oxabicyclic ketone (144 mg, 0.60 mmol, 1 eq), ethylamine 
hydrochloride (98 mg, 1.20 mmol, 2 eq), triethylamine (183 µl, 1.32 mmol, 2.2 eq) and 
pyridine-borane (85 µl, 0.84 mmol, 1.4 eq). After 16 h, the resulting mixture was treated with 
aq. 2 N HCl until pH<2 and left stirring for 30 min. Methanol was removed in vacuo and the 
aqueous layer was extracted with CHCl3 (3x). Then the aqueous layer was brought to pH>10 
by addition of 2 N NaOH and after several extractions with CHCl3, the combined extracts 
were dried (Na2SO4) and evaporated. Purification of the crude extract by column 
chromatography (MTBE/CH 3:1) afforded ethylamine 271.  
Yield:  141 mg (0.495 mmol), 24 % white solid 
 C14H23NO4 [269.34 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.27 (trm, J = 4.6 Hz, 1 H, H-3), 4.24 (bs, 1H, H-1), 4.23 (bs, 1H, H-5), 3.73 
(d, J = 3.0 Hz, 1H, H-7), 3.53 (d, J = 3.1 Hz, 1H, H-6), 3.11 (btr, J = 4.3 Hz, 
1H, H-2), 2.62 (m, 2 H, NHCH2CH3), 2.22 (dtr, J = 15.7, 4.6 Hz, 1 H, Hax, H-
4), 1.76 (bd, J = 15.7 Hz, 1H, Heq, H-4), 1.23 (s, 9 H, OCOC(CH3)3), 1.7 (tr, 3 
H, J = 7.15 Hz, NHCH2CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.3 (Cq, OCOC(CH3)3), 73.7 (CH, C-1), 70.9 (CH, C-5), 66.3 (CH, C-3), 
56.6 (CH, C-2), 53.9 (CH, C-6), 52.7 (CH, C-7), 41.5 (CH2, NHCH2CH3), 38.9 
(Cq, OCOC(CH3)3), 32.0 (CH2, C-4), 27.2 (CH3, OCOC(CH3)3), 15.5 (CH3, 
NHCH2CH3) 
IR (neat): 2976 m, 2928 m, 1749 s, 1717 vs, 1446 m, 1368 m, 1279 s, 1237 s, 1141 vs, 
1088 s, 953 s, 851 s. 
EI MS (rt): 297 (2, M+), 281 (2), 259 (3), 212 (2), 196 (6), 184 (8), 171 (79), 126 (19), 87 
(100), 84 (53), 57 (77), 43 (23), 29 (16). 
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 (1,5-Dimethyl-7α-pivaloyloxy-3,9-dioxatricyclo[3.3.1.02,4]non-6-yl)-ethyl-amine 272 
OPiv
O
NHEt
O
OPiv
O
O
O
207 272
 
A mixture of oxabicyclic ketone 207 (268 mg, 1.0 mmol, 1 eq), ethylamine hydrochloride 
(163 mg, 2.0 mmol, 2 eq) triethylamine (0.3 ml, 2.2 mmol, 2.2 eq) and titanium (IV) 
isopropoxide (0.6 ml, 2.2 mmol, 2 eq) in abs MeOH (4 ml) was stirred at rt for 16 h. NaBH4 
(57 mg, 1.5 mmol, 1.5 eq) was carefully added and the resulting mixture was stirred for an 
additional h. The reaction was quenched with 1 N NaOH and the resulting inorganic 
precipitate was filtered and washed with MeOH. The filtrate was concentrated in vacuo and 
dissolved in CHCl3. The aqueous phase was extracted thoroughly with CHCl3 and the 
combined organic layer was dried (Na2SO4), evaporated and purified by column 
chromatography (MTBE/CH 1:4) and ethylamine 272 was isolated.  
Yield:  36 mg (0.12 mmol), 12 % white solid 
 C16H27NO4 [297.39 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.26 (dtr, J = 4.8, 1.4 Hz, 1 H, H-3), 3.50 (d, J = 3.0 Hz, 1H, H-7), 3.31 (d, J = 
3.0 Hz, 1H, H-6), 2.71 (d, J = 4.8 Hz, 1H, H-2), 2.65 (dq, J = 11.2, 7.1 Hz, 1 H, 
NHCH2CH3), 2.48 (dq, J = 11.2, 7.1 Hz, 1 H, NHCH2CH3), 2.02 (dd, J = 15.6, 
4.8 Hz, 1 H, Hax, H-4), 1.84 (dd, J = 15.6, 1.4 Hz, 1H, Heq, H-4), 1.43 (CH3, 
C1-CH3),1.31 (CH3, C5-CH3), 1.22 (s, 9 H, OCOC(CH3)3), 1.7 (tr, 3 H, J = 7.1 
Hz, NHCH2CH3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.3 (Cq, OCOC(CH3)3), 80.2 (Cq, C-1), 76.4 (Cq, C-5), 66.8 (CH, C-3), 61.4 
(CH, C-2), 58.2 (CH, C-6), 56.7 (CH, C-7), 41.4 (CH2, NHCH2CH3), 39.0 
(CH2, C-4), 38.9 (Cq, OCOC(CH3)3), 27.2 (CH3, OCOC(CH3)3), 19.9 (CH3, 
C5-CH3), 17.7 (CH3, C5-CH3), 15.6 (CH3, NHCH2CH3). 
IR (neat): 3401 w, 2970 mw, 2937 m, 2874 m, 1724 s, 1282 m, 1146 vs, 1069 m, 1027 m, 
930 m. 
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13.2 Attempts to Section 6.4 
2-Methyl-4α-pivaloyloxy-7-oxa-2-azatricyclo[4.2.1.03,8]nonan-9β-ol 267 
OPiv
O
NHMe
O
OPiv
O
N
HO
Me
265 267
 
Methylamine 265 (120 mg, 0.47 mmol, 1 eq) was dissolved in THF (4.7 ml) and cooled to 
0°C. Vinylmagnesiumbromide solution (1 M in THF, 0.61 ml, 0.61 mmol, 1.3 eq) was added 
dropwise and the mixture was stirred at rt until completion of the reaction. After addition of 
aq. NH4Cl solution and sat. aq. Na,K tartrate solution, the aqueous phase was extracted with 
MTBE. The combined organic layer was dried (Na2SO4), evaporated and purified by column 
chromatography (MTBE/MeOH 10:1) to afford azetidine 267.  
Yield:  141 mg (0.495 mmol), 71 % white solid 
 C13H21NO4 [255.31 g/mol] 
Data for azetidine 267: 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.15 (dd, J = 7.1, 5.1 Hz, 1 H, H-1), 4.88 (dd, J = 8.8, 3.0 Hz, 1H, H-3), 4.47 
(dd, J = 8.9, 0.9 Hz, 1H, H-5), 4.20 (s, 1 H, H-6), 3.61 (dd, J = 5.2, 1.5 Hz, 1H, 
H-7), 3.52 (dd, J = 7.2, 1.5 Hz, 1H, H-2), 2.61 (ddd, J = 13.6, 9.2, 1.0, 1 H, 
Hax, H-4), 2.53 (s, 3 H, NHCH3), 2.00 (ddd, J = 13.5, 8.8, 0.9 Hz, 1H, Heq, H-
4), 1.28 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
177.7 (Cq, OCOC(CH3)3), 81.1 (CH, C-5), 78.4 (CH, C-6), 75.4 (CH, C-7), 
73.1 (CH, C-1), 68.3 (CH, C-3), 66.3 (CH, C-2), 42.5 (CH3, NHCH3), 38.7 (Cq, 
OCOC(CH3)3), 28.4 (CH2, C-4), 27.1 (CH3, OCOC(CH3)3). 
IR (neat): 3401 w, 2970 mw, 2937 m, 2874 m, 1724 s, 1282 m, 1146 vs, 1069 m, 1027 m, 
930 m. 
EA: Anal. Calcd for C13H21NO4 : C, 61.16; H, 8.29; N, 5.49. Found: C, 59.19; H, 
8.07; N, 5.25. 
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2,6,8-Trimethyl-4α-pivaloyloxy-7-oxa-2-azatricyclo[4.2.1.03,8]nonan-9β-ol 268 
OPiv
O
OPiv
O
NHMe
O
N
HO
Me
266 268
 
Methylamine 266 (57 mg, 0.20 mmol, 1 eq) was dissolved in THF (2 ml) and cooled to 0°C. 
Vinylmagnesiumbromide solution (1 M in THF, 260 µl, 0.26 mmol, 1.3 eq) was added 
dropwise and the mixture was stirred at rt until completion of the reaction. After addition of 
aq. NH4Cl solution and sat. aq. Na,K tartrate solution, the aqueous phase was extracted with 
MTBE. The combined organic layer was dried (Na2SO4), evaporated and purified by column 
chromatography (MTBE/CH 1:1) to afford azetidine 268.  
Yield:  47 mg (0.166 mmol), 83 % white solid 
 C15H25NO4 [283.36 g/mol] 
Data for product 268: See Section 13.1. 
13.3 Attempts to Section 6.6 
2,6,8-Trimethyl-4α-pivaloyloxy-7-oxa-2-azatricyclo[4.2.1.03,8]nonan-9-one 301 
OPiv
O
N
O
Me
OPiv
O
N
HO
Me
268 301
 
To a solution of oxalyl chloride (94 µL, 1.12 mmol, 4 eq) in DCM (5.7 ml) was added DMSO 
(84 µL, 1.18 mmol, 4.2 eq) at –78°C. A solution of azetidine 268 (79 mg, 0.28 mmol, 1 eq) in 
DCM (2.8 ml) was syringed and the mixture was stirred at –78°C for 1 h. Triethylamine (0.35 
ml, 2.52 mmol, 9 eq) was added in the solution and the mixture was stirred at –78°C for 1 h 
and at rt for 1 h. DCM was evaporated in vacuo and the residue was dissolved in MTBE and 
water. The aqueous phase was extracted with MTBE and the combined organic extracts were 
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dried (N2SO4) and evaporated. Purification by column chromatography (MTBE/CH 2:1) 
afforded ketone 301. 
Yield:  44 mg (0.155 mmol), 55 % yellowish solid 
 C15H23NO4 [281.35 g/mol] 
1H-NMR:  (400 MHz, CDCl3 with TMS) 
5.13 (ddd, J = 9.5, 8.5, 3.4 Hz, 1 H, H-3), 3.85 (d, J = 3.4 Hz 1H, H-2), 3.51 (s, 
1 H, H-7), 2.43 (dd, J = 14.4, 9.5 Hz, 1 H, Heq, H-4), 2.37 (s, 3 H, NHCH3), 
1.60 (CH3, C1-CH3), 1.42 (dd, J = 14.4, 8.5 Hz, 1H, Hax, H-4), 1.38 (CH3, C5-
CH3), 1.19 (s, 9 H, OCOC(CH3)3). 
13C-NMR:  (100 MHz, CDCl3 with TMS) 
208.4 (Cq, C-6), 177.4 (Cq, OCOC(CH3)3), 81.1 (Cq, C-5), 76.9 (Cq, C-1), 71.3 
(CH, C-7), 69.1 (CH, C-2), 67.7 (CH, C-3),38.6 (Cq, OCOC(CH3)3), 35.7 (CH3, 
NHCH3), 33.6 (CH2, C-4), 27.1 (CH3, OCOC(CH3)3), 20.9 (CH3, C5-CH3), 
20.1 (CH3, C1-CH3). 
IR (neat): 2976 m, 2928 m, 1749 s, 1717 vs, 1446 m, 1368 m, 1279 s, 1237 s, 1141 vs, 
1088 s, 953 s, 851 s. 
ESI MS: Calcd for C15H23NO4: 281.1627. Found: 281.0425. 
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